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Abstract 
DNA damage response (DDR) pathways are essential in maintaining genomic 
integrity in cells, but many DDR proteins have other important functions such as in the 
innate immune sensing of cytoplasmic DNA. Some DDR proteins are known to be 
beneficial or restrictive to viral infection, but most remain uncharacterised in this 
respect. Non-homologous end joining (NHEJ) is a mechanism of double stranded DNA 
(dsDNA) repair that functions to rapidly mend broken DNA ends. The NHEJ machinery 
is well characterised in the context of DDR but recent studies have linked the same 
proteins to innate immune DNA sensing and, hence, anti-viral responses. The aim of this 
thesis is to further investigate the interplay between herpes simplex virus 1 (HSV-1), a 
dsDNA virus, and two NHEJ proteins, DNA protein kinase catalytic subunit (DNA-
PKcs) and paralogue of XRCC4 and XLF (PAXX).  
PAXX was first described in the literature as a NHEJ protein in 2015, but whether it 
has any role in the regulation of virus infection has not been established. Here we show 
that PAXX acts as a restriction factor for HSV-1 because PAXX-/- (KO) cells produce a 
consistently higher titre of HSV-1 than the respective wild type (WT) cells. We 
hypothesised that this could be due to a role of PAXX binding viral DNA and directly 
inhibiting HSV-1 replication or activating an anti-viral innate immune response. We 
have been able to, at least partially, rule out both of these initial hypotheses by showing 
that there was a reduced number of viral genomes present in KO cells during active lytic 
infection, and that an identical level of type I interferons are produced from WT and KO 
cells during HSV-1 infection. Although further characterisation of HSV-1 infection in WT 
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and KO cells has not defined the molecular mechanism of restriction of HSV-1 by PAXX, 
we have uncovered a potential role for PAXX in mitogen-activated protein kinase 
(MAPK) signalling. In addition, and consistent with its function in restriction of HSV-1 
infection, we show that infection with this virus in WT cells induces a loss of nuclear 
PAXX protein. Preliminary data suggest that these changes in localisation may occur as a 
result of stimulation of the cells with DNA, but not the RNA analogue poly(I:C). 
The role of PAXX in the regulation of HSV-1 infection in vivo was investigated by 
studying KO mice. Despite previous observations that mice lacking NHEJ proteins have 
brain defects related to autoinflammatory pathology, there were no obvious defects in 
the development of Paxx-/- mice, and they had brains of normal weight. No significant 
difference in viral spread or viral protein expression was observed between WT and KO 
HSV-1 infected mice, and KO mice did not exhibit abnormal pathology. There were, 
however, small but significant differences in the cellular immune response to infection 
which might be explained by reduced MAPK signalling in KO cells. 
DNA-PKcs is another component of the NHEJ machinery that acts to assist in 
dsDNA break repair in the nucleus and as an innate sensor of cytoplasmic viral DNA, 
but the effect of DNA-PKcs on HSV-1 infection has not been fully explored. Murine skin 
fibroblasts (MSFs) derived from wild type and PRKDC-/- (DNA-PKcs deficient) mice 
were cultured ex vivo and used for innate immune studies. Although HSV-1 was able to 
infect and stimulate these cells, no differences in the stimulation of innate immune gene 
expression between the two genotypes was observed, suggesting that DNA-PKcs does 
not contribute to HSV-1 sensing in MSFs. It has previously been reported that the HSV-1 
protein ICP0 targets DNA-PKcs for degradation, although the reason for this is 
unknown. We confirmed these data, although found it to be cell-type specific and 
explored this interaction further using PRKDC-/- RPE-1 cells created using CRISPR/Cas9. 
HSV-1 infection in these cells followed unusual dynamics, and the development of 
cytopathic effect was accelerated as compared to WT cells. Together these observations 
confirm that DNA-PKcs regulates HSV-1 infection, but more work is required to fully 
understand the mechanisms involved. 
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1 Introduction 
1.1 The DNA Damage Response 
1.1.1 Introduction to the DNA Damage Response 
The genome of an organism is frequently damaged by a wide range of exogenous 
and endogenous processes. Exogenous factors include ionizing radiation, infection 
(Chumduri et al., 2016), and mutagenic chemicals, while endogenous factors include 
reactive oxygen species (ROS), errors in genome replication, and dysregulation of gene 
expression (Tubbs and Nussenzweig, 2017). It is estimated that on average each cell 
incurs over 100 genomic lesions daily (Lindahl, 1993), and each of these can interfere 
with genome replication and gene transcription. If the cell fails to repair lesions correctly 
mutations can arise, genome stability can be compromised, and cell and/or organism 
viability can be put at risk. Cancer, for example, arises following the accumulation of 
mutations in a cell genome which deregulate important homeostatic processes and result 
in further genomic instability. 
To address the threat posed by DNA damage, mammalian cells have evolved 
complex and interlinked pathways collectively termed the DNA damage response 
(DDR). In addition to attempting to repair damaged DNA, the DDR controls activation 
of cell-cycle checkpoints (Iliakis et al., 2003), modifies chromatin (Price and D’Andrea, 
2013), and controls transcription (Khanna and Jackson, 2001). If the damage of the DNA 
is too great, the DDR can induce various forms of cell death including apoptosis and 
necrosis (Surova and Zhivotovsky, 2013). DNA lesions can take a variety of forms, and 
the DDR responds to and repairs damaged DNA using complexes and pathways specific 
to the lesion type and extent of damage. These range from the replacement of damaged 
or mismatched nucleotides using base excision repair (BER), nucleotide excision repair 
(NER), or mismatch repair (MMR), to the religation of double-strand breaks (DSBs) 
using homologous recombination (HR) pathways or non-homologous end joining 
(NHEJ). 
DSBs are the most toxic form of lesion, of which there are an estimated ten per day 
per cell (Davis and Chen, 2013; Martin et al., 1985). The requirements for the repair of 
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DSBs are different for HR and NHEJ, and the fidelity of these two pathway types also 
varies greatly. HR uses the sister chromatid as a template for repair which allows for 
faithful repair of DSBs. In contrast NHEJ does not use a template and religates free ends 
regardless of sequence, and so is error-prone and is more likely to introduce mutations. 
In human cells, most DSBs are repaired by NHEJ, and, although there are times where 
NHEJ is necessary because the sister chromatid is not nearby or because the DSB 
occurred outside of the synthesis phase (S-phase) or second growth phase (G2) of the cell 
cycle, it is not known why mammalian cells have evolved to preferentially use NHEJ 
over HR in situations where both pathways are possible (Lieber, 2010; Liu et al., 2014). 
We shall now review the mechanisms of both NHEJ and HR before considering their 
roles during viral infection. 
1.1.2 Classical NHEJ  
1.1.2.1 Overview  
There are two different NHEJ pathways in mammals: the classical NHEJ (C-NHEJ) 
pathway and the alternative NHEJ (A-NHEJ) pathway (Davis and Chen, 2013; Lieber, 
2010). A-NHEJ is an MRN (comprising MRE11 (Meiotic recombination 11 homolog), 
RAD50, and NBS1 (Nijmegen Breakage Syndrome 1))-dependent, Ku-independent 
pathway that is more error-prone than C-NHEJ, resulting in chromosome translocations 
and large deletions (Della-Maria et al., 2011). A-NHEJ is not used as often as C-NHEJ, 
which is the pathway of primary interest for this thesis. C-NHEJ is initiated when the 
Ku70/Ku80 heterodimer recognises and binds to the free ends of DNA at a DSB in a 
sequence-independent manner, an event which occurs within seconds of laser-generated 
DSB formation (Mari et al., 2006). The Ku heterodimer then acts as a scaffold to recruit 
other C-NHEJ factors (Davis and Chen, 2013). One such factor, the DNA-dependent 
protein kinase (DNA-PK) catalytic subunit (DNA-PKcs), binds the Ku heterodimer in a 
DNA-dependent manner to form the DNA-PK complex (Gottlieb and Jackson, 1993). 
Subsequent autophosphorylation of DNA-PKcs regulates the early stages of C-NHEJ, 
depicted in Figure 1 (Uematsu et al., 2007). Independently of DNA-PKcs recruitment, Ku 
also recruits X-ray cross-complementing protein 4 (XRCC4) and XRCC4-like factor (XLF) 
(Costantini et al., 2007; Mari et al., 2006; Nick McElhinny et al., 2000; Yano and Chen, 
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2008; Yano et al., 2008). XRCC4 does not have any known enzymatic activity in NHEJ, 
but may act as a scaffold for other factors such as DNA ligase IV (LIG4). Indeed, XRCC4 
and XLF can form a filament which has been proposed to act as a bridge between DSB 
Figure 1: Schematic overview of C-NHEJ.  
1) Linear DNA. 2) A DSB caused by genotoxic damage is bound by the Ku70/80 heterodimer, which slides 
along the DNA to make room for subsequent complex formation. 3) DNA-PKcs binds to the Ku70/80 
heterodimer. 4) Factors, including aprataxin, APLF, PNKP, Artemis, WRN, Polλ, and Polμ modify the 
ends of the DNA if necessary. 5) PAXX and/or XLF bind Ku70/80 and recruit the XRCC4/LIG4 complex, 
which in turn ligates the DNA ends together. 
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ends. Ligation of the blunt ends of the DSB is then achieved by an XRCC4-LIG4-XLF 
complex. Paralogue of XRCC4 and XLF (PAXX) also binds to Ku and acts to stabilise the 
NHEJ complex (Ochi et al., 2015).  
Although the above pathway can be sufficient for DSB ligation, in many cases the 
structure of the free ends must first be modified (Davis and Chen, 2013). 5’ or 
3’ overhangs must either be cleaved off by the factors Ku (Choi et al., 2014; Roberts et al., 
2010), polynucleotide kinase-phosphatase (PNKP) (Bernstein et al., 2005), and aprataxin 
(Ahel et al., 2006), or the complementary strand filled in to recreate the duplex structure 
by the DNA polymerases μ and λ. 5’ hydroxyl groups and 3’ phosphate groups must be 
removed by the aprataxin-and-PNK-like factor (APLF) (Li et al., 2011), Artemis (Ma et al., 
2002; Povirk et al., 2007), and WRN (Werner Syndrome) (Perry et al., 2006). After these 
modifications, LIG4-dependent ligation can proceed as described. 
Having provided the context of C-NHEJ, we shall now discuss in more detail the 
roles of PAXX and DNA-PKcs, the two proteins of primary interest to this thesis. 
Henceforth C-NHEJ shall simply be termed NHEJ. 
1.1.2.2 PAXX 
PAXX, also known as XRCC4-like-small protein (XLS), is the most recently-
discovered NHEJ factor (Craxton et al., 2015; Ochi et al., 2015; Xing et al., 2015). Despite 
its name, it has not been determined that PAXX is a paralogue of XRCC4 and XLF in the 
strictest sense, but the potential misnomer arises due to its structural similarity to these 
proteins (Figure 2A). It is also true that the N-terminal sequences of these proteins have 
high sequence similarity, and the general domain structures are similar to that of PAXX 
(Figure 2B). PAXX also forms a homodimer in a similar manner to XLF and XRCC4 
(Ochi et al., 2015). In contrast the C-termini of these proteins are more variable, and may 
help define their different functions. The long C-terminal tail of PAXX is required for 
binding to Ku, whilst XRCC4 binds to the N-terminal head domain (Costantini et al., 
2007) and Figure 2C).  
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Following DSB formation PAXX is rapidly recruited through a direct interaction 
between the C-terminus of PAXX and a DNA-bound Ku heterodimer , but not with 
DNA itself (Ochi et al., 2015). PAXX stabilises the NHEJ complex, and cells without 
PAXX are more sensitive to induction of DSBs, although the requirement of PAXX is 
Figure 2: Schematic overview of PAXX structure.  
A) Models of the structures of PAXX, XRCC4, and the other members of the XRCC4-superfamily, XLF 
and SAS6, are overlaid to show structural similarity. Figure from Ochi et al. 2015. B) Structure of the 
PAXX gene, including the PISA motif which is common amongst the XRCC4-superfamily. C) Simplified 
structure of PAXX showing the location of the key domains. 
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dependent on the structure of the break; PAXX is redundant with XLF in the repair of 
‘simple’ DSBs which require little processing prior to ligation, but acts in concert with 
XLF for ‘complex’ DSBs where more processing of the DNA ends is required (Chang et 
al., 2016; Kumar et al., 2016; Liu et al., 2017; Xing et al., 2015).  
In contrast to the phylogenetically-conserved XRCC4 and XLF, PAXX is not present 
in most invertebrates or yeast (Xing et al., 2015), leading to the hypothesis that PAXX 
evolution has been shaped by V(D)J recombination (Mistrik and Bartek, 2015), a process 
required for the creation of T cell receptor diversity (described in more detail in Section 
1.3.3.1). However, PAXX and XLF show functional redundancy in V(D)J recombination 
(Lescale et al., 2016; Tadi et al., 2016), and PAXX is not required for the production of 
lymphocytes (Balmus et al., 2016). Paxx-/- mice are viable, fertile, and grow normally 
despite radiosensitivity (Balmus et al., 2016). In contrast Paxx-/-Xlf-/- mice exhibit synthetic 
lethality, and most embryos die before birth (Balmus et al., 2016; Liu et al., 2017). 
1.1.2.3 DNA-PKcs 
DNA-PKcs is a 469 kDa protein encoded by the PRKDC (protein kinase, DNA-
activated, catalytic polypeptide) gene in humans. It was originally discovered as a 
regulator of SP1 (specificity protein 1) transcription complexes (Jackson et al., 1990), but 
has since been shown to have a key role in NHEJ and the DDR (Blunt et al., 1995). 
Although at high concentrations DNA-PKcs is able to bind to DNA in the absence of Ku 
(Yaneva et al., 1997), DNA-dependent binding to Ku is required for its serine/threonine 
kinase activity (Gottlieb and Jackson, 1993; Yoo and Dynan, 1999). 
DNA-PKcs is a member of the phosphatidylinositol-3 (PI-3) kinase-like kinase 
(PIKK) family (Abraham, 2004; Hartley et al., 1995). This family includes two other 
proteins with important roles in the DDR, namely ataxia-telangiectasia mutated (ATM) 
and ATM and RAD3-related (ATR). ATM is responsible for orchestrating HR (Section 
1.1.3), while ATR mediates ATR-CHK1 (checkpoint kinase 1) pathways in response to 
regions of single-stranded DNA (ssDNA) next to double-stranded DNA (dsDNA) 
(Maréchal and Zou, 2013). The N-terminus of the PIKK family proteins contains 
Huntington-elongation-A-subunit-TOR (HEAT) repeats which are thought to act as 
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protein-protein interaction interfaces and allow flexibility in the arms of the N-terminal 
pincer shape (Figure 3A) (Perry and Kleckner, 2003; Sibanda et al., 2010). The largely α-
helical N-terminus of DNA-PKcs also contains a leucine rich region (LRR) between 
amino acid residues 1,503 and 1,602 which has been attributed to giving DNA-PKcs its 
affinity for DNA (Gupta and Meek, 2005). This region is situated within the centre of the 
pincer shape formed by the N-terminus and is thought to reside in the channel through 
which the DNA passes (Figure 3B) (Sibanda et al., 2010; Williams et al., 2008). The C-
terminal region is positioned on top of the N-terminal pincer. In vitro experiments 
determined that the Ku heterodimer binds to the DNA-PKcs amino acid residues 3,002-
Figure 3: Domains of the PRKDC gene and DNA-PKcs protein  
A) A map of PRKDC showing some of the key domains is shown. B) Some of the key domains of DNA-PKcs 
are mapped to a simplified cartoon of the structure of DNA-PKcs. 
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3,850 within the C-terminus (Jin et al., 1997), but the N-terminus is also required for the 
interaction with Ku (Davis et al., 2013). Structurally, the FAT (focal adhesion targeting) 
and FATC (FRAP, ATM, TRRAP C-terminal) domains are adjacent to the kinase domain 
and probably regulate the kinase activity of DNA-PKcs following DNA binding and 
mediate binding to other proteins (Lempiäinen and Halazonetis, 2009; Rivera-Calzada et 
al., 2005). 
Although DNA-PKcs is not required for the recruitment of XRCC4 and XLF during 
NHEJ, it is critical for the NHEJ process (Dobbs et al., 2010; Kurimasa et al., 1999a). In the 
DDR, DNA-PKcs phosphorylates a large number of proteins including p53 (Lees-Miller 
et al., 1992), the Ku heterodimer (Chan et al., 1999; Douglas et al., 2005), H2AX (histone 
2A variant) (Mukherjee et al., 2006; Stiff et al., 2004), XLF (Yu et al., 2008), XRCC4 (Lee et 
al., 2004; Yu et al., 2003), Artemis (Ma et al., 2005), LIG4 (Wang et al., 2004), and WRN 
(Perry et al., 2010; Yannone et al., 2001). There are also over 40 autophosphorylation sites 
identified within DNA-PKcs (Dobbs et al., 2010), and it has been proposed that the 
autophosphorylation of different sites has different outcomes, not only in DNA-PK-
mediated DNA repair, but also in determining DNA repair pathway choice (Cui et al., 
2005). 
For the purpose of this thesis we are primarily interested in the ability of DNA-PKcs 
to restrict herpes simplex virus 1 (HSV-1) infection. DNA-PKcs is known to sense 
cytoplasmic DNA species and induce an innate immune response (Section 1.3.1.2, 
Ferguson et al., 2012), but the importance of this during HSV-1 infection has not been 
fully characterised and there may be mechanisms outside of innate sensing which 
contribute to this restriction, such as interfering with replication of the viral genome 
(Section 1.2.6). 
DNA-PKcs also has functions in cell death, most notably apoptosis. DNA-PKcs and 
Ku contribute to the induction of apoptosis following shortening of the telomeres 
(Espejel et al., 2002a, 2002b), and inhibition of DNA-PK results in a diversion from 
apoptosis to necrosis following cisplatin treatment (Sand-Dejmek et al., 2011). DNA-PKcs 
and ATM differentially phosphorylate p53; whereas DNA-PK promotes apoptosis, ATM 
induces cell-cycle arrest (Wang et al., 2000). However, DNA-PK can also inhibit 
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apoptosis by activating Akt (Stronach et al., 2011) or stabilising apoptotic regulators such 
as receptor-interacting protein 1 (RIP1) and inhibitor of apoptosis proteins (IAPs) (Wang 
et al., 2017). DNA-PKcs is degraded during apoptosis (McConnell et al., 1997; Song et al., 
1996), and it has been hypothesised that this is to suppress pro-survival signals from 
DNA-PK (Bernstein et al., 2002). DNA-PKcs has also been implicated in necroptosis 
(Baritaud et al., 2012). 
DNA-PKcs has multiple other functions outside of NHEJ and viral restriction, and 
although coverage of the full extent of its roles is beyond the scope of this thesis, we will 
briefly address some of the salient points. DNA-PKcs activity has repeatedly been linked 
to various cancers, and for that reason there has been a lot of research into the inhibitors 
of DNA-PKcs for their potential uses as cancer therapeutics (Curtin, 2012; Goodwin and 
Knudsen, 2014). For instance, upregulation of DNA-PKcs is linked to resistance to 
radiotherapy and DNA damaging agents used in cancer treatment (Beskow et al., 2009; 
Shintani et al., 2003). Interestingly, even in the absence of DNA-damaging agents, 
DNA-PKcs expression correlates with poor prognosis for a number of cancer types 
(Goodwin and Knudsen, 2014; Hosoi et al., 2004; Tonotsuka et al., 2006; Xing et al., 2008). 
DNA-PK is also activated by hypoxia in the absence of DSBs, and does not result in 
subsequent recruitment of XRCC4, XLF, and LIG4 (Bouquet et al., 2011). In this context 
DNA-PK promotes cellular survival during hypoxia by positively regulating 
hypoxia-inducible factor-1 alpha (HIF-1α), a transcription factor which regulates genes 
required for adaptation to hypoxic conditions (Kang et al., 2008). DNA-PK also has roles 
in cellular metabolism, for example in the regulation of lipogenesis in response to insulin 
(Wong et al., 2009), and by phosphorylating AMP-activated protein kinase (AMPK), a 
master switch controlling the cellular response to changing energy levels (Amatya et al., 
2012). In addition the DNA-PK components localise to telomeres and are essential for 
telomere capping (Bailey et al., 1999; d’Adda di Fagagna et al., 2001; Gilley et al., 2001; 
Goytisolo et al., 2001).  
1.1.3 Homology-mediated repair 
Homology-mediated repair is the umbrella term for DNA repair pathways which 
repair lesions using a homologous sequence. These pathways include homologous 
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recombination (HR), single-strand annealing (SSA), and microhomology-mediated end 
joining (MMEJ). HR is the main pathway used, and is generally the main 
homology-mediated pathway of interest during viral infection (Section 1.2).  
HR (reviewed by Heyer et al. 2010; Maréchal & Zou 2013) is initiated when the MRN 
complex senses a DSB. MRN then activates ATM, the PIKK responsible for mediating 
HR, which has a large number of phosphorylation targets including H2AX, a histone 
variant found in 2 - 25 % of nucleosomes which helps mediate DSB DNA repair 
(Rogakou et al., 1998) Phosphorylated H2AX (γH2AX) recruits downstream effectors to 
the lesion site. Replication protein A 1 (RPA1) binds to single-stranded DNA (ssDNA) to 
remove secondary structures and allow for RAD51 (Ras associated with diabetes 51) 
filament assembly which is responsible for performing a search for homology and DNA 
strand invasion (Heyer et al., 2010). At this point, the repair machinery has the choice of 
three sub-pathways to complete the repair, coverage of which is beyond the scope of this 
thesis (reviewed Heyer et al. 2010).  
HR generally results in the activation of the ataxia telangiectasia and RAD3 related 
(ATR) pathway because ATR, another PIKK, is activated by ssDNA and some of the 
phosphorylated substrates of ATM. ATR acts in conjunction with ATM to regulate DNA 
repair, recruits ATRIP (ATR interacting protein) to ssDNA-bound RPA1, and activates 
cell checkpoint kinases to halt the cell cycle (Maréchal and Zou, 2013). ATR also activates 
the Fanconi anaemia (FA) pathway which repairs DNA interstrand crosslinks, 
coordinates HR and SSA, and suppresses NHEJ (Adamo et al., 2010; Ceccaldi et al., 2016). 
The SSA pathway is more error-prone than HR because it promotes recombination 
between tandemly-repeated DNA sequences when a DSB forms between two repeated 
sequences, and therefore introduces a deletion of the region between the repeats 
(Bhargava et al., 2016). SSA shares some components with other pathways, such as 
RAD52 (also used in A-NHEJ and HR), and ERCC1/XPF (also involved in MMEJ) 
(Bhargava et al., 2016). 
The final pathway, MMEJ, is perhaps the most poorly understood of the three. MMEJ 
is very error-prone because in mammalian cells it only requires one nucleotide of 
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homology (Sfeir and Symington, 2015). For this reason MMEJ might only be a back-up 
pathway used when HR is not present (Sfeir and Symington, 2015; Wang and Xu, 2017). 
Perhaps of greatest consequence to our work is the involvement of MRN, a complex also 
involved in HR and which is often targeted during viral infection (Section 1.2). Ligation 
is achieved by Ligases I and III. 
We have briefly reviewed how NHEJ and HR is coordinated following DSB 
formation, providing the background required to understand how DNA repair factors 
function in other contexts. This thesis is primarily concerned with the role of DNA repair 
proteins during viral infection, and the next section will discuss key examples of 
interactions between DNA repair proteins and DNA viruses during infection. 
1.2 DNA repair proteins and virus infection 
1.2.1 Introduction  
Viruses cannot survive independently of a host and require host machinery during 
their infection cycle, creating philosophical debate over whether viruses should be 
considered as alive (Koonin and Starokadomskyy, 2016). Viruses rely upon some aspects 
of the DDR during replication of the viral genome and activate them accordingly (Shah 
and O’Shea, 2015; Sinclair et al., 2006; Turnell and Grand, 2012). However, given the 
necessity to expose the viral genome during replication, it is perhaps unsurprising that 
the nucleic acids can activate the DDR and, in addition to DNA repair proteins which 
can benefit viral infection, other DNA repair factors can be activated which act to restrict 
viral infection (Shah and O’Shea, 2015; Sinclair et al., 2006; Turnell and Grand, 2012). The 
term ‘restriction’ is used in this context to describe a factor which reduces the efficiency 
of viral infection.  
This section will provide an insight of our current understanding of the interactions 
between DNA repair proteins and viral infection. Viruses requiring the DDR for 
replication tend to be those which undergo integration into the host genome or genome 
modifications. Furthermore, although RNA viruses are also affected by DDR proteins, 
most is known in the context of DNA viruses and retroviruses. As this context is also of 
greater relevance to this research, we shall focus primarily on DNA viruses. It is not 
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intended to be an exhaustive review, but will give important examples. It also stops 
short of describing the role of DNA repair proteins in the immune system, which is 
instead covered in Section 1.3.  
1.2.2 Adenoviruses and DNA repair 
Adenoviruses are non-enveloped viruses and which replicate their linear, ~36 kb 
dsDNA genomes within the host nucleus (Hoeben and Uil, 2013). These DNA genomes 
activate the DDR, and so they must inactivate DNA repair proteins to inhibit the ligation 
of viral genomes into concatemers that are too large to be packaged (Forrester et al., 2011; 
Stracker et al., 2002). During adenovirus infection, MRE11 and RAD50 are degraded by 
the E4 34k/E1b 55k complex, and MRN recruitment to replication centres is inhibited by 
E4orf3 expression, together preventing signalling of ATM and ATR pathways (Carson et 
al., 2003, 2009; Stracker et al., 2002). Interestingly, etoposide-induced DSBs in the cellular 
genome sequester MRN and allow for infection with adenovirus unable to degrade 
MRN (Shah and O’Shea, 2015). In addition adenoviruses degrade topoisomerase-IIβ–
binding protein 1 (TOPBP1) to prevent ATM/ATR signalling (Blackford et al., 2010). 
Strangely, despite the numerous mechanisms exploited by adenoviruses to inhibit DNA 
repair proteins, they also recruit a number of DNA repair proteins to viral replication 
centres, including ATR, ATRIP, RAD9, and RAD17, and replication protein A 32 
(RPA32) (Stracker et al., 2005; Turnell and Grand, 2012). The reason for recruitment and 
inhibition of the same proteins has not been confirmed, but it is possibly because they 
have both beneficial and restrictive roles (Turnell and Grand, 2012). However, it is 
important to note that the exact substrates targeted during adenovirus infection vary 
between serotypes (Forrester et al., 2011). 
Adenoviruses also target NHEJ proteins. E1B55K/E4orf6 prevents 
dephosphorylation of threonine 2609 of DNA-PKcs, reducing DSB repair probably by 
preventing DNA-PK disassociation from the DSB and preventing LIG4 from accessing 
the break (Hart et al., 2004). Although E1B55K/E4orf6 do not affect the kinase activity of 
DNA-PK (Hart et al., 2004), they may also target DNA-PK due to its ability to restrict 
viral alternative RNA splicing (Törmänen Persson et al., 2012). In addition, E4 34k and 
E1b 55k target another NHEJ protein, DNA LIG4, for degradation (Baker et al., 2007). 
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Finally, Protein phosphatase 2A (PP2A) is inhibited by adenovirus E4orf6 to 
maintain γH2AX phosphorylation and induce caspase-dependent and –independent cell 
death (Hart et al., 2007). 
1.2.3 Human papillomavirus and DNA repair 
Human papillomaviruses (HPVs) are non-enveloped and have relatively short, 
circular dsDNA genomes. As with all viruses, the infection cycle of HPVs is closely 
linked to DNA repair proteins, but there has been a lot of research on this topic and a 
full review is beyond the scope of this thesis. Instead we shall focus on key points and 
direct readers to previous reviews (McKinney et al., 2015; Pancholi et al., 2017; Turnell 
and Grand, 2012).  
The HPV proteins E6 and E7 induce DNA damage and enable integration of foreign 
DNA into the host genome, activities which may contribute to HPV-induced genomic 
instability, DDR activation, and cancer progression (Moody and Laimins, 2009). Viral 
genome replication in the suprabasal layers of the skin is dependent on the E7-induced 
activation of ATM, which may function to promote replication by inducing G2/M 
cell-cycle arrest (Moody and Laimins, 2009, 2010). Interestingly the dependency on ATM 
is cell-type specific; although ATM is constitutively activated in undifferentiated 
keratinocytes, its inhibition does not affect HPV infection (Moody and Laimins, 2009).  
HPV-induced activation of DNA repair proteins extends beyond the requirement for 
G2/M arrest. The MRN component NBS1 is required for productive replication of HPV31 
for an unidentified reason that is independent of cell cycle control, and HPV induces an 
increase in the levels of the MRN complex via E7 (Anacker et al., 2014). E7 also activates 
the FA pathway, and FA deficiency increases the risk of genome instability and HPV-
induced carcinogenesis (zur Hausen, 2002; Kutler et al., 2003; Moody and Laimins, 2010). 
In contrast to HR factors, the role of NHEJ in HPV infection has not been extensively 
studied. However, DNA-PK is likely to be detrimental to HPVs because HPV+ cells from 
head and neck carcinomas are deficient in DNA-PK expression (Weaver et al., 2015). 
Interestingly, head and neck cancer cell lines not only have decreased NHEJ-directed 
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repair, but also have reduced repair by HR (Bol, 2015). This suggests that HPV exploits 
the beneficial HR factors, and restricts other components which may be detrimental. 
It is interesting to consider that the HPV genome is circularised, and as such will not 
have exposed DNA ends most of the time. We have previously hypothesised that this is 
to avoid being detected by innate immune DNA sensors (Trigg and Ferguson, 2015), but 
this may also be to avoid triggering detrimental DDRs. 
1.2.4 Polyomaviruses and DNA repair 
The human polyomaviruses are generally benign, but some can cause complications 
in immunocompromised individuals (DeCaprio and Garcea, 2013). Although highly 
divergent, polyomaviruses have a similar genome structure comprising a single circular 
dsDNA genome of ~5.2 kb in length (DeCaprio and Garcea, 2013). 
 The canonical polyomavirus, Simian virus (SV)40, expresses large T (LT) antigen 
which activates ATM for efficient genome replication and infectious virus production 
(Dahl et al., 2005; Dey et al., 2002). ATM activity inhibits NHEJ by inhibiting recruitment 
of DNA-PK, and thereby prevents polyomavirus genome concatemerisation (Sowd et al., 
2014). 
JC virus (JCV) is another member of the polyomavirus family, and it expresses 
agnoprotein, a factor which reduces expression of the Ku heterodimer and induces Ku70 
relocalisation away from the viral genome (Darbinyan et al., 2004). SV40, another 
polyomavirus, induces the degradation of MRN components via LT antigen (Zhao et al., 
2008) and uses ATM to prevent NHEJ (Sowd et al., 2014). 
1.2.5 Retroviruses and DNA repair 
Retroviruses are enveloped RNA viruses which are of great medical importance. 
Retroviruses must integrate their genome into the host genome as a DNA provirus to 
replicate (Hayward, 2017), and almost half of human chromosomal DNA either 
originated from viral integration or have virus-like sequences (Blinov et al., 2017). 
Unsurprisingly these DNA species and the integration event stimulate the DDR. DNA-
PK is required for retroviral integration and prevention of apoptosis (Cooper et al., 2013; 
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Daniel et al., 1999; Li et al., 2001), and replication is delayed in cells depleted of Ku 
(Jeanson et al., 2002). ATM is activated during human immunodeficiency virus (HIV) 
integration into the human genome, and small molecule-mediated inhibition of ATM 
suppresses replication of HIV and increases cell death in infected cells (Lau et al., 2005). 
HIV activates the ATR pathway using Vpr (Viral protein R), possibly to induce G2/M 
cell-cycle arrest (Lai et al., 2005; Roshal et al., 2003; Zimmerman et al., 2004).  
1.2.6 HSV-1 and DNA repair  
Herpes simplex virus 1 (HSV-1) has a 152 kbp dsDNA genome which replicates in 
the nucleus. HSV-1 is the viral model used in this thesis, and so an in-depth introduction 
to its infection cycle and structure can be found in Section 1.4. One of the reasons that 
HSV-1 was selected for use in our experiments is that it is already well characterised, 
and a great deal is already known about HSV-1 and DNA repair proteins. This has been 
comprehensively reviewed in the literature (Lilley et al., 2005; Smith and Weller, 2015; 
Turnell and Grand, 2012), and this section will more briefly address some of the most 
pertinent points.  
HSV-1 genome replication occurs in the nucleus where it can access beneficial DNA 
repair factors, although this also exposes the genome to factors which may be 
deleterious. HSV-1 overcomes this by activating and inhibiting factors, as required 
(Figure 4). The HSV-1 genome is unusual in that it contains gaps and nicks (Section 
1.4.3), and these contribute to DDR stimulation along with the free ends of the HSV-1 
genome (Smith et al., 2014). These gaps and nicks trigger DNA-PK activity, and the HSV-
1 infected cell protein 0 (ICP0)-induced degradation of DNA-PKcs is required to relieve 
the DNA-PK-dependent restriction of viral infection caused by these gaps (Lees-Miller et 
al., 1996; Parkinson et al., 1999; Smith et al., 2014). Indeed, PRKDC-/- human malignant 
glioma cells produce a higher titre of infectious HSV-1 after two days of infection than 
their wildtype (WT) counterparts (Parkinson et al., 1999). In addition, Ku-deficient 
murine embryonic fibroblasts (MEFs) yield almost 50-times more infectious HSV-1 
(Taylor and Knipe, 2004). The HSV-1 genome also has a single-nucleotide 3’ overhang 
(Mocarski and Roizman, 1982) which may need to be processed by APLF (Section 1.1.2) 
before the recruitment of other NHEJ factors can occur (Davis and Chen, 2013). To our 
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knowledge the role of APLF in the context of HSV-1 infection has not been studied. 
Interestingly, although the NHEJ components Ku and DNA-PKcs restrict HSV-1 
infection, other NHEJ factors promote HSV-1 genome replication. Knockdown of LIG4 
or XRCC4 delays and reduces the production of infectious HSV-1, probably because 
these proteins are required for the formation of endless replication intermediates 
(Muylaert and Elias, 2007). This is despite the fact that LIG4 inhibits HR (Kurosawa et al., 
2013). 
Figure 4: Interactions between HSV-1 and the DDR. 
Following DNA damage multiple DDR pathways (black arrows) are activated, including HR, NHEJ, and 
MMR, and these can subsequently activate (black arrows) or inhibit (black blunt-ended line) other DDR 
pathways. Many proteins in these pathways are beneficial to HSV-1 infection (green boxes), but some are 
detrimental (red box). HSV-1 expresses proteins (italics) which activate (blue arrow) or inhibit (blue blunt-
ended line) these proteins via different mechanisms (not shown). Question marks indicate undefined HSV-1 
interactions. 
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In addition to the activation of DNA repair proteins by the HSV-1 genome, HSV-1 
proteins activate beneficial factors. The FA pathway is activated by HSV-1 during 
infection, and defects in FA result in impaired HSV-1 genome replication and gene 
transcription (Karttunen et al., 2014). Interestingly, inhibition of DNA-PKcs partially 
alleviates restriction caused by FA defects, leading to the proposal that FA-mediated 
inhibition of DNA-PKcs may be important (Karttunen et al., 2014). The FA pathway is 
also able to stimulate SSA, and SSA is activated by the HSV-1 recombinase complex 
component, alkaline nuclease (UL12), leading to suggestions that SSA is the homology-
mediated repair pathway used by HSV-1 (Schumacher et al., 2012). This was established 
using chromosomally-integrated GFP correction assays which also showed that HR, 
NHEJ, and MMEJ were inhibited (Schumacher et al., 2012). 
DNA mismatch repair (MMR) pathway factors localise to the HSV-1 replication 
compartments, and are required for efficient replication, probably due to defects in 
immediate early gene expression in the absence of the MMR factor MutL homologue 1 
(MLH1) (Mohni et al., 2011). Infected cell protein 0 (ICP0) induces the degradation of 
many components of nuclear bodies, but MLH1 protein levels are unaffected by ICP0. 
 The role of DNA repair proteins in HSV-1 infection is not always straightforward. 
ATR signalling is inhibited despite the fact that ATR and ATRIP are both recruited to the 
HSV-1 replication centre and are beneficial for HSV-1 infection (Mohni et al., 2010; 
Wilkinson and Weller, 2006). Similarly, although chromosomally-integrated GFP 
correction assays suggest that HR is repressed (Schumacher et al., 2012), HSV-1 
production is deficient in cells lacking MRN and WRN (Balasubramanian et al., 2010; 
Smith and Weller, 2015). Investigations into the importance of ATM are inconclusive; 
some studies report that HSV-1 infection activates ATM, but ATM inhibition does not 
have a large effect on HSV-1 genome replication (Gregory and Bachenheimer, 2008; 
Shirata et al., 2005), while others conclude that ATM defects reduce production of HSV-1 
(Alekseev et al., 2014; Smith and Weller, 2015).  
The role of exogenous DNA damage on herpesvirus infection is also uncertain. 
Although exogenous DNA damage induction reduces the infectivity of murine 
gammaherpesvirus 68 by inducing an antiviral state (Mboko et al., 2012), there is 
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evidence that DNA damage induced by topoisomerase inhibitors can promote HSV-1 
immediate early gene expression (Volcy and Fraser, 2013).  
Finally, it is interesting to consider that the accumulation of DNA lesions reported in 
neurodegenerative diseases may explain the correlation observed between HSV-1 
infection and conditions such as Alzheimer’s Disease (De Chiara et al., 2012; Itzhaki, 
2014). Indeed, HSV-1 infection restricts DNA repair in rat cortical neurones (De Chiara et 
al., 2016). Furthermore, HSV-1 infection induces ROS (reactive oxygen species) which 
could also contribute to the lesion formation and inflammation observed in 
neurodegenerative disease (Gonzalez-Dosal et al., 2011). 
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1.3 DNA repair proteins and the immune system 
1.3.1 DDR factors and the sensing of foreign DNA 
1.3.1.1 Overview of DNA sensing 
The innate immune system has evolved pattern recognition receptors (PRRs) to 
recognise pathogen-associated molecular patterns (PAMPs) and damage-associated 
molecular patterns (DAMPs) that initiate appropriate transcriptional responses. In the 
context of virus infection, recognition of viral nucleic acids is essential for initiating a 
type-1 interferon (IFN-I) response and inflammatory processes, responses which create 
an anti-viral environment and recruit leukocytes (Mansur et al., 2014). The innate sensing 
of DNA by these PRRs also has consequences for parasite and bacterial infection, 
carcinogenesis, and vaccine development (Kobiyama et al., 2013; Mansur et al., 2014; 
Woo et al., 2015).  
The first PRR shown to recognise DNA was Toll-like receptor (TLR) 9, which 
recognises CpG DNA in endosomal compartments (Hemmi et al., 2000). It was thought 
that TLR9 might be the only DNA sensor, but further experiments showed this not to be 
the case. Cytoplasmic DNA is usually kept at low levels in the cell by nucleases such as 
the lysosomal endonuclease DNase II (Evans and Aguilera, 2003). In macrophages, 
DNaseII is responsible for digesting the DNA from phagocytosed apoptotic cells and in 
DNase knock-out mice DNA accumulates in macrophages and induces interferon-β 
(IFNβ)-driven immunopathology causing the mice to die in feto (Krieser et al., 2002). 
Unexpectedly, crossing DNaseII-/- mice with TLR3-/- or TLR9-/- mice did not prevent 
CXCL10 and IFNβ expression in fetal liver macrophages and failed to rescue the 
embryonic-lethal DNaseII knock-out phenotype (Okabe et al., 2005). MyD88 and TRIF 
are adaptor proteins which interact with activated TLRs and initiate down-stream 
signalling, and every TLR able to respond to nucleic acids requires one of them 
(McGettrick and O’Neill, 2004), but MyD88-/-/TRIF-/- mice also continued to express 
CXCL10 and IFNβ, which suggested that there is a TLR-independent DNA sensing 
pathway (Okabe et al., 2005).  
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A large number of cytoplasmic DNA sensors have since been proposed 
(Unterholzner, 2013). Most recent research has focused on cyclic GMP-AMP (guanosine 
monophosphate–adenosine monophosphate) synthase (cGAS) which activates STING 
via the secondary signalling molecule circular guanidine-adenosine monophosphate 
(cGAMP) (Ablasser et al., 2013; Sun et al., 2013; Wu et al., 2013). 
Cytosolic DNA sensing pathways converge at an adaptor protein known as the 
stimulator of interferon genes (STING) (Surpris and Poltorak, 2016). Once activated, 
STING translocates to punctate perinuclear structures and recruits tank binding kinase 1 
(TBK1), which in turn phosphorylates and activates an IFN regulatory factor (IRF)3-
dependent response (Ishikawa et al., 2009; Saitoh et al., 2010; Stetson and Medzhitov, 
2006; Tanaka and Chen, 2012). STING has also been shown to activate the transcription 
factor NF-κB, although by a mechanism that is less clear (Abe and Barber, 2014).  
The activation of IRF3 and NF-κB results in the expression of IFNI and cytokines 
which mediate antiviral responses in bystander cells (Schoggins and Rice, 2011). The 
antiviral state is achieved through the expression of interferon-stimulated genes (ISGs), 
of which there are a vast number of varying potency. These restrict viral infection by 
targeting different stages of the viral infection cycle or by enhancing the propagation of 
the antiviral response (Schoggins and Rice, 2011). Tetherin, for example, is an ISG which 
inhibits viral release from the cell surface (Perez-Caballero et al., 2009), while protein 
kinase R is an example of an ISG which promotes the antiviral state by stabilising IFN 
mRNA (Schulz et al., 2010). IFNs and chemokines also influence the adaptive immune 
response. Chemokines attract leukocytes and drive their maturation (Jin et al., 2008), 
while IFNs and cytokines increase expression of factors such as MHC (major 
histocompatibility complex) which are important in the activation of lymphocytes 
(Grabowska et al., 1990; Panek and Benveniste, 1995). 
Interestingly, many of the PRRs important in the recognition of foreign cyt DNA are 
also DDR factors (Trigg and Ferguson, 2015). As might be expected, the recognition of 
mislocalised self DNA or damaged self DNA is also able to induce an antiviral response, 
although it is not yet clear whether the same pathways are stimulated (reviewed Section 
1.3.2). Therefore, it stands that the DNA damage response has considerable implications 
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in the DNA-induced stimulation of the immune system, and here we review the 
functions of DDR factors in the innate sensing of exogenous DNA. 
1.3.1.2 DNA-PK 
It has long been established that DNA-PK detects damaged DNA in the nucleus, but 
it also functions to sense cytoplasmic DNA and induce an innate immune response. 
Karpova et al. reported that Sendai virus infection activates DNA-PK via an unknown 
mechanism, and that this subsequently interacts with and activates the innate immune 
transcription factor, interferon regulatory factor 3 (IRF3) (Karpova et al., 2002). In 2012 
Ferguson et al. showed that DNA-PK detects cytoplasmic DNA and activates the 
stimulator of interferon genes (STING), TANK-binding kinase 1 (TBK1), and IRF3 
(Ferguson et al., 2012). They showed that DNA-PK immunoprecipitates with exogenous 
cytoplasmic DNA, and that DNA-PK localises to vaccinia virus (VACV) replication 
factories. Depletion of DNA-PK diminishes the IRF3-dependent and p65-independent 
induction of interferon (IFN) transcription in response to DNA, but not to RNA, and this 
is independent of the kinase activity of DNA-PK.  
More recently it has been demonstrated that DNA-PK is a component of a 
ribonuclear complex termed the HEXIM1-DNA-PK-paraspeckle components 
ribonucleoprotein complex (HDP-RNP) (Morchikh et al., 2017). The core components of 
the complex are hexamethylene bis-acetamide-inducible protein 1 (HEXIM1), and the 
long non-coding RNA, NEAT1 (nuclear enriched abundant transcript 1). The HDP-RNP 
also contains the paraspeckle proteins SFPQ (splicing factor proline- and glutamine-
rich), NonO (non-POU domain-containing octamer-binding protein), PSPC1 
(paraspeckle component 1), RBM14 (RNA binding motif protein 14), and Matrin3. 
Morchikh et al. showed that the HDP-RNP interacts with a previously-identified DNA 
sensor, cyclic-GMP-AMP synthase (cGAS), and that HDP-RNP is required for the 
activation of the cGAS-STING-IRF3 pathway. DNA-PK has further links to immunity 
due to its role in V(D)J recombination during lymphocyte production (discussed in more 
detail in Section 1.3.3.1) (Blunt et al., 1995; Kirchgessner et al., 1995; Kurimasa et al., 
1999b). 
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DNA-PK has also been shown to sense hepatitis B virus (HBV) infection (Li et al., 
2016). However, unlike the mechanisms already described, STING and IRF3 are not 
reported to be involved in the signalling pathways activated, and instead DNA-PK 
assembles PARP (Poly ADP ribose polymerase) at the site of recognition and signals via 
IRF1 to induce expression of CCL3 (chemokine (C-C motif) ligand 3) and CCL5, two 
ligands important in hepatitis (Li et al., 2016).  
1.3.1.3 IFI16 
Interferon gamma inducible protein (IFI16) is a human DDR factor and, as a member 
of the PYHIN protein family, contains a pyrin domain and two DMA-binding HIN 
(hematopoietic, interferon-inducible, nuclear) domains (Cridland et al., 2012). AIM2 
(absent in melanoma 2) is also a PYHIN protein, and upon binding dsDNA it recruits 
ASC (apoptosis-associated speck-like protein containing a caspase activation and 
recruitment domain) and activates caspase-1 (Hornung et al., 2009). During HSV-1 
infection, IFI16 is stimulated and relocalises from the nucleus to the cytoplasm, and 
cooperates with cGAS to induce IFNβ in an ASC-independent, STING-dependent 
manner (Almine et al., 2017; Orzalli et al., 2012; Unterholzner et al., 2010). There is 
evidence that IFI16 can also associate with ASC to form an inflammasome and induce 
IL-1β maturation (Johnson et al., 2013). Indeed, IFI16 and AIM2 upregulation and 
inflammasome formation have been linked to inflammatory bowel disease (Vanhove et 
al., 2015). Interestingly, another DDR factor, BRCA1 (breast cancer 1), may be required 
for IF16-dependent responses to DNA sensing (Dutta et al., 2015). 
1.3.1.4 MRE11 and RAD50 
MRE11 and RAD50 are members of the MRN complex of HR (Section 1.1.3). They 
were amongst the first cytoplasmic dsDNA receptors proposed, and act upstream of the 
STING, TBK1, and IRF3 pathway (Kondo et al., 2013). RAD50 can induce IL-1β via 
CARD9 (caspase recruitment domain-containing protein 9) and NF-κB (nuclear factor 
kappa-light-chain-enhancer of activated B cells) in dendritic cells (Roth et al., 2014), and 
there is evidence that MRN may be involved in NF-κB signalling following Kaposi 
sarcoma-associated herpesvirus infection (Sun et al., 2014). 
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1.3.2 Immune response to DNA damage 
Following DNA damage the DDR machinery regulates many downstream signalling 
responses, including those regulating the cell cycle and programmed cell death. Given 
the role of DDR proteins as sensors of exogenous DNA, it is perhaps unsurprising that 
genotoxic damage and DSB formation are also able to induce an innate immune 
response (Jackson and Bartek, 2009). One of the first studies linking DNA damage with 
the immune response showed that ultraviolet B (UV-B) was able to induce interleukin 
(IL) 8 expression (Kondo et al., 1993), and shortly after UV-C and γ-radiation were found 
to activate NF-κB via different mechanisms (Li and Karin, 1998). Since then a variety of 
genotoxic agents have been identified as stimulators of multiple innate immune 
pathways. Topoisomerase inhibitors and ionizing radiation (IR) induce ATM to 
relocalise to the cytoplasm, associate with IKK, and NF-κB signalling in a 
NEMO-dependent manner (Wu et al., 2006). ATM-dependent NF-κB activation is 
required for the activation of IRF1 and IRF7, important transcription factors for IFNα 
and IFNλ expression following etoposide treatment (Brzostek-Racine et al., 2011; Honda 
et al., 2005). Interestingly, ATM may have a role in negatively regulating IL-1β secretion, 
and activation of ATM by topoisomerase inhibitors can protect mice from sepsis during 
bacterial infection or LPS (lipopolysaccharide) treatment (Figueiredo et al., 2013). 
Genotoxic stress also activates the JNK (c-Jun N-terminal kinase) MAPK 
(mitogen-activated protein kinase) pathway, which then activates IRF7 (Kim et al., 2000). 
Additionally, IRF3 is phosphorylated and activated by a MAPKKK (MAPK kinase 
kinase)-related pathway following DNA damage (Kim et al., 1999; Servant et al., 2001). 
DNA-PK has been linked to IRF3 phosphorylation during virus infection, but this has 
not been shown in the context of DNA damage (Karpova et al., 2002). 
DNA damage can also induce innate immune responses indirectly. In healthy cells, 
small amounts of damaged self-DNA can escape from the nucleus and mitochondria, 
although these fragments are normally broken down by DNases such as DNaseII in 
endosomes, and 3’ repair exonuclease 1 (TREX1) in the cytoplasm. Mutation of these 
nucleases in mice and humans leads to the build-up of mislocalised DNA, causing the 
systemic autoinflammation and interferonopathy observed in diseases such as 
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Aicardi-Goutières syndrome (Ablasser et al., 2014; Crow et al., 2006; Stetson et al., 2008; 
Yoshida et al., 2005). Even in the absence of these mutations, extensive DNA damage can 
result in leakage of genomic fragments into the cytoplasm where they can stimulate 
cytosolic DNA sensors such as cGAS (Glück et al., 2017a). Furthermore, UV-B radiation 
can induce DDR-driven apoptosis, resulting in genome fragmentation and the release of 
nuclear autoantigens responsible in systemic lupus erythematosus (SLE) (Caricchio et al., 
2003). 
The immune response to DNA damage has implications in disease outcomes. IR 
induces cytokine and IFN expression which are useful in cancer immunotherapy 
(Friedman, 2002; Hong et al., 1999). Induction of the DNA damage-driven immune 
response can also protect against infection, as has been demonstrated with mouse 
gammaherpesvirus type 68 (Mboko et al., 2012). However, the importance of DNA repair 
proteins in immunity is not limited to the innate immune system, and we shall now 
consider their role in the creation of the adaptive immune response. 
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1.3.3 DNA repair and lymphocytes 
1.3.3.1 V(D)J recombination and SCID 
In jawed vertebrates, lymphocytes are arguably the primary cell type in the adaptive 
immune response. B lymphocytes express immunoglobulins (Ig; also called antibodies) 
which contribute to the humoral response, and T lymphocytes have a T-cell receptor 
(TCR) which enables them to recognise unhealthy or infected cells. Variation in the Ig 
and TCR repertoire is an essential feature of the adaptive immune response created 
during lymphocyte development by a process called V(D)J recombination which 
rearranges the variable (V), diversity (D), and joining (J) gene segments that encode the 
Ig and TCR (Schatz and Ji, 2011). V(D)J recombination is essential for B and T 
lymphocyte production, and jawed vertebrates unable to carry it out have severe 
combined immunodeficiency (SCID; also called alymphocytosis).  
V(D)J recombination requires a number of DNA repair factors from both HR and 
NHEJ (Xu, 2006). DSBs are introduced at recombination signal sequences by the 
recombination-activating gene (RAG) 1 and RAG2. This allows for the somatic 
recombination of the V, D, and J gene segments of the lymphocyte antigen receptors 
(Arya and Bassing, 2017; Xu, 2006). These DSBs activate ATM, which then coordinates 
the recruitment of DSB repair factors, phosphorylates proteins involved in cell cycle 
checkpoints, and activates NF-κB which induces transcription of important genes in 
lymphocyte development and antiapoptotic proteins (Arya and Bassing, 2017). 
The DNA repair factors required for V(D)J recombination are Artemis, DNA-PKcs, 
LIG4, XRCC4, Ku70 and Ku80 (Moshous et al., 2000, 2001; Xu, 2006). As such, Prkdc-/- 
mice (Blunt et al., 1995; Kirchgessner et al., 1995; Kurimasa et al., 1999b) and humans with 
mutations in PRKDC cannot make B and T lymphocytes and exhibit a SCID phenotype 
(Woodbine et al., 2013). Mice lacking Ku70 and Ku80 are also SCID, but Xrcc6-/- (Ku70-/-) 
mice can achieve reduced levels of V(D)J sufficient to produce a few abnormal T 
lymphocytes (Gu et al., 1997; Taccioli et al., 1994). XLF and PAXX are involved in V(D)J 
recombination, but display redundancy (Ijspeert et al., 2016; Lescale et al., 2016).  
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1.3.3.2 Class switching recombination and somatic hypermutation  
Class switching recombination (CSR) and somatic hypermutation (SHM) are 
required for effective Ig responses (Xu, 2006). CSR allows for the creation of different Ig 
subtypes (e.g. IgG, IgA) by switching the constant region. SHM introduces mutations 
which are important in affinity maturation of the antibody (Xu, 2006). Ku70 and Ku80 
are the only DNA repair factors currently known to be required for CSR or SHM, 
although many others are involved, including LIG4, DNA-PKcs, NBS1, and ATM (Xu, 
2006). 
1.3.3.3 DNA repair and cytotoxic lymphocyte activation 
DNA repair proteins have another important role in regulating the innate and 
adaptive immune responses. NKG2D (NK group 2, member D) and DNAM-1 (DNAX 
accessory molecule-1) are receptors expressed on the surface of natural killer (NK) cells, 
activated cluster of differentiation 8-positive (CD8+) T lymphocytes, and some other 
immune cells (Cerboni et al., 2014; Raulet, 2003). The ligands for NKG2D and DNAM-1 
are not normally expressed on healthy cells, but genomic instability caused by genomic 
lesions or viral infection induces their expression, inducing the cytotoxic killing of the 
affected cells by both NK and CD8+ T lymphocytes (Cerboni et al., 2014; Xu, 2006). The 
expression of these ligands is dependent upon ATM or ATR activity, and the inhibition 
of ATM can prevent their expression (Cerboni et al., 2014; Gasser et al., 2005). 
Furthermore, in response to DNA damage, fibroblasts upregulate MHC-1 , an important 
complex in antigen presentation to cytotoxic lymphocytes, further suggesting that the 
DDR is used to alert the immune system to stressed and unhealthy cells (Tang et al., 
2014). 
Rag2-/- and Prkdc-/- mice are SCID and lack B and T lymphocytes, but do still produce 
NK cells (Karo et al., 2014). DNA repair is important in all cells, but the rapid 
proliferation of lymphocytes makes them more susceptible to DNA damage than most, 
and this may explain why Prkdc-/- NK cells die considerably faster than WT NK cells in 
vivo (Karo et al., 2014). Interestingly, NK cells from Prkdc-/- mice were activated more than 
those from WT mice – whether this is due to increased DNA damage in somatic cells 
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Herpes simplex virus (HSV-1) is a member of the Herpesviridae family, a family of 
enveloped, dsDNA viruses. Herpesviruses get their name from the Greek word 
“herpein” (“to creep”) because typical infections are characterised by recurring cycles of 
latent and lytic infection (Novak and Peng, 2005). It is estimated that 3.4 billion people 
worldwide are infected with HSV-1, but most maintain the virus in the latent stage and 
remain symptomless (Gilden and Nagel, 2016; Looker et al., 2015). However, HSV-1 
infection can cause skin sores and, rarely, encephalitis (Gilden and Nagel, 2016) or 
blindness (Royer et al., 2015). There is also increasing interest in the link between HSV-1 
and neurological disorders such as Alzheimer’s disease (Itzhaki, 2014, 2017) and 
cognitive decline in patients with schizophrenia (Bhatia et al., 2017; Prasad et al., 2012). 
HSV-1 has also been linked to Bell’s palsy, a form of facial paralysis (Schirm and 
Mulkens, 1997). The virus is treated with antiviral drugs which interfere with HSV-1 
enzymes, including Acyclovir, Famciclovir, and Cidofovir, but these have clinical 
side-effects (Baram-Pinto et al., 2010). No vaccine is currently available, although 
ongoing research appears to be promising (Royer et al., 2016).  
1.4.2 HSV-1 Infection cycle  
HSV-1 initially infects epithelial cells and keratinocytes in the oral mucosa and 
ocular areas of the human host (Kollias et al., 2015). Lytic infection of these cells 
produces infectious virions which can then infect neighbouring cells, eventually 
infecting sensory nerve endings and travelling by retrograde transport to local ganglia 
(Kollias et al., 2015; Smith, 2012). Here the virus may continue productive infection and 
induce encephalitis, or, more commonly, enter latency where it will remain dormant 
until it reactivates (Smith, 2012). Mechanisms controlling HSV-1 latency and reactivation 
remain unclear.  
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At the molecular level, HSV-1 virions express glycoprotein C (gC) on their envelope 
which binds to heparan sulphate or chondroitin on host cells and mediates viral 
attachment (Baram-Pinto et al., 2010; Campadelli-Fiume and Menotti, 2007; Svennerholm 
et al., 1991). Subsequently other glycoproteins on the viral envelope, for example gB and 
gD, induce fusion with the cell membrane and release of the viral capsid and tegument 
into the host cytoplasm (Cai et al., 1988; Campadelli-Fiume and Menotti, 2007; Turner et 
al., 1998). The HSV-1 tegument contains viral transcripts, 23 viral proteins important in 
initiating infection, for example ICP0 (Section 1.4.4), and host factors which can help 
induce an antiviral state, for example cyclic GMP-AMP (cGAMP) (Gentili et al., 2015; 
Huffman et al., 2017; Smith et al., 2011). 
The HSV-1 capsid then travels via microtubule transport to the nucleus, and docks to 
nuclear pores (Sodeik, 1997). The pressure of the packaged HSV-1 genome is thought to 
drive initial translocation of viral DNA across the nuclear pore, although the mechanism 
by which this is initiated is not known (Huffman et al., 2017). Once inside the nucleus, 
transcription of HSV-1 genes begins. Over 80 viral genes are expressed in different 
phases, termed immediate early (IE; expressed immediately after entry of the viral 
genome into the nucleus. Exact timing is dependent on the cell type, but is usually 
between one and four hours after infection), early (expression is regulated by IE proteins 
and so usually detectable after about four hours), late (delayed expression, but 
detectable in the absence of viral genome replication by about 6 hours), and true late (γ; 
only after viral genome replication, roughly eight hours after infection) (Huffman et al., 
2017; Roizman, 1985; Weir, 2001). HSV-1 genome replication (Section 1.4.3) produces 
concatemers of the viral genome which are cleaved into monomers and packaged into 
viral capsids (Tong and Stow, 2010; Vlazny et al., 1982). The nuclear pores are too small 
for capsids to exit the nucleus, and so mature capsids wrap themselves in the inner 
nuclear membrane, which subsequently fuses with the outer nuclear membrane and 
releases the capsid into the cytoplasm (Hellberg et al., 2016). The virion tegument is 
sequentially packed around the capsid, and the capsid and tegument are wrapped in 
intracytoplasmic membranes, the outer of which fuses with the cell membrane to release 
the virion (Mettenleiter, 2002). Capsids are not required for tegumentation and 
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wrapping, leading to the production of non-infectious light (L) particles which are also 
released, and may contribute to the infectivity of infectious particles (Mettenleiter, 2002). 
After HSV-1 virions exit the cell, most remain associated with the cellular membrane, 
and cell-to-cell spread occurs across tight junctions or neural synapses (Sattentau, 2008). 
A small proportion of virions is released into the tissue fluid where they travel by 
diffusion. Some strains of HSV-1 form cellular syncytia because the glycoproteins left on 
the cell membrane induce neighbouring cells to fuse (Sattentau, 2008).  
1.4.3 HSV-1 genome structure, replication, and packaging 
HSV-1 has a linear 152 kbp (kilobase pair) dsDNA genome which has short 3’ 
overhangs at each end which may promote genome circularisation during replication 
(Mocarski and Roizman, 1982). The genome comprises of nicks and gaps approximately 
30 bases in length, although the purpose of these is unknown and virus genomes that 
have been modified so that the gaps are filled do not lose infectivity (Smith et al., 2014). 
The genome consists of two unique regions (unique long, UL; unique short, US) adjacent 
to inverted repeats, and has three origins of replication (Ward and Weller, 2011). HSV-1 
infection induces nuclear reorganisation to create replication compartments within 
which factors beneficial for replication are recruited, and detrimental factors are 
excluded (Weller and Coen, 2012). Replication of the genome requires seven viral 
proteins: UL9 (also called the origin-binding protein, OBP), UL30 (the catalytic subunit 
of DNA polymerase), UL42, UL5, UL8, UL52, and UL29 (also called infected cell protein 
8, ICP8) (Weller and Coen, 2012). ICP8 and UL9 distort the duplex genome at an origin 
of replication and allow the subunits of the helicase/primase (UL5, UL8, and UL52) to 
unwind the DNA and synthesise primers for UL30 to elongate, achieving synthesis of 
leading and lagging strands of the replication fork (Weller and Coen, 2012). 
Inside the virion the genome is linear, but endless forms of the genome form during 
replication (Weller and Coen, 2012). It remains controversial whether concatemeric, 
endless genomes are formed by HR, or created by rolling circle replication following 
circularisation of the genome (Weller and Coen, 2012). There is evidence for both 
hypotheses: HR is thought to be important due to the upregulation of SSA during HSV-1 
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infection (Weller and Coen, 2012), but knockdown of XRCC4 and LIG4 abrogate the 
formation of endless genomes, suggesting that NHEJ may play an important role in their 
formation (Muylaert and Elias, 2007). The HSV-1 genome is also branched, although 
little is known about why this occurs or whether it is advantageous to the HSV-1 
infection cycle (Severini et al., 1996). It is possible that the branches are caused by 
replication forks and that the branched structures are simply replication intermediates 
(Severini et al., 1996). 
These branched HSV-1 concatemers are cleaved into monomers and packaged into 
the icosahedral viral capsids (Homa and Brown, 1997). Cleavage of the genome is 
achieved by the HSV-1 terminase, a heterotrimeric complex of UL15, UL28, and UL33 
(Heming et al., 2014). The dogma in the field is that packaging is required for 
simultaneous genome cleavage (Heming et al., 2014; Muylaert and Elias, 2007). There is 
evidence that packaging can be aborted after genome cleavage, however this has only 
been observed using a virus with a mutation in the terminase component, UL15 (Yang et 
al., 2011). 
1.4.4 ICP0 
Infected cell protein 0 (ICP0) is a 775-amino acid protein with IE expression. It has 
multiple functions which make it important during HSV-1 infection, and viruses lacking 
ICP0 expression are attenuated in most cell types, especially at low multiplicities of 
infection (MOIs) (Smith et al., 2011). As is the case with many IE proteins, ICP0 is a 
HSV-1 transactivator (Cai and Schaffer, 1992; Everett, 1984), meaning that it activates the 
transcription of other HSV-1 genes. However, it also has extensive roles in overcoming 
intrinsic cellular resistance to infection. ICP0 has E3 ligase activity which allows it to 
ubiquitinate and induce the proteasomal degradation of target proteins (Lilley et al., 
2010; Smith et al., 2011). PML (promyelocytic leukaemia) and other components of 
nuclear domain 10s (ND10s) are able to repress HSV-1 infection by localising to the viral 
genome and repressing gene expression, but ICP0 induces degradation of PML and 
thereby prevents the accumulation of the other factors (Chelbi-Alix et al., 2007; Cliffe and 
Knipe, 2008; Gu et al., 2013; Smith et al., 2011; Wang et al., 2012). ICP0 also induces the 
degradation of IFI16 and DNA-PKcs to prevent their restrictive effects on viral infection 
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(Section 1.2.6) (Lees-Miller et al., 1996; Orzalli et al., 2016; Parkinson et al., 1999; Smith et 
al., 2011). Indeed, the ability of ICP0 to tip the balance against HSV-1 latency has been 
attributed to its ability to degrade DNA-PKcs (Smith et al., 2014). 
ICP0 also directly inhibits the immune response. IRF3 and IRF7 signalling are 
inhibited by ICP0, and as a result ICP0 mutants are hypersensitive to IFN-I (Eidson et al., 
2002a; Lin et al., 2004a; Mossman et al., 2000, 2001). ICP0 also inhibits toll-like receptor 2 
(TLR2) and NF-κB signalling (van Lint et al., 2010). Finally, ICP0 degrades CD83 on 
mature dendritic cells, which may help diminish T lymphocyte responses (Heilingloh et 
al., 2014; Kummer et al., 2007).  
1.4.5 HSV-1 Restriction factors 
Restriction factors are cellular proteins which reduce the efficiency of viral infection, 
and cells express such factors against most, if not all, viruses. The first reported example 
was the murine protein, Friend-virus-susceptibility-1 (Fv1), which protects mice from 
murine leukama (Lilly, 1970) by blocking a step between reverse transcription and 
integration of the viral genome (Jolicoeur and Baltimore, 1976; Sveda and Soeiro, 1976). 
Another famous example is APOBEC (apolipoprotein B mRNA editing enzyme, catalytic 
polypeptide-like) 3G which inhibits HIV-1 infection through the hyper-editing of the 
viral genome (Sheehy et al., 2002).  
We have already explored how some DNA repair proteins restrict HSV-1 infection 
(Section 1.2.6), but most HSV-1 restriction factors are not found in this pathway. These 
restriction factors are diverse and act via a multitude of mechanisms, meaning that a full 
review is beyond the scope of this thesis. However, it is worthwhile considering some 
key examples to help provide further context to the role that restriction factors have 
during HSV-1 infection. 
Autophagy is a process by which excess or disfunctional proteins or organelles can 
be broken down and recycled, but it is also an important anti-viral defence. Tripartite 
motif 23 (TRIM23) drives the autophagy of HSV-1 and other viruses (Sparrer et al., 2017). 
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MxB inhibits uncoating of viral DNA in a GTPase-dependent manner, preventing the 
viral genome from entering the nucleus for replication (Crameri et al., 2018). Genome 
expression is required for subsequent replication of genomes that successfully enter the 
nucleus, and there are factors such as IFI16 (Section 1.2.6) and the upstream binding 
factor (UBF) (Ouellet Lavallée and Pearson, 2015), which are able to reduce viral gene 
expression. The sirtuin family of proteins also restricts HSV-1 gene expression (Koyuncu 
et al., 2014). 
SAMHD1 is a restriction factor better known for inhibiting retroviral reverse 
transcription, but also inhibits HSV-1 replication, possibly by reducing the availability of 
deoxynucleotide triphosphates (dNTPs) (Kim et al., 2013). Restriction factors often target 
viral genome replication, with other examples including PML and other components of 
the ND10s (Section 1.4.4), or the genome itself. APOBEC3C hyper-edits the HSV-1 
genome through cytidine deamination, introducing mutations and reducing viral 
viability (Suspène et al., 2011).  
Restriction factors can also act to inhibit viral egress and spread. Tetherin is a 
restriction factor that is very effective at targeting a wide range of viruses, including 
HSV-1, and does so by preventing new virions from dissociating from the surface of the 
host cell, thereby preventing spread to neighbouring cells (Blondeau et al., 2013). 
1.5 HSV-1 infection in mice 
1.5.1 Overview 
HSV-1 has human tropism, and mice are not a natural host for the virus. However, 
studying the virus in humans is difficult because infection is generally asymptomatic. 
Furthermore, the neurotropic nature of HSV-1 mean that human samples are often 
limited to post-mortem studies. It is therefore necessary to study many aspects of 
infection in an alternative host, and mice are often used because their genetic, 
immunological, and neurological biology is already well-characterised (Kollias et al., 
2015). Here we describe the use of mice as a model for studying HSV-1 infection, with a 
particular focus on aspects of consequence for our study.  
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1.5.2 Pathology  
There are numerous infection routes commonly used for studying HSV-1 in mice, 
and the location of inoculation and the amount of virus inoculated will determine the 
pathology observed (Kollias et al., 2015). In most cases infection is asymptomatic, but 
mice with a reduced propensity to control HSV-1 infection or mice inoculated with a 
high dose of HSV-1 may experience pathology and, in extreme cases, mortality (Kollias 
et al., 2015). There is also variation based upon age and strain of mice (Ben-Hur et al., 
1983; Kastrukoff et al., 2012; Kollias et al., 2015). 
The most common signs of pathology observed are ruffled coats (a generic symptom 
of mouse distress), weight loss, and loss of mobility due to neurological damage (Kollias 
et al., 2015). In the case of inoculation of HSV-1 in the lip, spread of HSV-1 infection to 
the brain is often observed in mice unable to effectively control HSV-1 infection 
(Kastrukoff et al., 1982). This makes this inoculation route useful in the study of potential 
HSV-1 restriction factors, because mice which are deficient in the factor of interest can be 
tested for their ability to control HSV-1 infection. It is, however, important to remember 
that mouse pathology differs from that of humans; for instance, HSV-1 infection of the 
mouse brain spreads diffusely, as compared to the focal lesions observed in human 
brains (Kollias et al., 2015).  
1.5.3 The immune response to HSV-1 infection 
The innate immune response to HSV-1 infection is primarily driven by nucleic acid 
sensors. TLR9 recognises the HSV-1 genome and induces IFNα production (Hochrein et 
al., 2004). A number of the proposed intracellular DNA sensors have either not been 
verified in vivo, or have been found to be redundant during HSV-1 infection of mice 
(Ishii et al., 2008; Unterholzner, 2013). Those that have been shown to contribute to the 
innate immune response to HSV-1 in vivo are cGAS (Li et al., 2013) and DNA-PK 
(Ferguson et al., 2012), both of which signal via the STING-TBK1-IRF3 pathway to induce 
IFN-I (Unterholzner, 2013).  
The cellular immune response to HSV-1 is primarily driven by CD8+ T lymphocytes 
which secrete IFNγ (Cantin et al., 1995). IFNγ receptor-null mice are more susceptible to 
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HSV-1 infection and reactivation (Cantin et al., 1999, 1995; Knickelbein et al., 2008; Liu et 
al., 2000), possibly because IFNγ amplifies the antiviral effects of IFNβ (Halford et al., 
2005a, 2005b; Pierce et al., 2005). HSV-1-specific CD8+ cells are retained at sites of latency 
(Khanna et al., 2003). CD4 T lymphocytes also produce IFNγ in response to HSV-1 
infection, along with tumour necrosis factor α (TNFα), interleukin-2 (IL-2), and IL-4 
(Johnson et al., 2008). CD8+ and CD4+ T lymphocytes can respond directly to HSV-1 
antigens, of which gB is thought to be the immunodominant antigen (Johnson et al., 
2008; Khanna et al., 2003; Wallace et al., 1999).  
There is evidence that CD8α+ dendritic cells (DCs) are the key DC subset for priming 
CD8+ T lymphocytes (Smith et al., 2003), but the priming of CD8+ and CD4+ T cells is 
performed by both migrant and resident DCs, and the infection route determines their 
relative importance (Lee et al., 2009). 
Other cell types are less important in the cellular and adaptive immune responses. 
Rag2-/- mice unable to produce T and B lymphocytes retain some resistance to HSV-1 
which is not dependent on NK cells (Halford et al. 2005). Neutrophils are also 
nonessential in the response to HSV-1 infection (Hor et al., 2017). B lymphocytes are not 
essential for clearance of lytic HSV-1 infection, but they may contribute to preventing the 
spread of HSV-1 through the nervous system in mice (Simmons and Nash, 1987). B 
lymphocytes are also not required for resistance to secondary infection of HSV-1 
(Simmons and Nash, 1987). This is interesting because the HSV-1 IgG Fc receptor, a 
complex comprised of gE and gI (Johnson et al., 1988), is important to protect HSV-1 
against human IgG, but does not bind murine IgG and so would not provide protection 
against IgG during infection of mice (Nagashunmugam et al., 1998).  
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1.6 Aims of the project 
The primary aims of this project are to consider the roles of two NHEJ factors, PAXX 
and DNA-PKcs, during viral infection. To achieve this HSV-1 will be used as a model 
virus. More specifically, we have the following aims: 
- To determine whether PAXX influences HSV-1 infection. 
- To determine whether PAXX has a function in innate immune sensing during 
HSV-1 infection. 
- To determine whether Paxx-/- mice can restrict HSV-1 infection. 
- To further investigate the role of DNA-PKcs in HSV-1 infection.  
We hope that addressing these points will help contribute to the understanding of 
the interactions between NHEJ factors and HSV-1. 
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2 Materials and Methods 
2.1 Cell culture  
Cells were incubated at 37 °C, 5 % CO2, and 3 % O2. Human foetal foreskin 
fibroblasts (HFFFs) and U2OS (human osteosarcoma) cells were grown in Dulbecco’s 
Modified Eagle Medium (DMEM; Gibco) with 10 % volume per volume (v/v) 
heat-inactivated foetal bovine serum (FBS; Seralab), and 50 μg/mL of 
penicillin/streptomycin (P/S; Gibco). Retinal pigment epithelia (RPE-1) cells were 
cultured in DMEM-F12 with Glutamax, 10 % v/v FBS, 0.2 % weight/volume (w/v) 
sodium bicarbonate, and 50 μg/mL P/S. Murine embryonic fibroblasts (MEFs) were 
maintained in DMEM-F12 with Glutamax (Gibco), 15 % v/v FBS, 0.001 % v/v 
2-mercaptoethanol (2-ME), non-essential amino acids (glycine, L-alanine, L-asparagine, 
L-aspartic acid, L-glutamic acid, L-proline, L-serine; all 100 nM), 1 mM sodium 
pyruvate, and 50 μg/mL P/S. Primary cells grown ex vivo were maintained in DMEM-F12 
+ Glutamax-I with 15 % FBS. All cells were routinely tested for contamination with 
mycoplasma using the MycoAlert detection kit (Lonza).  
2.2 Transfection  
2.2.1 TransIT-LT1 transfection 
TransIT-LT1 (Mirus) is a cationic, lipid-mediated transfection reagent. For optimum 
transfection efficiency cells were seeded to be 70-80 % confluent at the point of 
transfection. TransIT-LT1 was mixed with OptiMEM (Gibco) at a ratio of 1:33 and 
incubated at room temperature for 5 minutes. DNA was then added at a ratio of 1 μg 
DNA:3 μl TransIT-LT1, and incubated for a minimum of 15 minutes. The transfection 
mix was then added to the cells directly into the culture medium. 
2.2.2 Nucleofection 
Cells were seeded to be 80 % confluent on the day of nucleofection. The cells were 
washed in phosphate-buffered saline (PBS), and disassociated from the tissue culture 
plate using trypsin (Gibco). The cells were washed in an excess of medium containing 
FBS to inactivate the trypsin, and then washed in PBS to remove the medium, and 
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resuspended in PBS. Cells were counted, and 1.2 x 106 were centrifuged, resuspended in 
120 μl of resuspension buffer (Neon Transfection System, ThermoFisher), and added to 
8 μg of DNA. The cell-DNA mixture was taken up in a gold-coated tip and nucleofected 
at 1400 V for a single pulse of 30 milliseconds using the Neon Transfection System 
(ThermoFisher).  
2.3 PMA stimulation  
Cells were counted and seeded so as to be 70-80 % confluent at the time of 
stimulation. The next day they were starved of serum for three hours prior to 
stimulation with 10 ng/mL of phorbol 12-myristate 13-acetate (PMA) in serum-free 
media. At appropriate time points the RPE-1 cells were harvested and the RNA isolated 
for use in qPCR (Section 2.6.3). 
2.4 Viruses 
2.4.1 HSV-1 viruses 
For consistency, all HSV-1 viruses were grown on U2OS cells because they are 
permissive for viruses lacking ICP0. Strain 17+ (S17) HSV-1 virus was used as the 
wild-type strain and was a kind gift from Professor Stacey Efstathiou. An S17 virus 
lacking ICP0 (referred to in the literature as dl1403) was a kind gift from Professor Gill 
Elliot (Stow and Stow, 1986). dl1403 contains a 2 kb deletion within both the TRL and IRL 
copies of Vmw110 (ICP0) which instead encode 105 amino acids from the original 
N-terminus followed by 56 amino acids altered by a frame shift. It should be noted that 
it has recently been published that, in addition to the loss of ICP0, dl1403 also lacks 
functional gC expression (Cunha et al., 2015). For the purpose of simplicity, dl1403 will 
henceforth be termed ΔICP0 HSV-1. S17 VP26-GFP was a gift from Professor Geoffrey 
Smith (Hollinshead et al., 2012). The ΔgE/VP26-YFP virus derived from a strain-16 (S16) 
parent and was a gift from Dr Colin Crump. In vivo studies used S16 HSV-1 virus 
expressing firefly luciferase under a cytomegalovirus (CMV) promoter, a gift from 
Professor Stacey Efstathiou. 
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2.4.2 Preparation of HSV-1 stocks 
U2OS cells were infected at an MOI of 0.01. Once cytopathic effect was observed in 
all cells (approximately 3 days post infection), cells were scraped into the media and 
centrifuged at 1900 g for 30 minutes. The pellet was resuspended in PBS and 
freeze-thawed three times before being centrifuged again. The resulting supernatant was 
aliquoted and frozen. Aliquoted stocks were thawed no more than twice to prevent 
deterioration of the stock. 
2.4.3 Plaque assay titration of HSV-1 
U2OS or Vero cells were seeded into 6-well plates to be confluent at the time of 
titration. The virus stock was serially diluted ten-fold in DMEM plus 2.5 % v/v FBS, and 
applied to the cells. The plates were rocked every 15 minutes for 1 hour, and then the 
medium was replaced with 1.5 % carboxymethyl cellulose (CMC) complemented with a 
final concentration of 1x minimum essential medium (MEM). The plates were incubated 
at 37 °C, 5 % CO2 and 3 % O2 until plaques were observed. The semi-solid overlay was 
then removed and cells were fixed and stained with 5 % v/v crystal violet (Sigma) and 
25 % v/v ethanol for 1 hr, washed with water, and the plaques were counted.  
2.4.4 Plaque assay titration of VACV 
The Western Reserve (WR, hereafter referred to as wildtype, WT) and modified 
vaccinia Ankara (MVA) strains of vaccinia virus (VACV) were kindly provided by 
Professor Geoffrey Smith. The stocks were serially diluted in duplicate, and titrated onto 
monolayers of BSC-1 cells in 6-well plates cultured in DMEM with 2.5 % v/v FBS and 
50 μg/ml of P/S. The plates were incubated at 37 °C for one hour and rocked every 
15 minutes. The medium was then replaced with 1.5 % carboxymethyl cellulose (CMC) 
complemented with a final concentration of 1x minimum essential medium (MEM) and 
the plates were incubated until large plaques were observed. The cells were stained and 
counted as described for HSV-1 titration.  
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2.4.5 Virus growth curves 
Cells of interest were counted using a Countess (Invitrogen) automated cell counter 
and seeded so that the cell numbers of different genotypes would be within 5 % of each 
other at the time of infection. MEFs were seeded into 6-well plates, and RPE-1 cells were 
seeded into T25 flasks. Prior to infection cells were counted to ensure that different 
genotypes had total numbers within 5 % of each other, and this count was also used to 
calculate the volumes required for specific multiplicities of infection (MOI) between cell 
types. At the desired time post infection, cells were scraped into the growth medium. The 
cell suspensions of all samples were freeze-thawed three times in parallel, and stored 
at -80 °C. Infectious virion numbers were determined by titration of each sample in 
duplicate (Section 2.4.3). 
2.4.6 MOI calculations 
Viral stocks of known titre were used to infect cells at specific MOIs. MOI is 
calculated by dividing the total number of infectious virions by the number of cells. The 
MOI used gives an indication of the proportion of cells which we expect to be infected 
when applied to the Poisson distribution (Fields et al., 2007). A simplification of the 
Poisson distribution can be used to calculate the number of cells infected with one or 
more virions. 
𝑃(𝑘) = 𝑒−𝑚𝑚𝑘/𝑘! 
The Poisson distribution: The proportion of cells infected with k virions, P(k), can be determined using 
the MOI, m. 
𝑃(> 0) = 1 − 𝑒−𝑚 
The Poisson distribution can be simplified to show the number of cells infected with at least one virion. 
 
The above formulae can be used to show that we expect infecting cells with an MOI 
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2.5 DNA manipulation 
2.5.1 Polymerase chain reaction 
The polymerase chain reaction (PCR) was used to amplify DNA sequences of interest 
for the purposes of cloning and genotyping. Primers were specifically designed for this 
purpose (Table 1). PCR was carried out using a Veriti thermocycler (Applied 
Biosystems). When high-fidelity replication was required, Platinum Pfx DNA 
polymerase (ThermoFisher) and its reaction buffer were used. For analyses which did 
not require the maintenance of sequence integrity, for example mouse genotyping by 
PCR, HotStarTaq polymerase (Qiagen) was used.  
Name Sequence (5’-3’) 
Paxx WT (genotyping - F) TCAACCTTGAGTACCGCC 
Paxx WT (genotyping - R) GCTGCCTGCCTTAAGACCTA 
Paxx KO (genotyping - F) GTTCCAGTTAGGGAGGCCAT 
Paxx KO (genotyping - R) CATACAGTACCTGCCAGCCG 
Table 1: Primer sequences used in PCR reactions. 
F = forward primer, R = reverse primer 
 
2.5.2 Agarose gel electrophoresis  
Agarose gel electrophoresis was used to analyse DNA samples, including PCR 
products. Agarose powder was dissolved in Tris, acetic acid, EDTA (TAE) buffer to a 
concentration of 1 or 2 % w/v, and SYBR Safe DNA gel stain (ThermoFisher) was mixed 
in at 1x concentration prior to the gel setting. Gels were run at 100 V until the dye in the 
molecular weight marker (HyperLadder 1kb; Bioline) reached the end of the gel. The gel 
was visualised using an ultraviolet (UV) lamp. 
2.5.3 Purification of DNA from an agarose gel 
DNA bands were excised from agarose gels using a clean scalpel under blue light. 
The QIAquick gel extraction kit (Qiagen) was then used to dissolve the gel and purify 
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the DNA. The concentration and purity of the DNA product was then analysed using a 
NanoDrop 2000 Spectrophotometer. 
2.5.4 Restriction enzyme digestion 
Restriction enzymes (New England Biosciences (NEB)) were used with their 
recommended buffers as supplied by the manufacturer. DNA was digested for 5 hours 
at 37 °C followed by an overnight incubation at 22 °C. 
2.5.5 DNA ligation 
50 ng of vector DNA and insert DNA were incubated in the presence of one unit of 
T4 DNA ligase (Promega) in the buffer provided by the manufacturer at 16 °C overnight. 
The amount of insert was initially adjusted to a molar ratio of 1:3 between the vector and 
the insert, but this ratio was optimised for each ligation reaction. If ligation was intended 
at two sites where the complementary ends are of the same sequence (e.g. insertion of a 
sequence at a single restriction site), prior to ligation 1.7 μg of the vector was incubated 
in a total volume of 20 μL containing one unit of shrimp alkaline phosphatase (SAP) and 
1x buffer supplied by the manufacturer for one hour at 37 °C, followed by heat 
inactivation of the SAP at 65 °C for 15 minutes. SAP treatment increases the specificity of 
the ligation by removing the 5’ phosphate from the ends from the vector, preventing 
religation to recreate the original, undigested vector. 
2.5.6 Creation of chemically competent E. coli 
Competent DH5α Escherichia coli (E. coli) were generated using the following 
protocol: 5 μL of DH5α E. coli were added to 3 mL of super-optimal broth (SOB) and 
incubated at 37 °C in a shaking incubator overnight. The broth was added to a further 
200 mL of SOB, and incubated at 37 °C until the optical density at 595 nm (OD595) 
reached 0.3 - 0.4 relative to a non-inoculated control. The broth was then centrifuged at 
1200 g for 20 minutes at 4 °C. The pellet was resupsended in RF1 buffer (100 mM KCl, 
50 mM MnCl2-4H2O, 30 mM Potassium acetate, 10 mM CaCl2-2H2O, and 15 % v/v 
glycerol, adjusted to pH 5.8 with 10 % v/v glacial acetic acid, and filter-sterilised through 
a pre-rinsed 0.22 μm membrane), and centrifuged at 1200 g for 20 minutes at 4 °C. The 
pellet was resuspended in filter sterilised RF2 buffer (10 mM MOPS pH6.8, 10 mM KCl, 
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75mM CaCl2-2H2O, and 15 % v/v glycerol), incubated on ice for 15 minutes, and then 
aliquoted, flash-frozen and stored at -80 °C. 
2.5.7 Transformation of E. coli, and purification of plasmid DNA 
To propagate DNA plasmids, chemically competent E. coli were mixed with 50 ng of 
the plasmid DNA, and the mixture was incubated on ice for 30 minutes. The E. coli were 
then heat-shocked at 42 °C for 30 seconds, and then placed back on ice for a further two 
minutes. The E. coli were allowed to recover in SOB at 37 °C for 1 hour before plating 
onto an agar plate containing 50 μg/mL kanamycin or 100 μg/mL carbenicillin. Plates 
were then incubated for 16 hours at 37 °C. Bacterial colonies were then picked, and 
allowed to grow in 5 mL or 50 mL of LB broth containing 50 μg/mL of kanamycin or 
100 μg/mL of carbenicillin at 37 °C for 16 hours. From this culture DNA plasmids were 
isolated using QIAprep miniprep and maxiprep kits (Qiagen). 
2.5.8 DNA sequencing 
Sanger DNA sequencing was performed by the Department of Biochemistry, 
University of Cambridge. The non-standard primer used to sequence the PX458 plasmid 
at the BbsI site was GGCTGTTAGAGAGATAATTGG. Sequencing results were analysed 
using MEGA or SnapGene.  
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2.5.9 Creation of concatemerised immunostimulatory DNA 
Immunostimulatory DNA was produced as previously described (Ku and Ferguson, 
2014). Oligomeric ssDNA constructs with complementary sequences (Table 2) were 
ordered from Integrated DNA Technologies (IDT) and resuspended in water to a 
concentration of 10 μg/μl, mixed in equal concentration, and heated to 75 °C for 
15 minutes to remove secondary structures. Subsequent cooling to RT allowed for the 
annealing of the oligomers to create dsDNA oligomers. 50 μL of 60 % w/v PEG8000 
(Sigma) was added to increase the effective concentration of solution, and 
polynucleotide kinase (PNK; Promega) was added in the presence of PNK buffer and 
incubated at 37 °C for 2 hours to phosphorylate the DNA ends in order to increase 
ligation efficiency. 3 units (U) of T4 DNA ligase (Promega) were then incubated with the 








Table 2: ssDNA constructs used in the creation of immunostimulatory DNA 
 
2.5.10 Phenol/chloroform DNA extraction 
Prior to purification, the total volume of the solution was increased by adding 300 μL 
of water. DNA was then purified by mixing with 400 μL of phenol (Fisher Chemical), 
centrifuging at 15,000 g for 1 minute, and isolating the aqueous layer. Phenol was added 
to this again, and the process was repeated three times or until evidence of 
proteinaceous contaminants was no longer visible. 400 μL of chloroform (Fisher 
Chemical) was added to the aqueous layer, and the solution centrifuged at 15,000 g for 
1 minute to remove any phenol contamination. DNA was precipitated by adding 800 μL 
of 100 % ethanol that had been pre-chilled to -20 °C, incubating at -20 °C for 16 hours, 
centrifuging at 15,000 g for 10 minutes, and aspirating the supernatant. The pellet was 
resuspended in 1 mL of 70 % v/v ethanol, and the solution was centrifuged again at 
15,000 g for 10 minutes. The supernatant was removed, and the pellet was allowed to 
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air-dry in the fume hood. Once dry, the pellet was resuspended in 50 μL of 
endotoxin-free water. The length distribution of the constructs was analysed using gel 
electrophoresis (Section 2.5.2), and the concentration ascertained using a NanoDrop 2000 
Spectrophotometer. 
2.5.11 Alternative immunostimulatory DNA creation 
As an alternative to the concatemerised immunostimulatory DNA described in 
Section 2.5.9, complementary ssDNA sequences of 90 bp in length comprised of the same 
sequence used in the concatemerised DNA, but repeated twice (Table 1), were 
resuspended in endotoxin-free water and mixed at a concentration of 500 ng/μL. The 










Table 3: ssDNA used to make alternative immunostimulatory DNA 
 
2.6 Nucleic acid detection assays 
2.6.1 Cellular RNA extraction  
Cells were lysed in situ using 250 μL of lysis buffer containing 4 M guanidine 
thiocyanate, 25 mM Tris pH 7, and 143 mM 2-ME. 250 μL of ethanol was added, and the 
solution was applied to a silica column (Epoch) and centrifuged; all centrifugation steps 
were for 30 seconds at 16,000 g unless stated otherwise. 500 μL of buffer containing 1 M 
guanidine thiocyanate, 25 mM Tris pH7, and 10 % ethanol was applied to the column 
which was then centrifuged. The column was centrifuged with 500 μL of a second wash 
buffer containing 25 mM Tris pH 7 and 70 % v/v ethanol, before a further 500 μL was 
added and centrifuged for 2 minutes at 16,000 g. The RNA was then eluted by adding 
30 μL of nuclease-free water and centrifuging at 16,000 g for 1 minute. The resulting 
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eluent was then passed back through the same column. RNA concentration was 
determined using a NanoDrop 2000 Spectrophotometer. 
2.6.2 cDNA synthesis 
Complementary DNA (cDNA) was generated from 500 ng of RNA. 1 μL of a 10 mM 
deoxynucleotide (dNTP) mixture and 500 ng of oligo(dT) (both Thermo Scientific) were 
incubated with the RNA at 65 °C for 5 minutes in a total volume of 13 uL. 40 U of 
RNaseOUT recombinant RNase inhibitor (Invitrogen), 50 U of Superscript III Reverse 
Transcriptase (Invitrogen), 2 μL of 10x first strand buffer, and 1 μL of 0.1 M 
dithiothreitol (DTT) were then added and the volume made up to 20 μL. This solution 
was incubated for 1 hour at 50 °C, and then at 72 °C for 15 minutes. 
2.6.3 Quantitative real time-polymerase chain reaction (qPCR) 
cDNA was diluted 1:3 in nuclease-free water prior to analysis. Each sample was 
analysed in duplicate, as a minimum. 2 μL of cDNA was added to the wells of a 
MicroAmp Fast Optical 96-well or 384-well reaction plate (Applied Biosystems). A 
mastermix was made containing 5 μL Fast SYBR Green Master Mix (Life Technologies) 
and 1 μL of 10 mM stocks of each of a forward and reverse primer per well, and 7 μL 
was added per well. The primers used for SYBR Green qPCR listed by species in  
Table 4. The plate was centrifuged for 1 minute at 180 g before being analysed on a 
7500 Fast Real-Time PCR System (Applied Biosystems). Following an initial 30 second 
melting step, 40 cycles of 3 seconds at 95 °C, and 30 seconds at 60 °C were used. The Ct 
value was exported and analysed relative to a housekeeping gene and control sample, 
where applicable.  
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Gene Forward Primer Reverse Primer 
Human 
PPIA TCCTGGCATCTTGTCCATG CCATCCAACCACTCAGTCTTG 
GAPDH ACCCAGAAGACTGTGGATGG TTCTAGACGGCAGGTCAGGT 
PRKDC CTGTGCAACTTCACTAAGTCCA CAATCTGAGGACGAATTGCCT 
PAXX TTCGTGTGCTACTGCGAAGG GTGAAGCAGGTGCTCCAAAG 
XRCC5 AGAAGAAGGCCAGCTTTGAG AGCTGTGACAGAACTTCCAG 
EGR1 AGCACCTGACCGCAGAGTCT AGATGGTGCTGAGGACGAGG 
CFOS CTGGCGTTGTGAAGACCAT TCCCTTCGGATTCTCCTTTT 
Murine 
Hprt GTTGGATACAGGCCAGACTTTGTTG GATTCAACTTGCGCTCATCTTAGGC 
Cxcl10 ACTGCATCCATATCGATGAC TTCATCGTGGCAATGATCTC 
Egr1 TCCTCTCCATCACATGCCTG CACTCTGACACATGCTCCAG 
Ifna* ARSYTGTSTGATGCARCAGGT GGWACACAGTGATCCTGTGG 
Ifnb CATCAACTATAAGCAGCTCCA TTCAAGTGGAGAGCAGTTGAG 
Isg15 GCAAGCAGCCAGAAGCAGACTCC CGGACACCAGGAAATCGTTACCCC 
Isg54 ATGAAGACGGTGCTGAATACTAGTGA TGGTGAGGGCTTTCTTTTTCC 
Cjun CCAGAAGATGGTGTGGTGTTT CTGACCCTCTCCCCTTGC 
Cfos CCTTCGGATTCTCCGTTTCTCT TGGTGAAGACCGTGTCAGGA 
Nfkbia CTGCAGGCCACCAACTACAA CAGCACCCAAAGTCACCAAGT 
HSV-1 
ICP27 GTGCAAGATGTGCATCCACCACAACCTGCC GCCAGAATGACAAACACGAAGGATGCAATG 
gB TGTGTACATGTCCCCGTTTTACG GCGTAGAAGCCGTCAACCT 
US11 CTTCAGATGGCTTCGAGATCGTAG TGTTTACTTAAAAGGCGTGCCGT 
ICP4 GACGTGCGCGTGGTGGTGCTGTACTCG GCGCACGGTGTTGACCACGATGAGCC 
US1 ATGCAATGCTACGGCGCTCGGT ACAGCTGATTGATACACTGGCGC 
 
Table 4: Primer pairs used in qPCR 
*Murine Ifna primers detect all Ifna subsets except Ifna4 
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2.6.4 Isolation of cellular and viral DNA for quantification by qPCR 
qPCR was used to quantify the relative numbers of viral genomes in HSV-1 infected 
cells. Infected cells were scraped into growth medium, centrifuged for 5 minutes at 
400 g, and the resulting pellet was resuspended in lysis buffer consisting of 5 μM 
sodium dodecyl sulphate (SDS), 10 mM Tris-HCl pH 8.3, and 100 μg/mL proteinase K. 
The amount of lysis buffer added was approximately 10x the volume of the cell pellet. 
The cells and buffer were then incubated at 50 °C for 90 minutes, before the proteinase K 
was deactivated by heating to 95 °C for 10 minutes.  
2.6.5 Quantification of viral DNA by qPCR 
For qPCR of cellular and viral genomes, primers and probes against the promoter 
regions of human GAPDH (glyceraldehyde 3-phosphate dehydrogenase) and HSV-1 
ICP0 were used (Table 5), and these were tagged with the fluorophores Cy5 (cyanine5) 
and FAM (6-carboxyfluorescein), respectively, coupled with the BlackBerry quencher 
(BBQ). A mastermix was created with final concentrations of 8 mM MgCl2 (Qiagen), 
0.8 mM dNTPs (Thermo Scientific), 5 % v/v DMSO, 0.8 U of HotStarTaq DNA 
polymerase (Qiagen), and Taq polymerase buffer. Primers and probes (TIB Molbiol) 
were added at concentrations that were previously optimised (Table 5). 19 μL of this 
mastermix was added per tube. Samples were analysed in triplicate by adding 1 μL of 
isolated cellular viral DNA (Section 2.6.4) to the appropriate tubes. A plasmid containing 
the GAPDH promoter region and one with the ICP0 promoter region were mixed and 
serially diluted at known concentrations. 1 μL of each of the dilution series were mixed 
with 19 μL of the mastermix and analysed to create a standard curve. qPCR of the 
samples and standards was carried out simultaneously on a Rotorgene 3000 (Corbett 
Research). The reaction was held at 95 °C for 15 minutes, before 45 cycles of 95 °C for 
30 seconds, and 60 °C for 60 seconds (the latter being the acquisition stage).  
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Name Sequence Final 
concentration 
ICP0 (forward primer)  GGAAAGGCGTGGGGTATAA 24 nM 
ICP0 (reverse primer)  AACGTAGGCGGGGCTTC 72 nM 
ICP0 probe 6FAM-TCGCATTTGCACCTCGGCAC-BBQ 50 nM 
GAPDH (forward primer) CGGCTACTAGCGGTTTTACG 72 nM 
GAPDH (reverse primer) AAGAAGATGCGGCTGACTGT 24 nM 
GAPDH probe Cy5-CACGTAGCTCAGGCCTCAAGACCT-BBQ 50 nM 
Table 5: Primers and probes used in TaqMan qPCR of cellular and viral DNA. 
 
2.6.6 Isolation of viral DNA for southern blotting 
Infected cells were scraped into the growth medium, and centrifuged at 400 g for five 
minutes. The pellet was resuspended in 1.6 mL of buffer containing 10 mM Tris, 50 mM 
EDTA, 0.5% SDS w/v and 163 mg/ml proteinase K before incubation at 37 °C overnight. 
The next day an equal volume of phenol and was added and gently mixed before the 
solution was centrifuged for 10 minutes at 1600 g and 20 °C. The top, aqueous layer was 
transferred to a clean tube, and the phenol wash was repeated. An equal volume of 
chloroform was added to the aqueous layer, and the solution was centrifuged for 
10 minutes at 1600 g and 20 °C. The aqueous layer was isolated and NaCl was added to a 
final concentration of 0.2 M. After mixing gently but thoroughly, absolute ethanol was 
added to a final concentration of 29 % v/v, and the solution mixed gently but thoroughly 
once more. The sample was then kept at -20 °C overnight before 15 minutes of 
centrifugation at 2900 g and 4 °C. The supernatant was removed and the precipitated 
DNA pellet was allowed to air-dry for several hours before being gently resuspended in 
300 μL of 10 mM Tris and 1 mM EDTA. The samples were then heated to 65 °C to 
increase the accuracy of the measurement of concentration by a NanoDrop 2000 
Spectrophotometer. The samples were stored at 4 °C until they were used. 
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2.6.7 Creation of hybridisation probe for southern blotting 
The HSV-1 BamHI K fragment (nucleotides 123459 to 129403 of strain S17) (McGeoch 
et al., 1988) was excised from a donor plasmid (pAT153 containing fragment Kpn A) and 
gel-purified. 100 ng of the excised fragment was added to nuclease-free water to a total 
volume of 34 μL. After boiling for 5 minutes, the solution was placed on ice for five 
minutes. A dNTP mix was created with final concentrations of 0.17 mM biotin-14-dATP 
(Invitrogen), 0.17 mM biotin-14-dCTP (Invitrogen), and 0.98 mM of each of dATP, dTTP, 
dGTP, and dCTP. The BamHI K fragment was then added to 5 μL of the dNTP mix, 1 μL 
of Klenow enzyme (NEB), and 10 μL of 5x labelling mix (NEB) and incubated at 37 °C 
for 3 hours. 200 μg of salmon sperm DNA and 30 μL of water were added prior to 
purification using a Qiagen PCR purification kit. 
2.6.8 Southern blotting 
Prior to southern blotting, isolated DNA (as described in Section 2.6.6) was digested 
with BamHI. The samples were then analysed on a NanoDrop 2000 Spectrophotometer, 
and an equal mass of DNA from each sample was loaded onto a 0.8 % w/v agarose gel 
containing ethidium bromide. Biotinylated molecular weight markers (NEB) were also 
loaded. The gel was run at 16 V overnight, and once sufficient separation of the samples 
was observed, the gel was rocked in 0.25 M HCl for 20 minutes to inefficiently hydrolyse 
the DNA and thereby improve transfer efficiency. The gel was then rocked in 0.4 M 
NaOH for 30 minutes. The semi-dry transfer apparatus was assembled on a layer of 
clingfilm (Figure 5). Four sheets of grade 3MM blotting paper (Sartorius Stadium 
Biotechnology) were soaked in 0.4 M NaOH, and air bubbles were excluded by rolling 
the paper flat. The gel was carefully placed on top and bubbles were rolled out. Biodyne 
B filter paper was wetted with water, briefly soaked in 0.4 mM NaOH, and placed on top 
of the gel. Four pieces of dry 3MM blotting paper followed by paper towels were 
stacked on top, and weights were applied to maintain pressure on the gel. The transfer 
was left overnight.  
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Figure 5: Schematic representation of the system used to transfer DNA from an agarose gel to filter paper. 
 
The filter paper was washed in 4x standard saline phosphate EDTA (SSPE, pH 7.4; 
750 mM NaCl, 800 mM NaH2PO4.H2O, and 20 mM Na2EDTA.2H2O) for 30 minutes. 
The filter paper was blocked in prehybridisation buffer (final concentrations of 
1x Denhardt’s solution, 200 μg/ml boiled salmon sperm DNA, 4x SSPE, 2 % w/v SDS, 
and 10 % w/v dextran sulphate) at 65 °C in a hybridisation oven for a two hours. The 
probe (Section 2.6.7) was then added to the prehybridisation buffer and allowed to 
hybridise at 65 °C overnight. The filter paper was washed twice in each of three wash 
buffers (2x SSPE; 2x SSPE, 1% w/v SDS; 0.1x SSPE) for 15 minutes at 65 °C. The filter 
paper was then incubated at room temperature in Odyssey block (LI-COR Biosciences) 
containing 1.2 % w/v SDS for 30 minutes, followed by a 30 minute incubation in Odyssey 
block, 1.2 % w/v SDS, and Streptavidin-IRDye 800 CW (LI-COR Biosciences). The filter 
paper was washed in PBST three times, and visualised using a LI-COR imaging system. 
2.7 Cellular genome manipulation 
2.7.1 CRISPR/Cas9 sgRNAs and plasmids  
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) and 
CRISPR-associated 9 (Cas9) were used to manipulate the PRKDC gene which encodes 
DNA-PKcs in RPE-1 cells. Single-guide RNAs (sgRNAs) creating a truncation within the 
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kinase domain (in the 83rd exon at approximately the 11782nd nucleotide of the coding 
sequence) of the PRKDC gene were designed and provided in the plasmid pD1301-AD 
as a kind gift by Horizon Biotechnology. pD1301-AD contains Cas9 under the CMV IE1 
promoter and enhancer, and the sgRNAs were under the control of the U6 promoter. 
DasherGFP is also encoded as a selection marker. sgRNAs targeting the 2nd exon of 
PRKDC (cutting at approximately the 205th nucleotide of the coding sequence) were 
designed using the human genomic PRKDC sequence available on Ensembl 
(ENSG00000253729, www.ensembl.org). Exons which were potential targets for CRISPR 
were analysed for sgRNA binding sites using the Broad Institute sgRNA Designer 
(www.broadinstitute.org/rnai/public/analysis-tools/sgrna-design). This tool provides 
information on the predicted on-target efficiency and probability of off-target effects for 
each sgRNA. In addition, sgRNAs containing PAM or repetitive sequences were 
avoided. sgRNAs were commercially synthesised as complementary DNA 
oligonucleotides, which were annealed and cloned into PX458 under the control of the 
U6 promoter and adjoining the sgRNA scaffold using a Bbs1 restriction site. PX458 was 
created by the Zhang lab (Ran et al., 2013), and encodes Cas9 under the control of the 
chicken β-actin promoter and CMV enhancer. It also encodes EGFP for selection 
purposes. The guide RNA sequences and the plasmids that they were delivered in are 
shown in Table 6. 
Name Plasmid sgRNA 
PRKDC N-terminal sgRNA PX458 (Cas9; EGFP) TTAACTCTTTAGCAATGCCT 
PRKDC Kinase sgRNA1 pD1301-AD (Cas9; GFP) GATCACGCCGCCAGTCTCCA 
PRKDC Kinase sgRNA2 pD1301-AD (Cas9; GFP) CAGACATCTGAACAACTTTA 
Table 6: The plasmids and sgRNAs used to induce mutations in PRKDC with CRISPR-Cas9 
 
2.7.2 Nucleofection, sorting, and isolation of CRISPR/Cas9 clones 
Transfection of RPE-1 cells with TransIT-LT1 is toxic, and so 8 µg of plasmids 
containing Cas9 and sgRNAs (Table 6) were nucleofected into RPE-1 cells (Section 2.2.2). 
Following nucleofection the cells were allowed to recover in a 10 cm dish in full media. 
After 48 hours GFP-positive cells were sorted into a well of a 6-well plate using an 
Astrios cell sorter. Once confluency was reached, the cells were seeded into a 6 cm dish 
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at a density of 500 cells per dish, and allowed to grow out into individual colonies. Once 
a sizeable colony was formed, trypsin was used to dissociate the cells from the dish so 
that a single colony could be picked and transferred to a well of a 96-well plate (this 
approach was taken because when cells were sorted individually into wells of a 96-well 
plate the RPE-1 cells did not survive). The clones were expanded, and the seeding of 500 
cells per dish was repeated, and further sub-clones created. The expression of the protein 
of interest was analysed by immunofluorescence and immunoblotting.  
2.8 Microscopy 
2.8.1 Immunofluorescence 
Coverslips with a diameter of 13 mm were sterilised in a 24-well plate by 
submerging in 70 % v/v ethanol for 10 minutes, and were subsequently washed twice in 
sterile PBS. Cells were seeded in standard growth medium onto sterile coverslips to be 
60-70 % confluency at the time of fixation, unless 100% confluency was required for 
infection. Cells were fixed by aspirating the medium and then incubating in 250 mM pH 
7.4 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES) with 4 % w/v 
paraformaldehyde (PFA) at 4 °C, and then a further 10 minutes in 8 % PFA and 250 mM 
pH 7.4 HEPES. The coverslips were washed twice in PBS, permeabilised in 1 % v/v triton 
X-100 in PBS for 5 minutes, and washed twice more in PBS. 5 % w/v milk from powder 
(Premier Food Groups) in PBS was used as a blocking agent for 1 hour at room 
temperature on a rocking platform. Primary antibodies (Table 7) were diluted to their 
working concentrations in 1 % w/v milk in PBS, and 50 μL of the dilution was pipetted 
onto a sheet of Parafilm M (Bemis). The coverslips were placed sample-side down onto 
the antibodies, and incubated at room temperature in a humidified chamber in the dark 
for 1 hour. Following this incubation, the coverslips were washed three times in PBS, 
and then incubated for 30 minutes in 200 μL of fluorophore-conjugated secondary 
antibodies (anti-rabbit or anti-mouse conjugated to Alexa Fluor488 or Alexa Fluor546; 
Invitrogen) diluted 1:1000 in 1 % w/v milk. The plates were washed twice in PBS and 
once in water. Coverslips were mounted onto slides using 10 μL of mounting solution 
(25 % glycerol v/v, 0.1 M Tris pH 8.5, 10 % Mowiol 4-88 w/v containing 
4',6-diamidino-2-phenylindole (DAPI)) and allowed to set in the dark overnight. 
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Samples were visualised and imaged using a Zeiss Pascal Confocal Microscope at 
63x magnification through oil, and images were collected using Zeiss LSM Image 
Browser. 
Antibody target Source Dilution 
DNA-PKcs (monoclonal cocktail) Thermo Scientific (MS423P1) 1:250 
DNA-PKcs (N-terminus) Abcam (ab1832) 1:250 
PAXX Sigma (HPA045268) 1:1,000 
Table 7: Primary antibodies used in immunofluorescence microscopy 
2.8.2 Electron microscopy 
Samples were prepared as previously described (Hollinshead et al., 2012). 3.5 cm 
dishes were infected at an MOI of 4 on ice for 1 hour to synchronise the infection, before 
being moved to 37 °C. After 12 hours at 37 °C the cells were fixed in their dish using a 
fixation buffer comprising 0.5 % v/v glutaraldehyde in 200 mM sodium cacodylate 
buffer for 30 minutes, and washed in fresh fixation buffer. Secondary fixation was 
achieved in 1 % w/v osmium tetroxide and 1.5 % w/v potassium ferricyanide for 
60 minutes. The samples were washed in distilled water and stained overnight in 0.5 % 
w/v magnesium uranyl acetate. The next day samples were washed again in distilled 
water, dehydrated in graded ethanol, and embedded in Epon resin in the dish. Ultrathin 
sections (typically 50-70 nm) were cut parallel to the dish and examined using an FEI 
Tecnai electron microscope with CCD camera image acquisition. 
2.9 Immunoblotting  
2.9.1 Preparation of whole cell lysates 
Cells were scraped into the medium, and the suspension was centrifuged at 1900 g 
for 5 minutes. The supernatant was aspirated, and the pellet resuspended in PBS before 
centrifuging at 1900 g for 5 minutes. The supernatant was aspirated again, and the cells 
were lysed in 250-500 μL of lysis buffer (150 mM NaCl, 20 mM Tris-HCl (pH 7.4), 10 mM 
CaCl2, 0.1% v/v triton X-100, and 10 % v/v glycerol) on ice for 30 minutes. When 
immunoblotting for phosphorylated proteins 10 mM sodium orthovanadate and 50 mM 
sodium fluoride were added to the lysis buffer to inhibit phosphatase activity, and 
cOmplete Mini EDTA-free protease inhibitors (Roche) were used to prevent protease 
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activity. After the 30 minutes the cell lysate was centrifuged at 16,000 g at 4 °C for 
10 minutes to pellet genomic DNA. The supernatant was flash-frozen in liquid nitrogen 
and stored at -80 °C. Prior to loading onto a gel, a bicinchoninic acid (BCA) assay 
(Thermo Scientific) was used to determine protein concentrations, allowing for the equal 
loading of protein samples. 6x sample loading buffer (300 mM Tris-HCl (pH6.8), 12 % 
w/v SDS, 60 % v/v glycerol, 0.6 % w/v bromophenol blue, and 600 μM 2-ME) was added 
to the samples before they were heated to 94 °C for 5 minutes prior to electrophoresis. 
2.9.2 Separating protein samples into cytoplasmic and nuclear 
fractions 
To create separate cytoplasmic and nuclear protein samples for immunoblotting a 
NE-PER nuclear and cytoplasmic extraction kit (Thermo Scientific) was used. This kit 
allows for the lysis of the outer cell membrane and nuclear membrane independently, 
and therefore soluble protein from these compartments can be harvested separately. 
2.9.3 Sodium dodecyl sulphate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS polyacrylamide gels were created using a Bio-rad Protean III system. The 
running gel comprised of 12 % v/v polyacrylamide, 0.39 M Tris (pH 8.8), 0.1 % w/v SDS, 
0.1 % w/v ammonium persulphate (APS), and 0.04 % w/v tetramethylethylenediamine 
(TEMED). The stacking gel comprised of 5 % v/v polyacrylamide, 0.13 M Tris (pH 6.8), 
0.1 % w/v SDS, 0.1 % w/v APS, and 0.1 % w/v TEMED. Running buffer contained 
2.5 mM Tris Base, 19.2 mM glycine, and 0.01 % w/v SDS. Samples were loaded in the 
wells in the stacking gel, and the system was run at 190 V for 55 minutes prior to 
analysis by immunoblotting.  
2.9.4 Nu-PAGE 
Precast 4-12 % bis-Tris gradient Nu-PAGE gels (Invitrogen) were used to blot higher 
molecular weight proteins. Gels were run in MES-SDS running buffer (Invitrogen) using 
the Novex Mini-Cell (Invitrogen) at 190 V for 50 minutes.  
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2.9.5 Semi-dry transfer 
SDS-PAGE and Nu-PAGE gels were equilibrated in transfer buffer (20 % v/v 
methanol, 2.5 mM Tris Base, and 19.2 mM glycine) for 5 and 15 minutes respectively. 
Nitrocellulose membrane (GE Healthcare) and blot paper (BioRad) were soaked in the 
transfer buffer, and a stack was created comprising (from bottom to top) blotting paper, 
nitrocellulose membrane, the equilibrated gel, and another layer of blotting paper. Air 
bubbles were removed from the stack using a roller. To transfer the bottom of the stack 
was placed next to the positive electrode. The proteins were transferred from the SDS-
PAGE gel to the nitrocellulose paper using a Trans-Blot Turbo semi-dry transfer 
machine (BioRad) at 25 V for 30 minutes. Protein was transferred from Nu-PAGE gels to 
nitrocellulose membrane using a Transblot SD semi-dry transfer cell (BioRad) for 
26 minutes at 18 V.  
2.9.6 Immunoblotting 
Following transfer of proteins to nitrocellulose membrane, the membrane was 
blocked in 5 % w/v milk for 1 hour. The membrane was washed three times in PBS with 
0.025 % v/v tween 20 (PBST), and incubated overnight at 4 °C in primary antibody (Table 
8) diluted in PBST. After three washes in PBST the membrane was incubated for two 
hours in 5 % w/v milk containing horseradish peroxidase (HRP)-conjugated secondary 
antibodies (Table 8). The membrane was washed three times in PBST. Enhanced 
chemiluminescent (ECL) reagent (125 mM luminol, 0.4 mM curaric acid, 0.1 M Tris 
pH 8.8) was applied to the membrane, and the signal detected using developing film 
(Kodak or GE Healthcare) in a dark room using a film processor (SRX101A, Konica 
Minolta). 
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Target Source Dilution 
DNA-PKcs (monoclonal cocktail) Thermo Scientific (MS423P1) 1:3,000 
DNA-PKcs (N-terminus) Abcam (ab1832) 1:1,000 
PARP-1 Abcam (ab6079) 1:1,000 
ICP0 Abcam (ab6513) 1:2,000 
Ku80 Santa Cruz (sc1483) 1:500 
Ku70 Abcam (ab3114) 1:1,000 
Tubulin Millipore (05-829) 1:15,000 
PAXX Sigma (HPA045268) 1:1,000 
HSV-1 VP22 Gift from G. Smith (AGV031) 1:20,000 
Mouse antibody (HRP-conjugated) Sigma (A4416) 1:10,000 
Rabbit antibody (HRP-conjugated) Sigma (A6154) 1:20,000 
Goat antibody (HRP-conjugated) Sigma (A5420) 1:20,000 
Table 8: Antibodies and their respective dilutions used in western blotting 
 
2.10 In vivo and ex vivo work 
2.10.1 Mice 
This research has been regulated under the Animals (Scientific Procedures) Act 1986 
Amendment Regulations 2012 following ethical review by the University of Cambridge 
Animal Welfare and Ethical Review Body (AWERB). Paxx-/-C57BL/6 mice and their WT 
counterparts were a kind gift from Professor Steve Jackson (Gurdon Institute, University 
of Cambridge). Mice were maintained under pathogen-free conditions. During 
experiments mice were weighed daily Mice set aside for breeding were not subsequently 
used in experiments. Mice were culled by dislocation of the cervical vertebrae. 
2.10.2 Genotyping mice 
Prior to experimentation the genotypes of the mice were confirmed by PCR. 
Genomic DNA was extracted from an ear clip by incubating it in 75 μL of alkaline lysis 
reagent (25 mM NaOH and 0.2 mM EDTA) at 95 °C for one hour. The sample was cooled 
to 4 °C, and 75 μL of neutralisation buffer (40 mM Tris HCl, pH 5) was added. 1 μL of 
the resultant solution was used as a template for PCR using HotStar Taq and the PAXX 
genotyping primers shown in Table 1 (Section 2.5.1). 
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2.10.3 Infection 
Luciferase-expressing HSV-1 virus stocks were diluted in sterile PBS to a 
concentration of 2.5 x 107 plaque-forming units (PFU)/ml. 20 μL of the diluted stock was 
injected intradermally into each whisker pad of the mice to be infected, resulting in the 
delivery of 1 x 106 PFU per mouse. Mice to be left uninfected were injected with 
equivalent volumes of sterile PBS. Injections were carried out under isofluorane 
anaesthesia. All virus dilutions were back-titrated (per normal HSV-1 titration) to ensure 
that the inoculation doses were accurate. 
2.10.4 Detecting luciferase activity using an in vivo imaging system 
(IVIS) 
The mice were injected intraperitoneally with 150 μg of luciferin (Xenogen) in 10 μL 
of PBS per gram of bodyweight under isofluorane-induced anaesthesia. After 20 minutes 
an in vitro imaging system (IVIS) Lumina Series (Perkin Elmer) machine was used to 
detect the luciferase-catalysed oxidation of luciferin. Living Image software (Perkin 
Elmer) allowed for the quantification of light emitted in photons/second. 
2.10.5 Isolation of cells from the spleen  
The spleen of each mouse was harvested under sterile conditions, and they were 
kept separately on ice in PBS. Tissue was forced through a 70 μm cell strainer (Falcon) 
using a sterile microcentrifuge tube, and the filter was then washed 3 times with PBS. 
The resulting cell suspension was centrifuged at 400 g for 5 minutes at 4 °C. The 
supernatant was discarded and the pellet resuspended in BD Pharm Lyse (BD 
Biosciences) to lyse erythrocytes. The cells were washed twice by centrifuging at 300 g 
for 5 minutes at 4 °C in RPMI media containing 50 μg/mL of penicillin and streptomycin, 
and 10 % v/v FBS. The pellet was resupended in fresh media, and passed through a 
70 μm pre-separation filter (Miltenyi). The cells were counted using trypan blue and an 
automated cell counter (Countess, Invitrogen) and resuspended to a concentration of 
one million cells per mL, and 6 mL was used per T25 flask. 
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2.10.6 Lymphocyte stimulation 
A protein transport inhibitor cocktail (eBioscience) containing brefeldin A and 
monensin (used at final concentrations of 10.6 nM and 2 nM, respectively) were added 
directly to the media of all conditions to prevent degranulation of the lymphocytes and 
promote the retention of synthesised protein. Lymphocytes were stimulated by one of 
two methods. The primary method was the addition of a cell stimulation cocktail 
(eBioscience) directly to the media. This contained PMA and ionomycin (used at final 
concentrations of 81 nM and 1.34 μM, respectively). The second method of stimulation 
involved the addition of a synthesised section of the HSV-1 peptide gB2 (AnaSpec). This 
peptide consists of amino acids 498-505 of gB (SSIEFARL) and was certified as 97 % pure 
by high pressure liquid chromatography by the supplier. The gB2 peptide was used at 
concentrations within the range 10-7 to 10-6 M. Following the addition of the appropriate 
stimulant, lymphocytes were incubated at 37 °C, 5 % CO2, and 3 % O2 for four hours. 
Transport inhibitor cocktail was added simultaneously during PMA stimulation, but for 
gB stimulation the inhibitor was added one hour after the peptide was added. Following 
stimulation, cells were scraped from their flasks and washed twice in PBS and stained 
for flow cytometry (Section 2.10.8). 
2.10.7 Isolation of cells from lymph nodes 
Lymph nodes were harvested under sterile conditions, and placed on ice in PBS. 
Lymph nodes were forced through a 70 μm cell strainer (Falcon), which was then 
washed 3 times with PBS. The resulting cell suspension was centrifuged at 400 g for five 
minutes at 4 °C. The supernatant was discarded and the pellet resuspended in BD 
Pharm Lyse (BD Biosciences) to lyse erythrocytes. The cells were washed twice by 
centrifuging at 300 g for 5 minutes at 4 °C in PBS. The pellet was resuspended in PBS, 
and passed through a 70 μm pre-separation filter (Miltenyi). The cells were counted 
using trypan blue and an automated cell counter (Invitrogen). 
2.10.8 Staining cells for flow cytometry 
Cells were counted and resuspended to a concentration of 5 million cells/mL in PBS. 
Zombie Green dye (BioLegend) was diluted 1:400 in the cell suspension, and the 
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suspension was incubated at room temperature for 20 minutes in the dark. The cells 
were washed once in PBS at 300 g for 4 minutes, and the pellet resuspended in 100 μL of 
PBS. 2 μL of purified rat anti-mouse CD16/CD32 (Mouse BD Fc Block) was added to 
each sample at 4 °C for 5 minutes. Antibodies (Table 9) were added to perform surface 
staining, and incubated for 20 minutes in the dark at room temperature. The samples 
were then washed in 200 μL of PBS for 4 minutes at 300 g, resuspended in 4 % w/v PFA 
in PBS, and transferred to FACS tubes for analysis. Cells were analysed by flow 




Alexa Fluor® 647 Mouse IgG1, κ Isotype Ctrl 400155 BioLegend 
CD19-BV421 (1D3) 562701 BD 
CD3-APC (145-2C11) 553066 BD 
CD3ε-BV605 (145-2C11) 100351 BioLegend 
CD3ε-BV605 (145-2C11) 100351 BioLegend 
CD4-APC-H7 (GK1.5) 560181 BD 
CD44-BB515 (IM7) 564587 BD 
CD45-PerCP (30-F11) 557235 BD 
CD62L-APC-Cy7 (MEL-14) 104428 BioLegend 
CD62L-APC-Cy7 (MEL-14) 104428 BioLegend 
CD8α-APC-R700 (53-6.7) 564983 BD 
CD8α-PE (53-6.7) 100708 BioLegend 
CXCR5-APC-R700 (2G8) 565503 BD 
GzmB-AF647 (GB11) 515406 BioLegend 
IFNγ-PE (XMG1.2) 505808 BioLegend 
TNFα-APC (MP6-XT22) 506308 Biolegend 
NK1.1-BV421 (PK136) 562921 BD 
NK1.1-BV605 (PK136) 108739 BioLegend 
PD1 (CD279)-APC (J43) 562671 BD 
PE Rat IgG1, κ Isotype Ctrl Antibody, κ 
Isotype Ctrl 
400408 BD 
Table 9: Antibodies used in the flow cytometry analysis of murine tissue 
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2.10.9 Isolation and culture of murine skin cells 
WT C57BL/6, or WT or Prkdc-/- C129 mice were euthanised in a carbon dioxide 
chamber by increasing carbon dioxide concentration, and immediately dissected. The fur 
of the mouse was sterilised with 70 % v/v ethanol, and skin sections of approximately 
1 cm2 were taken from the armpit or scalp. These regions were preferential due to their 
relatively low levels of fat which can interfere with enzymatic digestion. Skin was stored 
in sterile phosphate buffer saline (PBS) on ice and then the tissue was chopped up into 
fine pieces using scalpels before digesting with 0.14 Wünsch U/mL of liberase (Roche) in 
10 mL of DMEM/F12 media (Gibco) at 37 °C until the tissue became white and fibrous. 
The digested tissue was plated into 6 cm dishes and cultured in DMEM with 50 μg/mL 
penicillin-streptomycin and 15 % v/v FBS at 37 °C. 
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3 The role of PAXX in HSV-1 infection 
3.1 Introduction 
There are many interactions between proteins in the DDR and viruses. Our 
laboratory became specifically interested in the NHEJ machinery in this context 
following identification of the DNA-PK complex as an innate immune sensor of foreign 
intracellular DNA (Ferguson et al., 2012). These findings have since been confirmed by 
other labs (Li et al., 2016; Morchikh et al., 2017; Sui et al., 2017) and, along with the 
literature describing how other DDR proteins can affect innate immunity (Section 1.3.1) 
and contribute to DNA virus restriction (Section 1.2), led us to hypothesise that other 
NHEJ proteins might regulate innate immune responses to DNA viruses. Our laboratory 
identified PAXX as a cytoplasmic DNA-binding protein (B. Ferguson, unpublished data) 
and so, since any function of PAXX in infection is unknown, we aimed to establish 
whether PAXX regulates the host cell response to DNA virus infection. 
For these experiments, HSV-1 was selected as a model virus because it is regulated 
by other members of the NHEJ complex, including XRCC4 and LIG4 (Muylaert and 
Elias, 2007) and has been established as a model system for studying innate sensors of 
intracellular, foreign DNA (Ferguson et al., 2012; Orzalli et al., 2015; Unterholzner et al., 
2010). The primary aim of the experiments presented in this chapter is, therefore, to 
establish whether PAXX affects the HSV-1 infection cycle.  
3.2 PAXX restricts production of infectious HSV-1 virions 
To establish whether PAXX functions to regulate HSV-1 infection we infected RPE-1 
cells in which the PAXX gene has been deleted by CRISPR/Cas9 (previously described, 
Ochi et al., 2015). Infectious virus was then titrated onto Vero cells to determine the 
production of plaque-forming units (infectious virions; PFU) by WT and PAXX-/- RPE-1 
cells. RPE-1 cells were chosen because they are human epithelial cells which have 
retained epithelial characteristics despite immortalisation (Davis et al., 1995). Epithelial 
cells are naturally infected by HSV-1, and RPE-1 cells are also interesting in the context 
of HSV-1 because the ocular infection model through the cornea is frequently used in 
mouse models of HSV-1 infection (Kollias et al., 2015). Under the assumption that all 
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viable virions infect a cell, infection at MOI 4 should result in infection of over 98 % of 
cells according to the Poisson distribution (Section 2.4.6) (Fields et al., 2007). Therefore 
infection at MOI 4 results in single-step growth curves whereby virion production can be 
measured without considering confounding variables such as cell-to-cell spread. 
Infection at MOI 0.01 results in less than one percent of cells becoming infected (Section 
2.4.6), and as such a multi-step growth curve is created whereby the amount of 
infectious virus produced is reliant upon secondary infection as well as virion 
production. Although I contributed towards the infections, titrations, and analysis, the 
growth curves shown here were primarily conducted by a colleague. WT or PAXX-/- 
RPE-1 cells were infected at an MOI of 0.01, 2, or 4, and the amount of infectious virus 
produced was quantified by titration on Vero cells (Figure 6). After 48 hours of infection 
Figure 6: PAXX-deficient cells produce more infectious HSV-1 virions.  
WT and PAXX-/- RPE-1 cells were infected with HSV-1 at an MOI of A) 0.01, B) 2, or C) 4 for the time 
indicated, and subsequently infectious virus was titrated onto Vero cells. D) WT and Paxx-/- MEFs were 
infected at an MOI of 0.01 for the indicated times, and infectious virus was titrated onto Vero cells. All data 
points are the mean of a triplicate, and the data are representative of at least three independent experiments. 
Error bars show intra-experimental mean +/- standard error of the mean (SEM), and statistical significance, 
calculated using the Student’s t-test, is indicated using stars - * = p<0.05, *** = p<0.01. 
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at MOI 0.01, there were significantly more infectious virions in the PAXX-/- cells than in 
WT cells (Figure 6A). This phenotype was also observed after 12 hours at MOI 2 (Figure 
6B), and 48 hours at MOI 4 (Figure 6C). 
RPE-1 cells are derived from an immortalised cell line, and it is likely that mutations 
in key pathways will have arisen. This risk is amplified by the fact that PAXX-/- cells 
were clonally selected following the CRISPR/Cas9 protocol. As such growth curves were 
carried out in MEFs to complement the growth curves carried out in RPE-1 cells. 
Although immortalised, these MEFs have not been passaged as many times and are 
therefore less likely to have accrued mutations. The difference in infectious virion 
production in WT and Paxx-/- MEFs infected at an MOI of 0.01 was more significant than 
the difference observed in RPE-1 cells (Figure 6D), although WT cells had more 
advanced CPE (data not shown). Infection of MEFs with HSV-1 at MOI 4 induced early 
and advanced CPE, and so we decided that this experiment was not appropriate for 
investigating infectious virus production. These data suggest that HSV-1 infection of 
PAXX-/- human cells and Paxx-/- murine cells produces more infectious virions than 
infection of their WT counterparts. 
3.3 HSV-1 genome replication is restricted in PAXX-/- cells 
Having shown that PAXX reduces the titre of infectious HSV-1 virions following 
infection, we wanted to establish the mechanism responsible. PAXX is a core member of 
the NHEJ pathway (Section 1.1.2), components of which have already been shown to 
influence HSV-1 genome replication (Section 1.2.6), and so we hypothesised that PAXX 
may function to directly or indirectly restrict HSV-1 genome replication. To test this 
hypothesis, WT or PAXX-/- RPE-1 cells were infected at an MOI of 4 and total DNA 
(including cellular and viral DNA) was extracted at specified times post infection. This 
DNA was analysed by qPCR using TaqMan probes and primers which anneal to the 
promoter regions of human GAPDH and HSV-1 ICP0 so that only genomic DNA, and 
not mRNA, would be amplified. We conducted two experiments - one with an expanded 
time course where each time post infection was only sampled once (n=1; Figure 7A) to 
get an overview of the dynamics of viral genome replication, and one at fewer times post 
infection in triplicate (n=3; Figure 7B) to allow for statistical analysis. HSV-1 genome 
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replication was not overtly different between WT and PAXX-/- cells at any time sampled 
during the first six hours (Figure 7A). However, after 8 and 12 hours of infection, WT 
cells reproducibly had statistically higher numbers of viral genomes per cell in than 
PAXX-/- cells (Figure 7B). 12 hours post infection there were approximately twice as 
many viral genomes in WT cells than in PAXX-/- cells. Quantification of viral genomes 
present in WT and PAXX-/- cells infected for 12 hours at MOI 0.01 was also attempted, 
but genome copy numbers were not high enough for the sensitivity of the assay. These 
data indicate that, in contrast to what may have been predicted from the growth curve 
data, PAXX does not restrict viral genome replication, and may in fact contribute to 
efficient replication.  
 
 
Figure 7: PAXX-/- cells support reduced HSV-1 genome replication. 
WT and PAXX-/- RPE-1 cells were infected with HSV-1 at MOI 4, and the total DNA extracted at the indicated 
times post infection. qPCR was then used to determine relative levels of host and viral genome copy numbers, 
using GAPDH and ICP0 respectively. Relative signal intensity is used because it would be incorrect to assume 
that this is equivalent to calculating the number of virions per cell. The experiment was either carried out 
where A) n=1 at more times post infection (representative of three experiments), or B) in triplicate at fewer 
times. Error bars show intra-experimental mean +/- SEM. Statistical significance, calculated using the Student’s 
t-test, is indicated using stars - ** = p<0.02. Data is representative of three independent experiments.  
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3.4 PAXX may promote efficient endless HSV-1 genome 
formation during replication 
Components of DNA damage repair machinery have previously been shown to 
influence the processing of HSV-1 genomes (Section 1.2.6), for example the formation of 
endless (either circular or concatemeric) genomes is enhanced by LIG4 and XRCC4 
(Muylaert and Elias, 2007), and DNA-PK has also been proposed to contribute to HSV-1 
genome circularisation and thereby induce latency (Smith et al., 2014). In an attempt to 
explain why PAXX-/- cells produce more infectious virions despite promoting viral 
genome replication, we hypothesised that PAXX contributes to processes which initially 
support genome replication, but which are subsequently deleterious. More specifically, 
PAXX may support the formation of the endless HSV-1 genomes required for 
replication, but PAXX binding may inhibit subsequent cleavage and packaging of the 
genome. Alternatively, increased circularisation could result in the induction of latency 
as has been proposed for DNA-PK. Another explanation is that PAXX aids early 
replication but also contributes towards the creation of abnormal genome structures (e.g. 
through ligation of viral genomes to the nicks and gaps in other copies of the genome) 
that may affect subsequent processes, such as the packaging of the viral genome into 
capsids. During HSV-1 genome replication, endless forms of the HSV-1 genome are 
produced in the nucleus, and cleavage of the endless forms into the mature, monomeric 
form occurs during packaging (Section 1.4.3). Therefore, observing the levels of the 
endless and monomeric forms in PAXX-/- cells would indicate whether PAXX is required 
for endless genome formation and whether the presence of PAXX affects genome 
packaging, thereby testing our hypotheses.  
To experimentally investigate the formation of endless or monomeric genomes, 
southern blotting of the repetitive elements of restriction digested HSV-1 genomes can 
be used. Digesting the HSV-1 genome with BamHI creates DNA fragments named K, Q, 
and S (Figure 8A), amongst others. The Q and S fragments flank the long (UL) and short 
(US) regions of the genome, respectively, and are formed of repetitive sequences 
(annotated with lower case letters in Figure 8A). The fact that they flank the UL and US 
regions of the genome means that the ends of a linear genome will be either a Q or an S 
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fragment. Within a concatemer, a circular genome, or in the middle of a monomer, the Q 
and S fragments combine to form the intra-genomic K fragment. The fact that the K 
fragment is composed of the Q and S fragments means that randomly-primed, 
biotinylated, ssDNA probes created against the BamHI K fragment can be used to detect 
Figure 8: PAXX does not affect the proportion of endless HSV-1 genomes.  
Southern blotting was used to determine the relative levels of monomeric and endless viral genomes. A) The 
linear structure of the HSV-1 genome, indicating repetitive elements a, b, and c (e.g. a, a’, a’’ consist of the 
same, repeated sequence). Relevant BamHI restriction sites are shown by a red line, and the resultant S, Q, and 
K fragments created following cleavage are labelled. B) WT and PAXX-/- RPE-1 cells were infected at MOI 4, 
and total cellular and viral DNA was isolated at specified times post infection. The DNA extracts were 
digested with BamHI, and analysed by Southern blotting. The same mass of DNA was added to each well, 
and visualisation was achieved using random primers raised against the K fragment. These random primers 
anneal to each of the S, Q, and K fragments of the HSV-1 genome because of the repetitive ‘a’ sequence. The 
positioning of the repetitive sequences means that in concatemeric or circular genomes the S and Q fragments 
combine to form additional K fragments. This means that the relative ratio of K fragments to total signal 
indicates the relative level of endless genome forms. Two different exposures of the same blot are shown, and 
the sizes of the S, Q, and K fragments are indicated. The data is representative of two independent 
experiments.  
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all three fragment types. Southern blotting with these primers can reveal the ratio of K 
fragments to Q and S fragments, which is an indicator of the proportion of endless 
genomes in the viral population. This method is therefore appropriate to identify 
potential defects in endless viral genome formation. It is important to note that the K 
fragment is present in both circular and concatemeric genomes, meaning that these 
species are not distinguishable by this assay, and they are instead considered together as  
endless genomes.  
WT and PAXX-/- RPE-1 cells were infected with HSV-1 at MOI 4, and analysed by 
southern blotting using this method. No signal above background was detected in 
uninfected cells of either genotype (data not shown) or in cells infected for one hour 
(Figure 8B), demonstrating that the generated probe does not bind significantly to 
cellular genomic DNA and that the input virus DNA is below the detection limit of the 
assay. Only endless viral genomes could be detected five hours post infection, an 
observation previously reported early in HSV-1 infection (Muylaert and Elias, 2007), and 
WT cells had higher levels than PAXX-/- cells (Figure 8B). After 12 and 24 hours of 
infection both endless and monomeric forms of the viral genome could be detected, and 
the ratio between endless and monomeric species was similar for both genotypes. 
Although the total DNA loaded onto the gel prior to southern blotting was normalised, a 
lower signal was observed in the PAXX-/- cells, suggesting that viral DNA made up a 
lower proportion of total DNA, which would support the qPCR data quantifying viral 
genome numbers (Section 3.3). These data suggest that PAXX may be required for the 
efficient formation of endless genomes, and that PAXX defects may therefore result in 
less viral genome replication. 
3.5 Virion number and structure does not appear to be 
affected by PAXX 
Packaging is required for the cleavage of the HSV-1 genome (Heming et al., 2014; 
Muylaert and Elias, 2007), and therefore the creation of S and Q fragments observed by 
southern blotting suggest that efficient packaging is occurring. However, in some 
contexts packaging can be aborted after genome cleavage (Yang et al., 2011), and so we 
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wanted to explore the hypothesis that PAXX could affect packaging using an alternative 
method.  
Intracellular virions can be categorised into 3 types based on their contents, as 
previously described (Desai et al., 1994). Example electron microscopy images of the 
three capsid types are shown in Figure 9A. Type B capsids are the first to be formed and 
are comprised of the virion capsid and of structural proteins. These structural proteins 
Figure 9: Electron microscopy does not reveal virion structural or localisation differences in the absence of 
PAXX.  
WT or PAXX-/- RPE-1 cells were infected with HSV-1 at MOI 4 for 12 hours, fixed, and processed for electron 
microscopy imaging as described in Section 2.8.2. A) Example electron microscopy images of the different 
capsid types, as observed in RPE-1 cells. B) An example of a typical field of view within the nucleus of an 
infected RPE-1 cell following 12 hours of infection at an MOI of 4. The scale bar represents 0.5 μm. C) The 
relative ratios of the three capsid types to each other in the nucleus. D) The proportion of total virions found in 
each cellular location for each genotype. In total a minimum of 255 virions were counted per genotype. These 
virions were sampled from a minimum of 6 different cells per genotype. As explained in the main text, this 
experiment was only conducted once. 
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help in capsid assembly and genome packaging, and are lost as the genome is inserted 
into the capsid. The resultant DNA-containing capsids lacking structural proteins are 
termed type C capsids. Type A capsids are formed when genome packaging is aborted; 
the scaffold proteins are lost due to initiation of packaging, but the genome is not 
successfully packaged creating an empty capsid. We hypothesised that if packaging was 
affected by PAXX, this may be observable in changes in the ratio of these different 
capsid types inside cells during lytic HSV-1 infection. 
To compare the number and genomic status of virions, WT and PAXX-/- RPE-1 cells 
were infected with HSV-1 at MOI 4 and observed using electron microscopy. Infection at 
MOI 4 was used to ensure that as many cells were infected as possible whilst 
maintaining consistency with experiments where previous phenotypes were observed. 
Samples were fixed after 12 hours because genome copy numbers were significantly 
different from eight hours onwards (Figure 7), and we wanted to leave sufficient time 
after this for packaging to occur. The fixed samples were processed and analysed in a 
blinded manner to avoid unconscious bias in data collection and analysis. The ratios of 
nuclear type A to type C, and type A to type B capsids were not strikingly different 
between genotypes (Figure 9C). However, PAXX-/- cells exhibited a small increase in the 
ratio of scaffold-only to DNA-containing virions (type B to type C), meaning that a 
smaller proportion contained DNA. The experiment was only done once and so its 
reproducibility is unclear, but this assay might indicate defects in the initiation of DNA 
packaging. This analysis is also limited by only observing a single plane through the 
capsid, because a capsid may be falsely determined to be type A if the plane misses 
DNA or structural protein. For this reason, capsids where the plane clearly does not pass 
through the middle were discounted. It is also true that this error should be consistent 
between samples, and so it is reasonable to assume that it should not affect analysis. 
Visibly defective particles (e.g. DNA trailing out of the capsid, as shown in Figure 9A) 
were not observed at a noteworthy frequency in either genotype. 
In addition to considering the types of capsid present, we also analysed the 
localisation of capsids during infection of WT and PAXX-/- cells. A slightly higher 
proportion of virions were extracellular in PAXX-/- cells, but the difference was not 
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significant (Figure 9D). There were no notable differences in the proportion of virions in 
the nucleus or cytoplasm, and a comparison of total numbers of virions in each cellular 
location showed a similar pattern (data not shown). Together these data do not provide 
reason to suspect that PAXX influences the efficiency of viral genome packaging. This 
conclusion could be tested by extracting viral protein and viral DNA from purified 
virions, and comparing the protein:DNA ratio observed in WT and PAXX-/- cells. This 
would indicate what proportion of virions contain viral genomes. 
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3.6 PAXX may alter the proportion of cell-associated 
virions produced during infection. 
We have shown that WT and PAXX-/- cells contain similar numbers of virions, and 
that the packaging of genomes into these virions is not defective in either genotype. It 
also showed that the localisation of the virions was similar between WT and PAXX-/- 
cells, but it does not address the fate of virions upon egress. Ku70 is important in the 
internalisation of the bacterium Rickettsia conorii (Chan et al., 2009; Martinez et al., 2005), 
a novel function for DNA repair proteins. We therefore decided to test whether PAXX 
affects the egress of HSV-1. WT and PAXX-/- cells were infected at an MOI of 0.01 or 4 for 
24 hours and the cell-associated virions and virions in the growth medium were titrated 
separately. As is previously published (Sattentau, 2008), WT cells infected at both MOI 
0.01 and MOI 4 had more infectious cell-associated virions than were present in the 
growth medium (Figure 10A and B). Interestingly, the ratio of cell-associated to free 
virus was much lower in PAXX-/- cells at MOI 0.01 (Figure 10C). This suggests that PAXX 
may function to regulate HSV-1 egress or binding of HSV-1 to the cell membrane. 
However, the data shown is only representative of two technical repeats of the 
experiment, and further repetition of the experiment is required before we base 
hypotheses on these conclusions. The conclusions should also be tested with other 
experiments such as viewing the egress of tagged virions using confocal microscopy, or 
measuring the rate of plaque growth when cells are infected in a semi-solid medium. 





Figure 10: A lower proportion of virions from PAXX-/- cells remain cell-associated. 
WT or PAXX-/- RPE-1 cells were infected with HSV-1 for 24 hours at an MOI of A) 0.01 or B) 4, and the growth 
medium and cell-associated virions were titrated separately. C) The ratio of cell-associated infectious virions 
to infectious virions in the growth medium. All data points are the mean of a biological triplicate, and error 
bars show intra-experimental mean +/- standard error of the mean (SEM). Statistical significance, calculated 
using the Student’s t-test, is indicated using stars - * = p<0.05, *** = p<0.01. The data is representative of two 
technical repeats. 
 
The role of PAXX in HSV-1 infection   
 94. 
3.7 PAXX may affect innate immune signalling pathways 
Some DDR proteins have already been linked to innate immune responses to 
exogenous DNA and viral infection (Section 1.3.1). DNA-PKcs and IFI16 have been 
shown to detect the HSV-1 genome and initiate transcriptional responses via the STING 
and IRF3 pathway (Ferguson et al., 2012; Orzalli et al., 2012; Unterholzner et al., 2010). It 
has been proposed that Mre11 is able to sense cytoplasmic DNA and induce IFN-I 
transcription, although cells lacking Mre11 did not respond differently to HSV-1 
infection (Kondo et al., 2013). Following genotoxic damage the DDR machinery regulates 
many pathways of interest, including those controlling cell cycle regulation and 
programmed cell death (Jackson and Bartek, 2009). DNA damage and the DDR can also 
stimulate innate immune responses (Section 1.3.2). ATM has been shown to interact with 
NEMO to induce NF-κB signalling (Wu et al., 2006), and genotoxic damage has also been 
shown to activate IRF and IFN signalling (Brzostek-Racine et al., 2011; Kim et al., 1999). It 
is therefore a reasonable hypothesis that PAXX could also play a role in the responses to 
exogenous DNA stimuli. 
Primary MEFs were used to explore potential roles for PAXX in innate immune 
responses to nucleic acids and HSV-1 because they are thought to be better models for 
innate immune responses than cell lines, and because they have previously been shown 
to increase transcription of IFN-I and cytokines in response to HSV-1 infection (Ferguson 
et al., 2012; Honda et al., 2005). Experiments were executed on passage one (P1) MEFs as 
it has been previously noted that MEFs lose intracellular DNA-stimulated NF-κB 
signalling at later passages (B. Ferguson unpublished observation; Chiu, Macmillan, & 
Chen, 2009). The MEFs were kindly generated by Dr Gabriel Balmus from WT and 
Paxx-/- embryos. The MEFs were either transfected with 2 μg/mL of concatenated DNA, 
transfected with 2 μg/mL of poly(I:C), infected with ΔICP0 HSV-1 at MOI 5, or left 
untreated (mock). The concentrations of nucleic acids and the MOI were chosen 
following successful stimulation with similar concentrations in previous experiments in 
our laboratory (Ferguson, unpublished data; Ferguson et al. 2012). Poly(I:C) was used as 
a positive control because it is a strong stimulator of innate immune responses and we 
expected that PAXX would not affect its ability to stimulate cells. Instead of using WT 
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HSV-1, ΔICP0 HSV-1 was used in experiments probing the innate immune response. 
This is because ICP0 significantly reduces the induction of IFN-I responses from infected 
cells, meaning that any differences in innate immune stimulation between MEF 
genotypes is masked by the inhibitory effects of ICP0 (Eidson et al., 2002b; Lin et al., 
2004b; Mossman et al., 2001). Each condition was carried out in triplicate. Cells were 
harvested six hours after stimulation because we have previously observed strong 
responses at this time (Ferguson et al., 2012), the RNA was purified, and cDNA was 
created for gene expression analysis by qPCR (Figure 11). Isg54 mRNA levels were 
measured to investigate stimulation of the IRF3-dependent signalling pathway because 
its transcription is IRF3-dependent (Navarro et al., 1998), Nfkbia, was measured because 
its activity is NF-κB-dependent (Rupec et al., 1999), and CXCL10 can be activated by both 
IRF3 and NF-κB (Spurrell et al., 2005). Cjun and Cfos expression was quantified to 
monitor MAPK signalling (Eriksson et al., 2007). 
No differences were observed between cellular genotypes in the transcriptional 
response to ΔICP0 HSV-1 infection, suggesting that PAXX is not involved in innate 
immune sensing of HSV-1 in MEFs or that other DNA sensors such as cGAS create 
redundancy (Figure 11). Some differences were, however, noted following the 
transfection of DNA or RNA. Transfection of DNA lacking CpG motifs, which targets 
the STING-depending signalling pathways (Ishikawa and Barber, 2011), induced similar 
levels of Cxcl10 and Ifnb in WT and Paxx-/- cells, but slightly lower Isg54 and Nfkbia 
transcription was observed in Paxx-/- cells (Figure 11A-D). This may suggest that other 
DNA sensors such as cGAS create redundancy in some pathways but not in others. 
DNA stimulation did not induce a large change in expression of Cjun and Cfos in WT 
cells relative to mock treatment, but the difference was statistically significant (Figure 
11E and F). In contrast, this response was completely abrogated in Paxx-/- cells, where 
Cjun and Cfos levels were not significantly different to those of mock-treated cells 
(Figure 11 E and F). 
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Figure 11: PAXX may affect innate immune signalling pathways in MEFs.  
MEFs were infected with ΔICP0 HSV-1 at MOI 5, or stimulated with 2 μg/mL of concatenated DNA or 
poly(I:C). RNA was extracted six hours post infection. RNA was converted to cDNA, and relative expression 
levels of A) Cxcl10, B) Ifnb, C) Isg54, D) Nfkbia, E) Cjun, F) Cfos, and G) Egr1 were analysed by qPCR and 
normalised to Hprt. All data points are the mean of a triplicate, and data is representative of three independent 
experiments. Error bars show intra-experimental mean +/- SEM, and statistical significance was calculated 
using the Student’s t-test, and some instances of statistical significance was indicated using stars - * = <0.05, ** 
= p<0.02, *** = p<0.01. 
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Perhaps surprisingly, following the transfection of poly(I:C), an RNA mimetic that 
stimulates intracellular RNA PRRs, no differences were observed in Nfkbia, Isg54 or Cjun 
transcription, but Cxcl10 and Cfos levels were significantly higher in WT versus Paxx-/- 
cells (Figure 11).  
Together these data suggest that PAXX may be required for innate responses to 
nucleic acids. These were most notable in response to DNA stimulation, but differences 
were also observed following poly(I:C) stimulation. However, no difference was 
observed in the response of different cellular genotypes to ΔICP0 HSV-1 infection. 
3.8 RPE-1 cells do not initiate responses to DNA 
stimulation or ΔICP0 HSV-1 infection 
We hypothesised that the defects in innate signalling observed in Paxx-/- MEFs could 
explain the increased production of infectious virus in these cells, and that innate 
immune signalling defects could also explain why PAXX-/- RPE-1 cells produce more 
infectious HSV-1 virions (Figure 6). Although immortalised with hTERT, RPE-1 cells 
retain epithelial characteristics and are not cancer-derived and so are less likely to have 
as many mutations in innate immune signalling pathways as other cell lines (Davis et al., 
1995). We therefore decided to test whether these cells were suitable for studying the 
innate immune response. Several pilot experiments were carried out to characterise the 
innate immune response to intracellular nucleic acids and HSV-1 in WT RPE-1 cells. 
Cells were infected with ΔICP0 HSV-1 at an MOI of 4, or stimulated by transfecting 
5 μg/mL of DNA or poly(I:C). Higher concentrations were used than in the experiments 
with MEFs because we knew that the transfection efficiency of RPE-1 cells is low, and 
because we expected responses to be weaker. RNA was harvested and mRNA 
expression was analysed by qPCR. DNA stimulation and ΔICP0 HSV-1 infection did not 
induce an increase in innate immune signalling pathways (Figure 12). Although 
poly(I:C) was able to induce ISG54 and CXCL10 transcription (Figure 12A and E), the 
fold-increase was considerably lower than would normally be expected. Although poor 
stimulation by DNA or poly(I:C) could be explained by poor transfection efficiency, this 
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does not explain the poor response following infection with ΔICP0 HSV-1. As such it is 
likely that RPE-1 cells are not strongly stimulated by nucleic acids. 
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Figure 12: RPE-1 cells are not stimulated by infection or nucleic acid transfection.  
WT RPE-1 cells were infected with ΔICP0 HSV-1 at MOI 4, transfected 5 μg/mL with linear DNA, transfected 
with 5 μg/mL of poly(I:C), or left untreated (mock). After 4 and 6 hours of infection or stimulation, the cells 
were harvested for RNA. qPCR was used to analyse gene expression of A) IFNβ, B) ISG54, C) IFNλ, D) 
NFKBIA, E) CXCL10, and F) CFOS, all relative to GAPDH. These data are representative of three independent 
experiments. 
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3.9 PAXX does not affect the expression of the HSV-1 genes 
tested 
Although we were unable to consistently stimulate RPE-1 cells, we remained 
interested in potential roles of PAXX in the innate response to DNA and viral infection, 
and the effects that these may have on HSV-1. Reduced expression of EGR1, a MAPK 
transcription factor, reduces lethality of HSV-1 infection in mice (Chen et al., 2008), and 
EGR1 is able to bind to the promoter region of ICP4 and ICP22 and repress their 
expression (Bedadala et al., 2007). Following our observation that some MAPK signalling 
pathways are abrogated in Paxx-/- MEFs, we hypothesised that PAXX may indirectly 
affect ICP4 and ICP22 expression. As a control we also looked at expression of the 
immediate-early gene ICP27. WT and PAXX-/- cells were infected at MOI 5 for 4 or 8 
hours, RNA was isolated, and qPCR was used to determine relative levels of viral gene 
transcripts during infection of RPE-1 cells. These times were selected so that early gene 
expression could be observed, and because we knew that replication started earlier than 
8 hours post infection and so late gene expression should be observed. Only small 
differences were observed in ICP27 or ICP4 gene expression between WT and PAXX-/- 
cells at either time point, with ICP27 expression slightly higher in KO cells, and ICP4 
expression higher in WT cells (Figure 13A and B). 
Following our observation in Section 3.3 that PAXX-/- cells produce fewer viral 
genomes, we were also interested in late viral gene expression. Some HSV-1 genes, 
termed true (γ2) late, are only expressed after viral genome replication. We hypothesised 
that the expression of these genes may be lower in PAXX-/- cells. The expression of gB (γ1 
late) and US11 (γ2 true late) genes were unaffected by PAXX (Figure 13C). These data 
suggest that HSV-1 gene expression is unaffected by PAXX, and that the increased viral 
genome replication in WT cells does not manifest itself in late gene transcription. 
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V 
Figure 13: HSV-1 gene expression is unaffected by PAXX.  
WT and PAXX-/- RPE-1 cells were infected with HSV-1 at an MOI of 5, and the RNA harvested after 4 or 8 
hours. The gene expression of the immediate-early genes A) ICP27 and B) ICP4, C) the γ1 late gene gB, and 
the γ2 true late gene US11 were analysed by qPCR, and calculated relative to GAPDH expression. Samples 
were taken at four and eight hours after infection with the exception of gB and Us11 which were only 
sampled after eight hours. All data points show the fold increase in expression in PAXX-/- cells relative to WT 
cells, calculated from the mean of a triplicate, and data is representative of three experimental repeats. D) WT 
and PAXX-/- RPE-1 cells or E) WT or Paxx-/- MEFs were infected at an MOI of 1 and harvested at specified 
times post infection. Anti-HSV-1, anti-ICP0, or anti-ICP4 primary antibodies were used. Tubulin was used as 
a loading control in both cases. The data in D) was produced in collaboration with a colleague (I created the 
samples, and they did the western blotting). The data in E) was produced by a colleague. Both D) and E) are 
representative of three independent experiments. 
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3.10 PAXX may affect viral protein levels in MEFs, but not 
in RPE-1 cells. 
By quantifying gene transcripts we have shown that there are no differences in viral 
gene expression in WT or PAXX-/- cells, but post transcriptional regulation means that 
this does not necessarily represent viral protein levels. To complement the analysis of 
viral gene expression a colleague investigated whether PAXX affects viral protein 
production (Figure 13D and E). For these experiments WT and PAXX-/- RPE-1 cells were 
infected with HSV-1 at MOI 1, and lysed at various time points post infection for 
immunoblotting. A polyclonal antibody raised against HSV-1 virions was used which is 
likely to recognise primarily capsid proteins, creating a bias towards late proteins. We 
also used antibodies recognising ICP4, VP5, and ICP0. There was no difference in 
expression of any of these genes during infection of RPE-1 cells (Figure 13D). However, 
we did observe less HSV-1 protein expression in Paxx-/- MEFs relative to their WT 
counterparts (Figure 13E). These data suggest that PAXX does not affect protein 
production in RPE-1 cells, but that PAXX may function to regulate HSV-1 protein 
production in MEFs. 
3.11 PAXX localisation changes during HSV-1 infection 
So far this chapter has focussed on defining PAXX as a restriction factor for HSV-1 
and attempting to explain how this protein reduces the production of infectious HSV-1 
virions. HSV-1 has, however, evolved to interfere with the function of many cellular 
restriction factors (Section 1.4.4), and so we hypothesised that HSV-1 may also regulate 
PAXX. This hypothesis is especially interesting given the observation that HSV-1-
induced inhibition of the DDR may be a contributory factor towards the development of 
Alzheimer’s Disease (De Chiara et al., 2016; Itzhaki, 2014). The NHEJ protein DNA-PKcs 
restricts HSV-1 and is degraded during during infection (Lees-Miller et al., 1996; 
Parkinson et al., 1999), so we therefore decided to investigate whether PAXX is also 
degraded during HSV-1 infection. To investigate whether HSV-1 degrades PAXX, U2OS 
cells were infected with WT HSV-1 at MOI 10, the cells were lysed at various time points 
post infection, and the nuclear and cytoplasmic fractions were separated prior to 
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immunoblotting (Figure 14A). U2OS cells were used because PAXX localisation during 
DSB repair has previously been investigated in these cells (Ochi et al., 2015). Antibodies 
against tubulin and PARP-1 were used as cytoplasmic and nuclear markers respectively 
to ensure that fractionation was effective, and an antibody against the HSV-1 protein 
VP22 was used to demonstrate productive HSV-1 infection. In uninfected cells PAXX 
was observed in both the nucleus and the cytoplasm, although the nature of the 
fractionation means that no conclusions can be drawn on relative amounts. Eight hours 
post infection a large reduction in the amount of nuclear PAXX was observed despite 
cytoplasmic levels remaining unaffected. A similar pattern was observed after 16 hours. 
Interestingly, overall levels of PAXX appeared to be unaffected (Figure 14B)  
The cytoplasmic and nuclear fractionation kit used for the creation of the samples for 
immunoblotting primarily recovers soluble proteins, and the recovery of DNA-bound 
proteins is inefficient (ThermoFisher Scientific, 2017). It is therefore possible that if PAXX 
is directly or indirectly bound to the HSV-1 genome, less nuclear PAXX would be 
recovered. We therefore wanted to confirm our observations using confocal microscopy. 
U2OS cells were infected with a recombinant HSV-1 virus which encoded the capsid 
protein VP26 tagged with YFP, and lacked the protein gE. gE forms part of the HSV-1 
IgG Fc receptor, and its absence prevents formation of the complex and reduces 
nonspecific binding of the primary and secondary antibodies (Bell et al., 1990). 16 hours 
post infection at MOI 1 over 80 % of cells exhibited a change in the localisation of PAXX 
from a nuclear (as observed by the DAPI stain and previously described by Ochi et al., 
2015) to dispersed distribution, as compared with about 5 % of uninfected cells (Figure 
14D). Of the 5 % of uninfected cells with dispersed PAXX staining, the majority had 
morphology or DAPI-staining which indicated that the cells were probably undergoing 
cell division, for example nuclear breakdown (Figure 14C), although this was not 
quantified. Throughout infection the proportion of cells in which PAXX distribution has 
changed increases (Figure 14D). These data support the observations made using 
immunoblotting, and suggest that HSV-1 infection induces the distribution changes of 
PAXX. 
I  g 
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Figure 14: The distribution of PAXX changes during viral infection.  
A) U2OS cells were infected at an MOI of 10. Cells were harvested at the indicated timepoints, and the 
cytoplasmic (C) and nuclear (N) fractions separated as described in section 2.9.2 Western blotting was used to 
observe PAXX. PARP-1 and tubulin controlled for fractionation, and VP22 demonstrated successful infection. 
Ku80 was used as a loading control. NI = not infected. B) U2OS cells were infected as in A), but protein samples 
were not fractionated so that overall levels of PAXX could be ascertained. C) U2OS cells were infected with ΔgE 
VP26-YFP HSV-1 or A5-GFP VACV at an MOI of 1 for 16 hours and analysed by immunofluorescence. Scale bars 
denote 20 μm. D) U2OS cells infected with ΔgE VP26-YFP HSV-1 at an MOI of 1 were fixed and stained for 
immunofluorescence. A minimum of 100 cells were counted, and the percentage of all cells that had dispersed, 
cytoplasmic PAXX staining was calculated. E) U2OS cells were infected with ΔgE VP26-YFP HSV-1 or VACV at an 
MOI of 1 for 16 hours, and processed and counted as in D). The data in this figure is representative of three 
independent experiments. 
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To investigate whether the nuclear localisation of the viral genome is important in 
the induction of PAXX distribution changes, we wanted to investigate whether a virus 
which replicates in the cytoplasm also induces these changes. Vaccinia virus (VACV) is a 
member of the Poxviridae family, and it replicates its dsDNA genome in the cytoplasm, 
making it a useful model for testing whether nuclear entry of the viral genome is 
required to trigger PAXX dispersal Interestingly, infection of U2OS cells with VACV at 
MOI 1 for 16 hours was also able to induce distribution changes of PAXX (Figure 14E). 
These data suggest that PAXX distribution changes are not specific to HSV-1, and that 
the trigger might be the genome of the viruses themselves. 
3.12 Stimulation with DNA may be sufficient to induce 
changes in PAXX localisation 
The loss of PAXX from the nucleus observed during HSV-1 and VACV infection 
could be actively induced by the virus, or could represent a cellular response to the 
infection. It has been reported that XLF, a NHEJ protein with homology to PAXX, 
translocates from the nucleus to the cytoplasm following DNA damage (Liu et al., 2015). 
We therefore hypothesised that changes in PAXX localisation could occur following the 
detection of the HSV-1 genome, and that the detection of any DNA with free ends may 
trigger this response. To test this hypothesis, we transfected U2OS cells with linear 
DNA, the pcDNA3.1 plasmid not encoding any protein, pcDNA3.1 encoding GFP, or 
poly(I:C). This experiment was designed to test whether DNA was sufficient to induce 
PAXX localisation changes, and whether any particular DNA structure was required. 
Poly(I:C) was intended as a control, although after observing differences in the innate 
immune responses of WT and PAXX-/- RPE-1 cells to poly(I:C) (Figure 11), we also 
recognised that poly(I:C) may also induce changes in PAXX. The transfection of all DNA 
species was sufficient to induce changes in PAXX localisation (preliminary data, Figure 
15) but, poly(I:C) was unable to induce the response, suggesting that the induction of 
PAXX localisation changes is specific to DNA (Figure 15). This preliminary data 
suggests that the changes observed in the localisation of PAXX during HSV-1 infection 
may be induced by the detection of the viral genome. It is interesting that circular DNA 
that lacks free ends is sufficient to induce this response.  
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Figure 15: DNA is sufficient to induce distribution changes of PAXX.  
A) U2OS cells were transfected with pcDNA3.1 expressing GFP, ‘empty’ pcDNA3.1, or polyI:C for 24 hours, 
and fixed and stained for immunofluorescence. B) GFP-tagged ICP0 was transfected into U2OS cells, and 
immunofluorescence was used to quantify the percentage of GFP-positive cells in which PAXX distribution 
changed relative to cells that have either been infected or transfected with GFP. C) As in B), except cells 
displaying PAXX localisation changes are presented as a percentage of all cells. D) The percentage of all cells 
with dispersed PAXX was quantified 24 hours after the transfection of a plasmid expressing GFP-FLAG, an 
‘empty plasmid (pcDNA3.1), linear DNA, or poly(I:C). The data in this figure is representative of two 
independent experiments and is therefore only preliminary. The experiments need to be repeated. 
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3.13 Discussion 
Many DNA repair proteins have been shown to influence HSV-1 infection (Section 
1.2.6). The NHEJ proteins LIG4 and XRCC4 promote HSV-1 infection (Muylaert and 
Elias, 2007), while the Ku heterodimer and DNA-PKcs restrict viral infection (Parkinson 
et al., 1999; Smith et al., 2014; Taylor and Knipe, 2004). This chapter has explored the role 
of PAXX, a relatively recently discovered member of the NHEJ machinery, during 
HSV-1 infection. PAXX-/- human cells and Paxx-/- murine cells produce a larger titre of 
infectious virus than their WT counterparts, suggesting that PAXX restricts HSV-1 
infection. We hypothesised that this restriction would be caused by PAXX directly 
binding the viral genome and inhibiting replication, or that PAXX may be involved in 
the activation of an innate immune response to DNA. We have tested both hypotheses 
and shown that surprisingly PAXX-/- cells produced fewer viral genomes during lytic 
infection than their WT counterparts, and that PAXX is not required for innate 
transcriptional responses to HSV-1 infection. Although we have not identified the 
mechanism which explains the restriction of HSV-1 by PAXX, we have uncovered a 
potential role of PAXX in MAPK signalling in MEFs. In addition we have observed that 
during HSV-1 infection PAXX is lost from the nucleus. Preliminary data suggests that 
the changes in subcellular localisation of PAXX can be induced by DNA species, but not 
by the RNA analogue poly(I:C). Although we have not determined a mechanism to 
explain how PAXX restricts HSV-1 we have made many interesting and novel 
observations, and we will now discuss the implications of these observations and the 
hypotheses that we can derive from them. However, it is important to note that 
characterisation of the PAXX-/- RPE-1 cells through genome sequencing and western blot 
analysis is required to strengthen these conclusions. 
3.13.1 PAXX and the HSV-1 genome 
The fact that PAXX-/- cells produce more infectious virus (Figure 6) but contain fewer 
viral genomes (Figure 7) is perhaps our most informative observation. These data 
indicate that viral genome replication is not disrupted by the presence of PAXX, and is, 
in fact, faster. It is not the first time that a DDR protein has been shown to both promote 
and restrict HSV-1 infection; ATR is recruited to viral replication centres and is essential 
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for efficient virus production, yet HSV-1 also inhibits its activity (Mohni et al., 2010, 
2013). 
Models explaining the mechanism of HSV-1 genome replication, more specifically 
whether rolling circle replication or recombination is responsible for creating 
concatemers, remain controversial (Smith and Weller, 2015; Weller and Coen, 2012). This 
is because factors from both the HR and NHEJ pathways have been shown to be 
beneficial to HSV-1 infection (Section 1.2.6). It is not clear whether HSV-1 balances 
competing NHEJ and HR functions, or whether these factors function in conjunction. It 
is interesting to hypothesise that HSV-1 recruits factors from different pathways to fulfil 
a custom function, thereby allowing for maximum control over the end result. It is 
conceivable that PAXX could be utilised to recruit LIG4 and XRCC4, two NHEJ factors 
which have already been shown to enhance HSV-1 genome replication and virion 
production (Muylaert and Elias, 2007). It would be interesting to consider whether the 
loss of beneficial HR factors (e.g. ATM, WRN), PAXX and LIG4/XRCC4 is epistatic in 
reducing HSV-1 genome replication.  
It has been proposed that DNA-PKcs supports circularisation of the genome (Smith 
et al. 2014; Section 1.2.6), a process which could be important in genome replication but 
which has also been linked to increase latency of HSV-1 (Efstathiou et al., 1986; Jackson 
and DeLuca, 2003). It is also conceivable that circularised genomes would not be able to 
be packaged into capsids. It is natural to hypothesise that PAXX could contribute to 
genome circularisation, and this could explain the reduced production of infectious 
virions despite increased replication in the presence of PAXX. Analysis by southern 
blotting suggests that the amount of endless genomes is indeed reduced in PAXX-/- cells, 
supporting this argument (Figure 8B). In contrast the ratios between endless and 
monomeric forms of viral genomes remain similar between WT and PAXX-/- cells at all 
times observed (Figure 8B), suggesting that PAXX is not required for subsequent 
replication, and that the reduced total amount of viral genomes present is due to the 
initial defect in the formation of endless genomes.  
The reduced viral genome replication observed by southern blotting was in keeping 
with the qPCR data showing fewer viral genomes in PAXX-/- cells. Further evidence that 
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PAXX does not restrict HSV-1 genome replication comes from our study of viral gene 
expression. True late (γ2) HSV-1 genes such as US11 should only be expressed following 
viral DNA replication (Kibler et al., 1991). Despite the increased replication of the viral 
genome observed in WT RPE-1 cells, there is no correlative increase in US11 expression 
(Figure 13). As far as we are aware the relationship between the number of viral 
genomes and gene expression has not been characterised, so it cannot be said that a 
correlation should necessarily be observed. On the other hand, this may indicate that a 
higher proportion of the genomes produced in the WT cells are not transcriptionally 
functional. The observation that PAXX does not affect viral gene expression is important 
in itself because many DDR proteins have been linked to the silencing of viral gene 
expression, for example IFI16, RNF8 and RNF168, and DNA-PKcs (Lilley et al., 2010; 
Orzalli et al., 2013; Smith and Weller, 2015). 
We also considered the hypothesis that PAXX affects the packaging of the viral 
genome. Although we found no difference in the proportion of endless genomes, PAXX 
could create other structural changes that prevent efficient packaging. However, current 
dogma indicates that the fragments Q and S (Figure 8) should only be observed from 
encapsidated, mature viral DNA because cleavage occurs during packaging (Heming et 
al., 2014; Muylaert and Elias, 2007). Therefore the detection of the Q and S fragments in 
the southern blot suggest that packaging is occurring in WT and PAXX-/- cells with 
comparable efficiency. However, many of the inferences that underlie this dogma are 
based on comparisons to pseudorabies virus and bacteriophages (Selvarajan Sigamani et 
al., 2013), not based on experiments in HSV-1. The best evidence for concomitant 
packaging and cleavage of the HSV-1 genome is that the capsid protein UL6 is required 
for the formation of Q and S BamHI fragments, even though UL6 is not required for 
assembly of the terminase complex (Patel et al., 1996). One study proposed that cleavage 
is possible without packaging using a mutant in the terminase complex component 
UL15, but the authors of this study acknowledge that the mutant probably initiates 
packaging and packaging is subsequently aborted as opposed to the cleavage occurring 
in the absence of packaging (Yang et al., 2011). To avoid any doubt and avoid 
unnecessary assumptions, we decided to use a separate method to assess how HSV-1 
packaging is affected by PAXX. Electron microscopy was used to count virions in the 
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nucleus because it has previously been reported that virions lacking DNA or with 
defective DNA that is significantly too short do not exit the nucleus (Ladin et al., 1980; 
Vlazny et al., 1982). Interestingly, contrary to the conclusions of the above studies, low 
numbers of type A and type B capsids were observed outside of the nucleus in both WT 
and PAXX-/- RPE-1 cells, and in some instances these even appeared to have undergone 
wrapping (data not shown). We did not, however, identify any change in the frequency 
of packaging defects between WT and PAXX-/- cells (Figure 9) using electron 
microscopy. This observation could be tested by extracting viral protein and viral DNA 
from purified virions, and comparing the protein:DNA ratio observed in PAXX-/- and 
WT cells. 
3.13.2 PAXX and infectious virion production 
We have showed that PAXX does not affect HSV-1 gene expression or protein 
production in RPE-1 cells (Figure 13A-D), but have observed differences in total HSV-1 
protein production in MEFs (Figure 13E). In contrast to RPE-1 cells, in MEFs we 
observed differences in MAPK responses to DNA stimulation (Figure 11), and MAPK 
pathways have been linked to the transcriptional activity of some genes (e.g. ICP4 and 
ICP22 – Section 3.9), so it would be interesting to look at HSV-1 gene transcription in 
MEFs. However, the lack of PAXX-dependent restriction on viral gene expression or 
protein production in RPE-1 cells suggests that this mechanism is not responsible for the 
reduced production of infectious virions in PAXX-/- RPE-1 cells. 
We have observed that PAXX-/- RPE-1 cells release a higher proportion of infectious 
virions into the growth medium. It is interesting to note that Ku70 has been proposed to 
be important for the internalisation, but not cell adhesion, of the bacterium Rickettsia 
conorii (Chan et al., 2009; Martinez et al., 2005), and it would be interesting to investigate 
whether PAXX is also involved in this process. This observation may impact on the low 
MOI growth curves because convection currents or diffusion may move these virions 
away from a developing plaque, resulting in the infection of more cells early. Each cell 
has a limited capacity for viral production, and so dispersing the infection in this way 
would be likely to allow viral production early in infection to be faster. It would be 
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interesting to eliminate this variable by conducting a growth curve with semi-solid 
medium to prevent viral spread through the medium.  
Virions which contain DNA are not necessarily infectious; HSV-1 infection creates a 
high particle:PFU ratio, caused by the production of a large number of non-infectious, 
defective particles (Frenkel et al., 1975; Watson et al., 1963). The genomes of defective 
particles would be detected by southern blotting because the genome must contain the 
‘ac’ fragment to be packaged (Vlazny et al., 1982), and this contains the sequence 
detected by our assay. This would potentially explain why WT cells create more copies 
of the HSV-1 genome than PAXX-/- cells during infection, but produce fewer infectious 
virions. It is therefore a possibility that PAXX alters the particle:PFU ratio of HSV-1, and 
it future work should investigate whether this is the case.  
3.13.3 PAXX and the innate immune response 
We have also investigated whether PAXX is involved in the regulation of innate 
immune responses. The data suggest that, in MEFs, PAXX might contribute to the 
initiation of innate signalling pathways following nucleic acid stimulation, but not 
during HSV-1 infection. The difference in responses of WT and Paxx-/- cells to ΔICP0 
HSV-1 may be abrogated because of other inhibitors of the IRF3 pathway, or as a result 
of PAXX relocalisation (Section 3.11). The strongest phenotype was observed in MAPK 
signalling pathways; loss of PAXX in MEFs abrogated Cfos and Cjun transcription 
following stimulation with DNA (Figure 11). Paxx-/- MEFs also exhibited reduced 
transcription of IRF-3- and NF-κB-dependent genes. DNA death pathways constitute 
one area in which we have not investigated potential roles for PAXX. DNA-PKcs and 
Ku70 have been linked to the induction of apoptosis following DNA DSBs, although the 
PAXX homologue XLF is not involved (Abe et al., 2008). It would be interesting to 
further explore whether the delayed CPE observed in Paxx-/- MEFs (Section 3.2) is linked 
to abrogated signalling pathways.  
We had originally hypothesised that PAXX may affect the innate immune response 
to DNA because it can bind indirectly to DNA and because other DDR proteins have 
been implicated as innate immune sensors of DNA (Section 1.3.1). It is therefore 
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interesting to note that the loss of PAXX also had effects on cytoplasmic poly(I:C)-driven 
transcription of Cxcl10 and Cjun (Figure 11). This does raise concerns that PAXX might 
instead be involved in transcription rather than innate sensing. However, PAXX may 
indeed be involved in orchestrating an innate response to RNA, so it would therefore be 
interesting to investigate whether PAXX affects RNA virus infection using a similar 
experimental approach as we have taken here. 
Together, these data provide justification for further exploration of a potential role of 
PAXX in the innate immune response. Unfortunately our resources were limited, and we 
were unable to continue experimentation on first passage MEFs. Accordingly we 
attempted to investigate the role of PAXX in RPE-1 cells. Unfortunately neither ΔICP0 
HSV-1 infection nor cytoplasmic DNA stimulation were sufficient to induce elevated 
transcription of any of the genes investigated in WT RPE-1. We have observed low 
transfection efficiency in RPE-1 cells which may help explain the lack of response to 
DNA, but we know that these cells are infected by ΔICP0 HSV-1 (Figure 24) so it is likely 
that there is an intrinsic defect in pattern recognition receptor signalling in these cells. 
Interestingly innate immune transcription was stimulated in RPE-1 cells following 
poly(I:C) transfection, but this was not pursued further.  
Following the observation that Paxx-/- MEFs have reduced MAPK responses, we 
wanted to find an alternative MAPK stimulator to study the requirement for PAXX. In 
contrast to DNA transfection, we found that PMA was able to induce transcriptional 
responses in WT RPE-1 cells. Unfortunately, the transcriptional responses of RPE-1 cells 
to PMA were too inconsistent for the production of reliable data. The poor 
transcriptional responses of innate immune genes to DNA stimulation and the 
inconsistency of MAPK gene transcription following PMA stimulation highlight the 
importance of using primary cells for innate immune studies. Taken together these data 
suggest that, although innate responses may contribute to the increase in infectious virus 
produced by Paxx-/- MEFs, it is unable to explain the same phenotype in RPE-1 cells. 
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3.13.4 Changes in subcellular PAXX distribution 
We hypothesised that PAXX may be degraded by HSV-1, but found that instead 
PAXX localisation changes during HSV-1 infection, and we have observed these 
HSV-1-induced changes in in multiple systems (Figure 14). From six hours post infection, 
the proportion of cells with changes in PAXX localisation increases with time (Figure 
14D). After 16 hours, PAXX was dispersed in over 80 % of cells. Our data show that a 
small proportion of uninfected cells also exhibited these changes in PAXX localisation, 
but the morphology and genome structure of these cells suggested that they were 
undergoing cell division (Figure 14C). PAXX distribution changes during cell division 
are perhaps unsurprising given the breakdown of the nuclear envelope during mitosis. 
During infection HSV-1 halts the cell cycle at one of either the G1/S or G2/M checkpoints 
(Li et al., 2008b), so it is interesting to note that no cells were observed with PAXX 
distribution changes after four hours of infection. It is possible that after four hours of 
infection HSV-1 had initiated a cell-cycle checkpoint, thereby preventing 
mitosis-dependent PAXX localisation changes, but had not yet induced changes in the 
distribution of PAXX itself.  
More work is required to establish the mechanism and implications of the changes in 
PAXX localisation. Some DNA-repair proteins exit the nucleus following DNA damage, 
for example Ku80 and WRN (Dejmek et al., 2009). We therefore tested the ability of 
exogenous DNA to induce PAXX localisation changes, and preliminary data suggests 
that transfection of DNA, but not poly(I:C), is sufficient to induce the change in 
localisation (Figure 15). Interestingly circular DNA species can trigger the localisation 
changes of PAXX; it is possible that the plasmid is digested upon entry into the cells, but 
it is also conceivable that unlike NHEJ, stimulation of changes in PAXX do not require 
free DNA ends.  
These preliminary data suggest that it may be viral genomes, not viral proteins, 
which induce changes in PAXX distribution, although further repetition of these 
experiments is required to confirm that DNA is sufficient to induce the chenage. 
Interestingly, the homologue of PAXX, XLF, is phosphorylated by Akt following DNA 
damage, resulting in relocalisation from the nucleus to the cytoplasm where it is 
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subsequently degraded (Liu et al., 2015). It is possible that exogenous DNA triggers Akt 
activity which in turn induces PAXX relocalisation. However, we do not observe a 
reduction in cytoplasmic PAXX protein levels which might be indicative of degradation, 
suggesting that this mechanism might not be responsible. Regardless, it would be 
interesting to investigate whether Akt is required for PAXX localisation changes. An 
alternative hypothesis is exemplified by another DDR protein, IFI16, which has been 
shown to form an inflammasome complex and relocalise from the nucleus to the 
cytoplasm following HSV-1 infection (Johnson et al., 2013). It is especially tempting to 
speculate that PAXX may have a similar function given the potential role of PAXX in 
innate immune sensing or signalling. However the dynamics of the change in IFI16 
distribution is much faster than that of PAXX, with increases in cytoplasmic IFI16 
observed as early as 2 hours post infection as compared with 6 hours with PAXX. 
3.13.5 HSV-1, the DDR, and PAXX 
Following DNA damage a number of different DNA repair pathways can be 
stimulated, and the decision regarding repair mechanism is determined by a number of 
factors including the form of DNA lesion and cell cycle stage. It is tempting to consider 
the role of the DDR proteins during HSV-1 infection in terms of their pathways, and to 
brand each pathway as either promoting or inhibiting HSV-1 infection. However, 
different proteins from the same pathway can have polarising effects on HSV-1 infection, 
and HSV-1 has evolved to activate and inhibit individual proteins accordingly. For 
example, cells deficient in the HR proteins ATM, MRN, or WRN are less efficient at 
HSV-1 production (Balasubramanian et al., 2010; Lilley et al., 2005; Taylor and Knipe, 
2004), yet the HR pathway as a whole is suppressed during HSV-1 infection 
(Schumacher et al., 2012).  
Indeed, a single protein can be both beneficial and detrimental to HSV-1. Activity of 
ATR is inhibited by HSV-1, yet ATR is recruited to viral replication centres and is 
essential for efficient virus production (Mohni et al., 2010, 2013). It has been suggested 
that this is because although the protein ATR promotes HSV-1 genome replication, the 
pathways it stimulates downstream are deleterious (Smith and Weller, 2015). A similar 
conclusion is plausible for PAXX; PAXX may enhance HSV-1 genome replication, but it 
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may also signal to downstream pathways which have detrimental effects. This would 
help reconcile the seemingly paradoxical data that PAXX aids viral genome replication 
(Figure 7) but restricts the production of infectious virions (Figure 6). Parallels can be 
drawn between this hypothesis and data for DNA-PKcs which suggests that DNA-PKcs 
may be involved in the circularisation of the HSV-1 genome (Jackson and DeLuca, 2003; 
Smith et al., 2014), despite its known detrimental effects on HSV-1 (Ferguson et al., 2012; 
Lees-Miller et al., 1996; Parkinson et al., 1999). 
As a relatively new discovery, the roles of PAXX in NHEJ are still to be fully 
elucidated. As our understanding of PAXX in this context improves, we may also gain 
insight into how PAXX functions during infection. Already it is able to inform our future 
investigations. For instance, PAXX and XLF are redundant in the repair of simple DSBs, 
yet cooperate in repairing complex lesions (Kumar et al., 2016; Xing et al., 2015); indeed 
the function of PAXX in NHEJ has been described as masked by XLF (Tadi et al., 2016). 
Future work should therefore consider whether XLF and PAXX function cooperatively 
during HSV-1 infection, and this may help us to disentangle the conflicting roles PAXX 
appears to play. 
3.13.6 Summary 
The data presented in this chapter show that PAXX is able to restrict the production 
of infectious HSV-1 virions, as is demonstrated by the increased numbers of infectious 
virions produced by PAXX-/- cells. We tested the hypothesis that PAXX may be 
detrimental for HSV-1 genome replication, but showed that PAXX-/- cells supported 
lower levels of viral genome replication and we did not identify any defects in viral 
genome structure or packaging into virions. However we did observe that MEFs lacking 
PAXX showed a reduced innate response to DNA, although it is unclear whether RPE-1 
cells are able to respond to these stimuli at all. Finally, PAXX distribution may change 
following stimulation with DNA or DNA virus infection, but the mechanisms and 
implications remain to be elucidated. Work is also required to characterise the PAXX-/- 
RPE-1 cells, preferably through sequencing of the genome and western blotting analysis. 
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In summary, we have identified that PAXX is able to restrict HSV-1 infection, and 
made some progress towards understanding the mechanisms by which this is achieved. 
However, further work is required to fully disentangle what are likely to be multiple 
roles for PAXX in HSV-1 infection. To address this, the next chapter will explore the 
potential roles of PAXX during HSV-1 infection in vivo. 
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4 The role of PAXX in vivo 
4.1 Introduction 
In Chapter 3 we have shown that PAXX restricts HSV-1 infection in both human and 
murine cells. In the murine system, fibroblasts (MEFs) lacking PAXX produce more 
infectious virus during infection. We also showed that these cells might have impaired 
MAPK responses following DNA stimulation. MAPKs have pleiotropic roles in vivo, 
regulating multiple aspects of innate and adaptive immunity including pattern 
recognition receptor signalling and the differentiation and activation of T lymphocytes 
(reviewed Rincón, Flavell, & Davis, 2001). Indeed, MAPKs affect HSV-1 infection 
outcome in mice (Chen et al., 2008). We therefore postulated that the absence of PAXX 
might impact HSV-1 in vivo so, to further assess the physiological relevance of our 
findings in Chapter 3, we infected mice lacking PAXX with HSV-1 and analysed the 
outcome of infection. 
The observations in Chapter 3 were made in cell culture, and investigating the in vivo 
role of a protein is significantly more complicated because there are many more 
processes that may be affected by loss of function experiments in a whole organism. 
NHEJ factors are required for V(D)J recombination to different extents, and therefore the 
development of lymphocytes in NHEJ mutant mice varies (Section 1.3.3.1). Prkdc-/- mice 
exhibit a SCID phenotype (Blunt et al., 1995; Kirchgessner et al., 1995; Kurimasa et al., 
1999b). The loss of XLF results in mild to severe immunodeficiency in humans (Cipe et 
al., 2014; Ijspeert et al., 2016), although in XLF-deficient mice V(D)J recombination is only 
slightly reduced (Balmus et al., 2016; Li et al., 2008a). In contrast XRCC4 mutations in 
humans do not cause a SCID phenotype (Murray et al., 2015). Since lymphocyte 
populations can affect the outcome of virus infection, we therefore wanted to investigate 
whether PAXX was required for V(D)J recombination and lymphocyte production. 
Another implication of NHEJ defects in vivo is genomic instability. In cell culture 
genomic instability can create immunostimulatory micronuclei or lead to DNA leaking 
into the cytoplasm (Glück et al., 2017b; Harding et al., 2017; Mackenzie et al., 2017), 
triggering DNA sensing pathways and inducing autoinflammation. Autoinflammatory 
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disease can cause pathology in the skin or central nervous system (CNS) (Rodero and 
Crow, 2016; Woodbine et al., 2013), and these tissues are both very relevant to HSV-1 
infection. NHEJ mutations have also been linked to growth defects and microcephaly in 
both humans and mice (Bunting and Nussenzweig, 2013). In humans, mutations in 
XRCC4, ATR, and NHEJ1 (encoding XLF) can cause immunodeficiency, primordial 
dwarfism, and microcephaly (Buck et al., 2006; Cipe et al., 2014; Murray et al., 2015; 
O’Driscoll et al., 2003; Ogi et al., 2012; Qvist et al., 2011; Shaheen et al., 2014). In mice, 
deficiency in XRCC4 or LIG4 expression is embryonic-lethal due to defective 
neurogenesis and lymphogenesis (Gao et al., 1998, 2000), and Ku70-deficient mice are 
about half the size of wild type counterparts at all ages (Gu et al., 1997). These examples 
indicate why it is important that we considered the role of PAXX in this context before 
exploring its role in controlling HSV-1 infection. 
The aims of the experiments in this chapter are to characterise the morphological, 
neurological, and adaptive immune development of Paxx-/- mice, and to subsequently 
investigate whether PAXX contributes to the control of HSV-1 in mice.  
4.2 PAXX expression might not affect brain weight  
Defects in DNA repair machinery are often associated with microcephaly (Woodbine 
et al., 2014). A partial explanation for this is that defects in DNA repair machinery are 
also linked to type I interferonopathies, manifestations of which generally either affect 
the skin or the CNS, and many have been shown to result in neurological defects 
(Rodero and Crow, 2016; Woodbine et al., 2013). We therefore investigated whether 
PAXX-deficiency caused defects in brain size. PCR genotyping was used to confirm that 
WT and Paxx-/- mice were of the correct genetic background (Figure 16A). The brains of 
Paxx-/- mice were weighed, a common measure of the extent of microcephaly and 
neuronal cell death (Huang et al., 2016; Li et al., 2008a; Pulvers et al., 2010), and compared 
to their WT counterparts. Preliminary data suggests that Paxx-/- mice do not show any 
defects in brain weight (Figure 16B). Certainly, Paxx-/- mice do not display overtly 
abnormal growth, and there were no obvious behavioural defects which may have been 
indicative of neurological complications. 
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Figure 16: Paxx-/- mice have brains of normal weight.  
A) The genotypes of WT and Paxx-/- mice were confirmed using PCR for each experiment conducted. B) The 
brains of six mice from each genotype were weighed in a single experiment. Preliminary data from a single 
experiment suggests that the brains of Paxx-/- mice do not have significantly different masses to those of WT 
mice. Error bars denote intra-experimental mean +/- standard error of the mean (SEM). 
 
4.3 Paxx-/- mice have normal lymphocyte populations 
NHEJ factors are important in V(D)J recombination and lymphogenesis (Section 
1.3.3), and PAXX and XLF show redundancy in human and mouse V(D)J recombination 
(Kumar et al., 2016; Lescale et al., 2016). We therefore wanted to investigate whether 
lymphocyte development was normal in Paxx-/- mice. The spleen and lymph nodes were 
collected from WT and Paxx-/- mice, and cells were isolated. These organs were selected 
for analysis because they contain large numbers and high proportions of lymphocytes. 
The isolated cells were stained using antibodies (Section 2.10.8) raised against CD45 (a 
marker for lymphocytes), CD19 (a marker for B lymphocytes), CD3 (a marker for T 
lymphocytes), CD4 (a marker for T helper lymphocytes), and CD8 (a marker for 
cytotoxic T lymphocytes), and then analysed by flow cytometry. The flow cytometer was 
operated by a colleague for all experiments shown in this chapter, but I was responsible 
for all other stages of the experiments. Figure 17A shows the gating strategy used to 
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analyse the isolated cells. We were particularly interested in CD45+ lymphocytes because 
they require V(D)J recombination for their development, and because T lymphocytes are 
particularly important in the control of HSV-1 in mice (Section 1.5.3).  
The total numbers of cells recovered were similar between WT and Paxx-/- samples 
(data not shown), and so the proportion of each cell type was determined to avoid using 
absolute counts where variation in the isolation protocol could confound analysis. The 
proportion of all cells in the lymph node and spleen which had CD45, a marker of 
lymphocytes, was unchanged in Paxx-/- mice (Figure 17B and 2G). The CD45+ 
populations were further subdivided into CD3+ T lymphocytes, and CD19+ B 
lymphocytes. The proportion of CD45+ cells which had CD3 (T lymphocytes) was 
unchanged in PAXX-/- cells (Figure 17C and Figure 17H), as were the proportions of T 
lymphocytes with CD4 (Figure 17D and Figure 17I) or CD8 markers (Figure 17E and 
Figure 17J). Similarly, the proportion of CD45+ cells with CD19 was not affected by 
PAXX (Figure 17F and Figure 17K). We were therefore able to conclude that Paxx-/- mice 
were able to create normal lymphocyte populations, and that V(D)J recombination was 
not deficient. Whilst we can be confident in this conclusion, further experiments are 
required to determine whether there is a significant difference in lymphocyte 
populations between genotypes, because the experiment has only been conducted twice 
with two mice per group. 
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Figure 17: Paxx-/- mice have normal lymphocyte populations in the spleen and lymph nodes.  
A) Cells extracted from the spleen were analysed by flow cytometry using the gating protocol illustrated. 
Doublets and dead cells were removed from analysis, and CD45+ cells were isolated. CD19 and CD3 were 
used to identify B and T lymphocytes, respectively. NK1.1+CD3+ cells were removed to discount NKT cells, 
and CD8 and CD4 were used to identify CD3+ subsets. Cells were isolated from the spleen and analysed to 
determine the proportions of B) CD45+ cells, C) CD45+ cells that are CD3+, D) CD3+ cells that are CD4+, E) 
CD3+ cells that are CD8+, and F) CD45+ cells that are CD19+. Cells were isolated from the lymph nodes and 
analysed to determine the proportions of G) CD45+ cells, H) CD45+ cells that are CD3+, I) CD3+ cells that are 
CD4+, J) CD3+ cells that are CD8+, and K) CD45+ cells that are CD19+. Two mice were used per group. Error 
bars denote intra-experimental mean +/- SEM. Data representative of two independent experiments.   
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4.4 PAXX is not required to restrict HSV-1 infection in vivo 
Having shown that the Paxx-/- mice did not have a SCID phenotype, which could 
confound any observations made in response to infection of these mice with pathogens, 
we wanted to investigate the role of PAXX during HSV-1 infection in mice. We showed 
in Section 3.2 that Paxx-/- MEFs and PAXX-/- RPE-1 cells supported the production of 
more infectious HSV-1 virions in comparison with WT cells. We therefore hypothesised 
that Paxx-/- mice may have a reduced capacity to control HSV-1 infection. To test this 
1 x 106 PFU of HSV-1 expressing a firefly luciferase gene under the control of a CMV 
promoter was injected intradermally into the whisker pads of four mice per genotype, 
and PBS of the same volume was injected into two control mice for each genotype. 
HSV-1 infection is generally asymptomatic in mice, but in cases where mice are severely 
compromised in their ability to control HSV-1 infection, pathology may be observed 
(Kollias et al., 2015). Pathology is generally in the form of neurological complications or 
weight loss, and so we monitored mice for both during infection. No neurological 
pathology was observed in any mice. The weight of the mice was measured daily, and 
there was no significant change in the weight of either WT or Paxx-/- mice during 
infection (Figure 18A). Sometimes lesions can form on the lips or, in the event of 
anterograde transport along the ocular nerves, the eyes (Kollias et al., 2015), but no 
lesions were observed in any mice. 
Although no pathology was observed in WT or Paxx-/- mice, Paxx-/- mice may still 
have a reduced ability to control HSV-1 infection. In mice HSV-1 spreads from the 
whisker pads to the trigeminal ganglia where it usually establishes latency, but in mice 
that are compromised in their ability to control the virus, lytic infection is established 
and the virus spreads to other tissues (Kollias et al., 2015). HSV-1 expressing luciferase 
was used so that the locatio of HSV-1 infection can be determined using an in vitro 
imaging system (IVIS). Mice are injected with luciferin, and 20 minutes later they were 
anaesthetised and placed into the IVIS. The firefly luciferase produced by HSV-1 
catalyses the oxidation of luciferin, and light is emitted as a by-product. The location and 
intensity of the light is detected by the IVIS, allowing for interpretation of the location 
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and amount of virus during infection. This system was used to observe the spread of 
HSV-1 in infected mice every second day post infection.  
Signal above background was not observed in WT or Paxx-/- mock-treated 
(uninfected) mice at any time (Figure 18B). Signal was observed in the nasal area of 
infected WT mice after 2 days, the first time luciferase activity was measured (Figures 
18B and C). For the duration of the study, signal was limited to this region in all WT 
Figure 18: PAXX deficiency does not affect outcome of HSV-1 infection in vivo.  
WT and Paxx-/- mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 expressing 
luciferase, or with PBS (mock). A) The weight of each mouse was monitored throughout the experiment and 
is shown as the weight relative to its initial weight. The graph only shows infected mice and is representative 
of two experiments each with three mice per group. B) IVIS was used to observe the spread of the viral 
infection. Representative examples after 6 days of infection are shown. The top panel shows a magnified 
image of the nasal area, while the bottom panel shows an image of the whole body. C) IVIS was used to 
quantify the luciferase activity during the course of infection. Mock infected mice are not shown, and three 
mice were used per group. The graph shows a representative example of two independent experiments. 
Error bars denote intra-experimental mean +/- SEM. 
 
The role of PAXX in vivo   
 124. 
mice. After 6 days of infection, the total signal observed in WT mice had started to drop, 
suggesting that lytic infection was being controlled (Figure 18C). After 10 days of 
infection total luciferase activity was at background levels. 
In general, the infection of Paxx-/- mice followed was very similar to that observed in 
WT mice (Figures 18B and C). However, in one experiment a Paxx-/- individual had 
luciferase signal that aligned with the brain after 4 days of infection, but it had been 
cleared by day 6. Spread of HSV-1 infection to the brain is often observed in mice unable 
to effectively control HSV-1 infection following lip inoculation (Kastrukoff et al., 1982). 
Otherwise there was no indication from the localisation or intensity of luciferase 
production that the Paxx-/- mice were any less competent at controlling HSV-1 infection 
than their WT counterparts. We repeated this experiment and found similar results with 
the same conclusions. We therefore concluded that PAXX is not required for the 
restriction of HSV-1 infection in mice, although a further repetition of the experiment 
would enhance our confidence in this conclusion. 
4.5 PAXX deficiency does not result in changes to 
lymphocyte populations during infection 
Mutations in some NHEJ factors can cause a SCID phenotype in mice and humans 
because they are required for V(D)J recombination, an important part of lymphocyte 
maturation (Section 1.3.3.1). We have observed that Paxx-/- mice have normal lymphocyte 
populations in the absence of infection (Section 4.3), and that they are able to control 
HSV-1 to a similar extent as their WT counterparts (Section 4.4). However, we wanted to 
investigate whether there was an observable difference in the lymphocyte populations of 
Paxx-/- mice relative to their WT counterparts during infection. 
To test for differences between lymphocyte populations, cells were isolated from the 
spleen or lymph node 11 days after infection, stained, and analysed by flow cytometry 
using the gating strategy shown in Figure 17A. After the removal of doublets and dead 
cells, CD45+ cells were subdivided into CD3-CD19+ B cells and CD3+NK1.1- T cells, the 
latter of which were further subdivided into CD8+ and CD4+ cells. B cells and T cells 
were also stained for CD62L, a marker indicative of lymphocyte memory. Proportions of 
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different cell types were then calculated. 11 days after infection the proportion of the 
different lymphocyte population was similar to uninfected controls in both the spleen 
(Figure 19) and lymph nodes (Figure 20). These data show that at these times after 
infection the relative proportions of lymphocyte subsets are not different between 
infected and uninfected mice. Paxx-/- mice do not have significantly different proportions 
of lymphocyte subsets compared to WT mice. 




Figure 19: HSV-1 infection does not alter the relative proportions of lymphocytes from the spleen.  
WT and Paxx-/- mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 
expressing luciferase, or with PBS. Cells were isolated from the spleen after 11 days and analysed by 
flow cytometry using the gating strategy shown in Figure 17 to determine the proportions of A) CD45+ 
cells, B) CD45+ cells that are CD3+, C) CD3+ cells that are CD4+, D) CD3+ cells that are CD8+, and E) CD45+ 
cells that are CD19+. Infected groups consisted of three mice, mock groups had two mice. Error bars 
denote intra-experimental mean +/- SEM. Figures are representative of two independent experiments. 
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Figure 20: HSV-1 infection does not alter the relative proportions of lymphocytes from the lymph nodes.  
WT and Paxx-/- mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 expressing 
luciferase, or with PBS. Cells were isolated from lymph nodes after 11 days and analysed by flow cytometry 
using the gating strategy shown in Figure 17 to determine the proportions of A) CD45+ cells, B) CD45+ cells 
that are CD3+, C) CD3+ cells that are CD4+, D) CD3+ cells that are CD8+, and E) CD45+ cells that are CD19+. 
Infected groups consisted of three mice, mock groups had two mice. Error bars denote intra-experimental 
mean +/- SEM. Figures are representative of two independent experiments. 
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4.6 PAXX is not required for the stimulation of 
lymphocytes with PMA 
After the observation that the proportions of lymphocyte subpopulations remain 
similar between WT and Paxx-/- cells, we wanted to investigate whether lymphocytes 
isolated from the two genotypes were equally primed for activation following infection. 
Phorbol myristate acetate (PMA) activates T lymphocytes, and can be used to investigate 
the proportion of T lymphocytes primed to respond (Touraine et al., 1977).  
Lymphocytes were extracted from the spleen or lymph nodes of infected and 
uninfected mice, were stimulated with PMA or left unstimulated, and analysed by flow 
cytometry to investigate production of IFNγ and TNFα, and the expression of CD62L 
(Figure 21A). IFNγ was studied because it is a marker of lymphocyte activation and is 
important in restricting HSV-1 infection (Section 1.5.3). TNFα is produced by activated T 
lymphocytes (Cuturi et al., 1987; Sung et al., 1988). CD62L is used as a marker of naïve T 
cell lymphocytes (Picker et al., 1993). Unstimulated cells were used to determine 
appropriate thresholds for analysis (Figure 21B). The T lymphocytes were activated by 
the PMA (Figure 21B and C), but there were not any significant differences between WT 
and Paxx-/- lymphocytes in the expression of any of these proteins in CD4+ or CD8+ T 
lymphocytes (Figure 22). This suggests that PAXX is not required for the activation of 
lymphocytes by PMA. 
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Figure 21: Gating strategy and examples of flow cytometry analysis.  
Three WT mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 expressing 
luciferase, and two were injected with PBS. Cells were isolated from the spleen after 11 days, stimulated 
with PMA or left unstimulated for four hours. A) Cellular debris was excluded from analysis using forward 
and side scatter. Single cells were isolated from doublets, and analysed using Zombie green so that only live 
cells were selected for analysis. CD45+CD3+ cells were isolated, and split into CD4+CD8- and CD4-CD8+ 
subpopulations. CD4+CD8+ cells were not included in subsequent analysis. B) and C) The isolated subsets 
were then analysed for IFNγ, TNFα, and CD62L. B) An example of non-stimulated CD4+CD8- cell staining. 
C) An example of PMA-stimulated CD4+CD8- cell staining. FSC – forward scatter; SSC – side scatter. Figures 
are representative of two independent experiments. 
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Figure 22: Paxx-/- lymphocytes respond to PMA stimulation.  
WT and Paxx-/- mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 expressing 
luciferase, or with PBS. Cells were isolated from the spleen after 11 days, stimulated with PMA (black bars) 
or left unstimulated (grey bars) for four hours, and analysed by flow cytometry using the gating strategy 
shown in Figure 21. This analysis was used to determine proportions of CD3+ CD4+ cells expressing A) IFNγ, 
B) TNFα, and C) CD62L, and CD3+ CD8+ lymphocytes expressing D) IFNγ, E) TNFα, and F) CD62L. Error 
bars denote intra-experimental mean +/- SEM. N.S. = no significant difference. Figures are representative of 
two independent experiments, except for figures C) and F) which depict a single experiment. Infected 
groups consisted of three mice, mock groups had two mice. 
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4.7 gB498-505 stimulates expression of IFNγ but not TNFα, 
and does not reduce CD62L presentation. 
PMA is a generic stimulator of T lymphocytes, so we wanted to stimulate 
lymphocytes with the peptide gB498-505 (amino acids 498-505 from gB; SSIEFARL) to test 
HSV-1-specific responses. gB498-505 is from the major HSV-1 antigen, gB, which was 
selected because it is considered an immunodominant antigen during HSV-1 infection 
(Khanna et al., 2003; Wallace et al., 1999). Cells were stimulated with 10-7 to 10-6 M of 
gB498-505 for four hours, and analysed by flow cytometry using the same gating strategy 
described in Figure 22A. CD4+ and CD8+ cells both produced IFNγ in response to all 
concentrations of gB498-505 tested, and the levels were similar to those following PMA 
stimulation (Figure 23A and D). In contrast to PMA stimulation, gB498-505-stimulated T 
cells did not produce TNFα (Figure 23B and E) or lose CD62L (Figure 23C and F). Since 
the activation observed was incomplete, we did not explore stimulation with gB498-505 
further. 
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Figure 23: The gB peptide, SSIEFARL, is able to induce IFNγ in CD3+ cells from WT mice, but does not 
induce TNFα production or loss of CD62L presentation.  
WT mice were infected intradermally in the whisker pads with 1 x 106 PFU of HSV-1 expressing luciferase. 
Cells were isolated from the spleen after 11 days, stimulated with PMA, stimulated with varying 
concentrations of the gB peptide, or left unstimulated for four hours. Cells were analysed by flow cytometry 
using the gating strategy shown in Figure 21. Analysis determined the proportion of CD4+CD8- cells 
expressing A) IFNγ, B) TNFα, and C) CD62L, and the proportion of CD4-CD8+ cells expressing D) IFNγ, E) 
TNFα, and F) CD62L. Error bars denote intra-experimental mean +/- SEM. Data representative of one 
experiment. Infected groups consisted of three mice, mock groups had two mice. 
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4.8 Discussion 
In Chapter 3 we showed that PAXX restricts HSV-1 infection in cell culture. We were 
therefore interested in whether PAXX restricts HSV-1 infection in vivo. Before testing this 
hypothesis we wanted to investigate whether Paxx-/- mice have normal development, in 
part to ensure that there are no confounding pathologies exhibited by these mice. Xrcc6-/- 
mice are roughly 50 % of the size of WT mice (Gu et al., 1997), and defects in XRCC4 
have been shown to cause primordial dwarfism in humans (Murray et al., 2015). 
However, Paxx-/- mice did not share this phenotype. DNA damage has been shown to 
stimulate the innate immune response (Brzostek-Racine et al., 2011; Kim et al., 1999; Wu 
et al., 2006), and DNA repair-deficiencies can lead to genomic instability which can 
create immunostimulatory micronuclei or lead to DNA leaking into the cytoplasm 
(Mackenzie et al., 2017). As a result, DNA sensing pathways can be triggered, and 
autoinflammation may occur in vivo. Autoinflammatory disease often manifests itself in 
at least one of the skin or CNS, often both (Rodero and Crow, 2016), and these tissues are 
both very relevant to HSV-1 infection. Mutations in human PRKDC have been shown to 
result in neurological complications as well as SCID (Woodbine et al., 2013). We did not 
observe pathology in the skin of Paxx-/- mice (data not shown). The behaviour of Paxx-/- 
mice was not indicative of neurological problems, and the weights of their brains were 
not different to those of WT mice (Figure 16B). Although this suggested that the loss of 
Paxx expression did not have major adverse effects on the skin and CNS of the mice, it 
would be interesting to look directly at IFN-I levels in Paxx-/- mice using ELISA (enzyme-
linked immunosorbent assay). 
The DNA repair machinery has also been shown to be important in the development 
of lymphocytes. DNA-PKcs is required for V(D)J recombination, and therefore Prkdc-/- 
mice lack B and T cell lymphocytes and exhibit a SCID phenotype (Blunt et al., 1995; 
Kirchgessner et al., 1995; Kurimasa et al., 1999b; Woodbine et al., 2013). Ku70 and Ku80 
have also been shown to be required for efficient V(D)J recombination, although Xrcc6-/- 
(Ku70-/-) mice are still able to achieve inefficient V(D)J recombination which is sufficient 
for the production of some abnormal T cells (Gu et al., 1997; Taccioli et al., 1994). 
Although humans with XRCC4 mutations do not have a SCID phenotype (Murray et al., 
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2015), we therefore hypothesised that PAXX may also be important for V(D)J 
recombination. We used flow cytometry to show that the spleens and lymph nodes of 
Paxx-/- mice contained both B and T lymphocyte populations, and that the proportions of 
the different lymphocytes were similar to those of WT mice (Figure 17). This suggests 
that PAXX is not required for V(D)J recombination in mice, and others have made the 
same conclusion (Balmus et al., 2016). As discussed in Chapter 3, it would be interesting 
to account for potential redundancy between PAXX and XLF by comparing Paxx-/-Nhej1-/- 
to single knockouts, but an inducible or tissue-specific system would be required in vivo 
due to the embryonic lethality of the double knockout (Balmus et al., 2016). 
Having confirmed that Paxx-/- mice do not have overt developmental defects and that 
they have normal lymphocyte populations we wanted to investigate whether PAXX 
restricts HSV-1 infection in vivo. Mice unable to control HSV-1 infection usually lose 
weight and allow spread of the virus to the brain (Kollias et al., 2015). Neither WT nor 
Paxx-/- mice lost weight during infection with HSV-1 (Figure 18A). We also monitored 
the spread of HSV-1 expressing luciferase using IVIS. Following intradermal injection 
into the whisker pads, HSV-1 established infection in the noses of both WT and Paxx-/- 
mice (Figure 18B). There was one instance in a Paxx-/- mouse where signal was observed 
in the brain at day four, but this had been cleared by day six and otherwise signal was 
limited to the nasal area. By day six mice of both genotypes had started to clear the 
infection, and the luciferase activity detected dropped (Figure 18C). There were no 
significant differences in the luciferase activity detected between WT and Paxx-/- mice at 
any time during infection, and both genotypes had almost cleared the lytic infection by 
day ten. We also showed that after 11 days of infection the relative proportions of 
lymphocyte subsets had not changed. However, this analysis was only conducted at one 
time post infection, and so analysis would need to be conducted at other times post 
infection to ensure that our conclusions are robust.  
These data suggest that PAXX is not required to restrict and clear HSV-1 infection in 
vivo, but there are a number of ways in which this conclusion could be tested further. In 
Chapter 3 we showed that PAXX restricts the production of infectious virus, and so it 
would be interesting to infect WT and Paxx-/- mice and to titrate the infectious virus 
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produced. Similarly, applying other techniques developed in Chapter 3 to determine 
viral genome copy numbers and genome structures would be informative, especially 
when considering a potential role for PAXX in the establishment of HSV-1 latency. 
Finally, the protocol could be adapted to better assess the immune response to HSV-1 
infection in both genotypes. For example, ELISA could be used to investigate the innate 
immune response to infection, and antibody titres could be analysed using a plaque 
neutralisation assay. However, we decided that we could not ethically justify pursuing 
our original hypotheses further. 
Although we had concluded that PAXX is not required to restrict and clear lytic 
HSV-1 infection in vivo, we investigated whether WT and Paxx-/- T cells were equally 
primed for activation following HSV-1 infection. To establish whether PAXX is required 
for the activation and IFNγ production of T cells in mice, lymphocytes isolated from the 
spleen and lymph nodes were activated with PMA and stained for IFNγ, TNFα, and 
CD62L. Lymphocytes from both WT and Paxx-/- mice were activated by PMA, regardless 
of whether they were isolated from individuals infected with HSV-1 or not, as is 
evidenced by an increased proportion of lymphocytes expressing IFNγ and TNFα, and 
the reduced proportion of lymphocytes expressing CD62L (Figure 22). There were no 
observable differences between the activation of WT and Paxx-/- lymphocytes, and this 
was true for both CD4+ and CD8+ lymphocytes (Figure 22). It is also interesting to 
consider that in Chapter 3 we observed that PAXX might be involved in MAPK 
signalling, and MAPK signalling has been shown to be important for activation and 
IFNγ production in CD4+ (Dong et al., 1998, 2000; Sabapathy et al., 1999) and CD8+ T cells 
(Merritt et al., 2000). This is exemplified by the activation of T cells by the generic MAPK 
stimulator, PMA. Furthermore, c-Jun is important in effector CD8+ T lymphocyte 
differentiation (Kuroda et al., 2011). However, these data suggest that PAXX is not 
required for PMA-induced activation of T lymphocytes, and that if MAPK signalling is 
defective in Paxx-/- cells, it does not affect T lymphocyte activation. 
In addition to the general activation state of T lymphocytes, we also wanted to look 
at a HSV-1-specific activator of T lymphocytes, and so we explored the potential of using 
the gB498-505 peptide from the HSV-1 glycoprotein gB. gB498-505 is thought to be targeted by 
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70-90 % of HSV-1-specific CD8+ T cells (Wallace et al., 1999). Although gB498-505 activated 
IFNγ production in CD4+ and CD8+ cells, it did not stimulate T lymphocytes to produce 
TNFα or to remove CD62L (Figure 23). We therefore did not pursue gB498-505 stimulation 
of T lymphocytes further.  
Together, the data from this chapter show that Paxx-/- mice develop normally and do 
not have an overt pathological phenotype. We have also shown that PAXX is not 
required for the creation of lymphocytes, and that Paxx-/- lymphocytes are able to 
respond normally to PMA stimulation. Having presented our data on the role of PAXX 
during HSV-1 infection both in cell culture and in vivo, Chapter 5 will investigate the role 
of DNA-PKcs, another NHEJ protein, during HSV-1 infection. 
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5 The role of DNA-PKcs during HSV-1 infection 
5.1 Introduction 
In Chapters 3 and 4 we have discussed the role of PAXX during HSV-1 infection. In 
this chapter we will explore the role of another NHEJ protein, DNA-PKcs, in the same 
context. This is a subject of interest because the DNA-PK complex restricts HSV-1 
infection, and, in response, HSV-1 has evolved to induce DNA-PKcs protein degradation 
(Lees-Miller et al., 1996; Parkinson et al., 1999). Human PRKDC-/- malignant glioma cells 
produce more infectious HSV-1 virus than their WT counterparts after two days of 
infection (Parkinson et al., 1999). The mechanisms by which DNA-PKcs inhibits HSV-1 
infection are not currently known, and we hope to address this issue in this chapter. 
There are multiple potential mechanisms through which DNA-PKcs could restrict 
HSV-1, and not all of these have been studied in the context of HSV-1 infection. Firstly, 
DNA-PKcs functions as an innate immune sensor of DNA, and the cytokine responses to 
HSV-1 infection are reduced in Prkdc-/- mice relative to their WT counterparts (Ferguson 
et al., 2012; Morchikh et al., 2017). It has also been proposed that the DNA-PK complex 
may contribute to HSV-1 genome circularisation, and therefore induce latency (Smith et 
al., 2014). This hypothesis is consistent with the observation that ICP0 promotes lytic 
HSV-1 infection (Jackson and DeLuca, 2003). Finally, DNA-PK can initiate some 
programmed cell death pathways, most notably apoptosis (Section 1.1.2.3), but this has 
not been investigated during HSV-1 infection. 
The aim of the experiments in this chapter was to begin exploring the different roles 
of DNA-PKcs during HSV-1 infection, and to ultimately provide a more complete 
picture about how DNA-PKcs regulates HSV-1 infection. 
5.2 HSV-1-induced degradation of DNA-PK complex 
components is cell-type specific 
It has previously been reported that DNA-PKcs is degraded during HSV-1 infection, 
and that ICP0 is responsible for inducing this (Lees-Miller et al., 1996; Parkinson et al., 
1999). However DNA-PKcs levels are stable during HSV-1 infection of rat cortical 
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neurons, whereas Ku80 is degraded (De Chiara et al., 2016). DNA-PKcs degradation has 
also been reported as absent in Vero cells, derived from the kidney of African green 
monkeys, however the authors only checked seven hours post infection, which may be 
too early to be conclusive (Wilkinson and Weller, 2004). We hoped that studying the cell 
type-dependency of DNA-PKcs and Ku80 degradation might help us to better 
understand the function of these proteins during HSV-1 infection. To further investigate 
this, RPE-1, U2OS, and HFFF cells were infected at MOI 10 with HSV-1, and protein was 
harvested at various times post infection for analysis by immunoblotting. We also 
infected cells with ΔICP0 HSV-1 to test whether DNA-PKcs degradation is dependent on 
ICP0 as described. RPE-1 cells were used because they are of epithelial origin, a natural 
target for HSV-1 infection, and for continuity with the experiments in Chapter 4. U2OS 
cells were chosen because they are permissive to 𝚫ICP0 infection, and so we 
hypothesised that the ICP0-induced degradation of DNA-PKcs might not be required for 
HSV-1 infection in these cells. HFFF cells were used at an early passage because they are 
fibroblasts that have the attributes of primary cells. As was expected, a drop in DNA-
PKcs protein levels was observed in RPE-1 and HFFF cells (Figure 24A and B), but 
unexpectedly DNA-PKcs protein levels were stable in U2OS cells (Figure 24C). The 
reduction in DNA-PKcs protein was not observed in RPE-1 and HFFF cells infected with 
ΔICP0 HSV-1, suggesting that ICP0 is responsible for inducing DNA-PKcs degradation 
in these cells. HSV-1 infection of rat cortical cells induced a reduction in Ku80 protein 
(De Chiara et al., 2016). In all of the cells tested here, however, both Ku70 and Ku80 
protein levels were stable. VP22 expression confirms that ΔICP0 HSV-1 successfully 
infected the cells. PARP-1 is cleaved by a range of host proteases and is indicative of the 
activation of cell death pathways (Chaitanya et al., 2010). HFFFs have no cleaved 
PARP-1, which may indicate that alternative or no cell death pathways are activated. In 
contrast RPE-1 cells exhibit a lot of PARP-1 cleavage. This suggests that PARP-1 cleavage 
and DNA-PKcs degradation are disconnected. VP22 expression and PARP-1 
degradation is delayed relative to the kinetics observed with WT HSV-1, suggesting that 
the kinetics of ΔICP0 HSV-1 infection are slower. Finally, multiple bands are observed in 
RPE-1 cells when using an antibody recognising the N-terminus of DNA-PKcs for 
immunoblotting, and following HSV-1 infection all of these bands disappear, suggesting 
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that these bands may represent isoforms, degradation products, or differential 
post-transcriptional modification of DNA-PKcs. 
 
Figure 24: DNA-PKcs degradation is cell-type specific.  
A) RPE-1, B) HFFF, and C) U2OS cells were infected with WT or ΔICP0 HSV-1 at MOI 10. At the indicated 
times post infection whole cell lysates were created. Immunoblotting was used to analyse the levels of DNA-
PKcs, Ku70, and Ku80. PARP-1 levels were observed because cleavage of PARP-1 is indicative of caspase 
activation and cell death pathways. Tubulin was used as a loading control, and VP22 was used to 
demonstrate successful infection. Blotting for ICP0 showed that the ΔICP0 HSV-1 does not express ICP0. 
Data are representative of three independent experiments. 
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5.3 PRKDC-/- RPE-1 cells are not permissive to 𝚫ICP0 HSV-
1 infection 
Infection of most cell types with 𝚫ICP0 HSV-1 at a low MOI does not produce 
infectious virions, but U2OS cells are permissive to 𝚫ICP0 HSV-1 infection (Deschamps 
and Kalamvoki, 2017). It has recently been proposed that this is due to dysfunctional 
STING signalling (Deschamps and Kalamvoki, 2017), in keeping with observations that 
ICP0 inhibits the IRF3 pathway (Lin et al., 2004a). STING signalling is impaired in 
response to DNA stimulation in the absence of DNA-PKcs (Ferguson et al., 2012; 
Morchikh et al., 2017). It has also been proposed ICP0-induced degradation of DNA-
PKcs helps prevent progression to latency because DNA-PKcs may induce 
circularisation of the viral genome (Smith et al., 2014). Therefore abrogating DNA-PKcs 
expression may be sufficient to prevent both innate immune activation and viral latency 
resulting from the absence of ICP0. We therefore hypothesised that PRKDC-/- cells would 
be permissive to 𝚫ICP0 infection.  
To test this hypothesis, CRISPR/Cas9 genome editing was used to create PRKDC-/- 
RPE-1 cells. RPE-1 cells were used in this study because we had already observed that 
ΔICP0 HSV-1 can infect these cells, and because ICP0 was required for the degradation 
of DNA-PKcs in these cells (Figure 24A). To maximise confidence that any phenotypes 
observed in PRKDC-/- cells would be due to the targeted genetic lesion rather than off-
target effects of CRISPR, we created single guide RNAs (sgRNAs) that targeted two 
different sites in the PRKDC gene. The first sgRNA was designed to create an insertion 
or deletion mutation (InDel) at the N-terminus to create a frame-shift and disrupt the 
rest of the gene (Figure 255A). The second sgRNA created an InDel at the C-terminal 
end of the kinase domain. This mutant is of additional interest because previous studies 
have shown that the 83 C-terminal amino acids are required for DNA-PKcs NHEJ 
activity (Blunt et al., 1996), but not for the innate sensing of cytoplasmic DNA (Ferguson 
et al., 2012). Therefore if a lesion here does not create a functional KO, this could be used 
to help us to disentangle the two roles of DNA-PKcs during HSV-1 infection. RPE-1 cells 
were treated with CRISPR/Cas9 (Section 2.7.1), clones were created, and DNA-PKcs 
expression of the clones was tested using immunoblotting with an antibody recognising 
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the N-terminus of DNA-PKcs showed that a clone created with an sgRNA targeting the 
kinase domain did not express DNA-PKcs, but that two clones created with the sgRNA 
targeting the N-terminus did (Figure 255B). Given that the sgRNA targeted the kinase 
domain towards the C-terminus, this suggests that the truncated version may be 
degraded, and immunofluorescence was used to confirm that this clone (referred to as 
PRKDC-/- RPE-1 cells hereafter) did not express DNA-PKcs (Figure 255C). We therefore 
decided to use this clone in our analysis. We attempted to sequence the site at which we 
expected the mutation to be made, but had technical difficulty. Although the 
immunoblot and immunofluorescence have increased our confidence that this clone is a 
KO, a sequence should be attained in the future to further increase confidence in the 
clone. DNA-PKcs is a 469 kDa protein, and the PRKDC gene (excluding introns) is 13509 
bp in length. As a result, rescue of the gene with current technology was not feasible.  
To test our hypothesis that PRKDC-/- cells are permissive for 𝚫ICP0 infection, 
monolayers of WT RPE-1 cells, PRKDC-/- RPE-1 cells, and U2OS cells were infected with 
30 PFU of WT or 𝚫ICP0 HSV-1 so that plaque formation could be observed. WT virus 
was able to form plaques in all cell types, while 𝚫ICP0 HSV-1 only formed plaques in 
U2OS cells (Table 10). ΔICP0 HSV-1 is often able to overcome restriction at higher MOIs 
(Everett et al., 2004), and both WT and PRKDC-/- RPE-1 cells showed CPE plaque 
formation, an indicator of productive infection, after infection with ΔICP0 HSV-1 at 
MOI 4. 
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Figure 25: CRISPR/Cas9 was employed to create PRKDC-/- RPE-1 cells. 
A) Map of sgRNA binding sites in PRKDC. B) Immunoblotting using an antibody recognising the N-terminus 
of DNA-PKcs was used to confirm the loss of DNA-PKcs expression in the clone where DNA-PKcs was 
targeted at the kinase domain (K), and two clones that were targeted at the N-terminus (N1 and N2). C) 
Immunofluorescence using an antibody recognising the N-terminus of DNA-PKcs was used to ensure that 
the PRKDC-/- clone was not a mixed population of WT and PRKDC-/- cells. Data is representative of three 
independent experiments. 








Table 10: DNA-PKcs does not affect whether RPE-1 cells are permissive to ΔICP0 HSV-1 infection. 
WT RPE-1 cells, PRKDC-/- RPE-1 cells, and WT U2OS cells were infected with 30 PFU of WT (S17) HSV-1 or 
ΔICP0 HSV-1, or at MOI 4 with ΔICP0 HSV-1. After 5 days of infection the cells were stained with crystal 
violet solution. The formation or absence of plaques in each condition is denoted by a ‘+’ or ‘-‘, respectively. 
Data are representative of three independent experiments. 
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5.4 DNA-PKcs may alter the kinetics of infectious HSV-1 
virion production 
Although PRKDC-/- RPE-1 cells were not permissive to 𝚫ICP0 infection, this result 
does not preclude DNA-PKcs from having a role in regulating HSV-1. Indeed, it has 
previously been reported that after two days of infection PRKDC-/- human malignant 
glioma cells produce a higher titre of HSV-1 or 𝚫ICP0 than WT cells (Parkinson et al., 
1999). However, the WT human malignant glioma cells were permissive to ΔICP0 HSV-1 
infection and the loss of DNA-PKcs expression affected WT and ΔICP0 HSV-1 titres to a 
similar extent, indicating that these cells do not behave like most other cells during HSV-
1 infection. We therefore wanted to investigate whether DNA-PKcs-deficient cells also 
produce more infectious virions when derived from a non-cancerous cell line. We also 
wanted to investigate how DNA-PKcs affects the kinetics of infectious HSV-1 virion 
production because LIG4- and XRCC4-deficient cells are delayed in their production of 
infectious HSV-1 virions (Muylaert and Elias, 2007). WT and PAXX-/- RPE-1 cells were 
infected at an MOI of 0.01 or 4, and the output of infectious virus was quantified by 
titration on Vero cells. MOI 0.01 was used to investigate multi-step infection dynamics, 
while MOI 4 was used to investigate single-step infection (as described in more detail in 
Section 3.2), and both experiments were repeated twice. In one experiment at MOI 0.01, 
WT RPE-1 cells produced significantly more infectious virions than PRKDC-/- RPE-1 cells 
24 hours post infection, but 48 hours post infection the infectious virion production in 
PRKDC-/- RPE-1 cells had surpassed that of WT cells (Figure 26A). In the second repeat 
the titres of infectious virus were similar 24 hours post infection, but PRKDC-/- RPE-1 cells 
produced significantly more infectious virus 48 hours post infection (Figure 26B). The 
preliminary nature of these results is highlighted by their inconsistencies, and further 
repeats are required for any conclusions to be drawn. The experimental repeats at MOI 4 
were more consistent in the shape of the curve, although there was a 10-fold difference 
between repeats (Figure 26C and D). 12 hours post infection at MOI 4 WT cells produced 
significantly more infectious virions than WT RPE-1 cells, but this phenotype was 
reversed 48 hours post infection where PRKDC-/- RPE-1 cells produced more infectious 
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virions than WT cells. Although these results are more consistent, further repeats are 
required before strong conclusions can be made. 
Figure 26: HSV-1 infection of PRKDC-/- cells produces fewer infectious virions than WT cells early in 
infection, but more later in infection.  
A) and B) show two experiments where WT and PRKDC-/- RPE-1 cells were infected at MOI 0.01, and at the 
indicated times post infection the number of infectious virions was quantified by titration onto Vero cells. C) 
and D) show two experiments with the same setup as in A) and B), but at MOI 4. All data points are the 
mean of a biological triplicate, and error bars show intra-experimental mean +/- standard error of the mean 
(SEM). Statistical significance, calculated using the Student’s t-test, is indicated using stars - * = p<0.05, ** = 
p<0.02, *** = p<0.01. 
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5.5 Endless HSV-1 genomes can be observed in cells lacking 
DNA-PKcs. 
It has been proposed that DNA-PKcs may be required for the circularisation of the 
HSV-1 genome (Smith et al., 2014). We therefore hypothesised that PRKDC-/- RPE-1 cells 
produce less infectious virus than WT cells 12 hours post infection at MOI 4 (Figure 26B) 
because DNA-PKcs is required for genome circularisation, and therefore for efficient 
rolling circle replication of the HSV-1 genome. HSV-1 genome circularisation is 
correlated with HSV-1 latency (Jackson and DeLuca, 2003; Rock and Fraser, 1985; Smith 
et al., 2014), so this may also explain why WT cells produce fewer infectious virions than 
PRKDC-/- 48 hours post infection. We therefore wanted to investigate whether HSV-1 
genome circularisation occurs efficiently in absence of DNA-PKcs. To test this, WT and 
PRKDC-/- cells were infected with HSV-1 at MOI 4, and the viral genomes were analysed 
by southern blotting to detect endless forms of the genome (Section 2.6.8). Preliminary 
results suggest that WT and PRKDC-/- cells support similar levels of HSV-1 
circularisation at 5 hours post infection (Figure 27). There also appears to be less viral 
Figure 27: Endless HSV-1 genome form efficiently in PRKDC-/- cells, but genome replication is restricted.  
WT and PRKDC-/- cells were infected at MOI 4, and total cellular and viral DNA was isolated at indicated 
times post infection. The DNA extracts were digested with BamHI, and the HSV-1 S, K, and Q fragments were 
visualised by southern blot. The same total mass of DNA was added to each well. The sizes of the K, Q, and S 
fragments are indicated. This preliminary experiment has only been performed once. 
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DNA in PRKDC-/- cells after 12 hours of infection in a manner reminiscent of that 
observed in PAXX-/- cells (Section 3.4, Figure 8). The smear observed in the PRKDC-/- 
sample after 24 hours is likely to be due to problems with the BamHI digestion of the 
viral DNA and so requires repeating prior to full analysis of the results. Although these 
data suggest that DNA-PKcs is not required for HSV-1 genome circularisation, and that 
genome replication is less efficient in the absence of PAXX, several repeats of this 
experiment are required before robust conclusions can be made. 
5.6 Prkdc-/- primary murine skin fibroblasts respond 
normally to DNA stimulation and infection 
DNA-PKcs is an innate sensor of cytoplasmic DNA (Section 1.3.1.2), but the exact 
mechanisms of its function are not well characterised. We wanted to further investigate 
the role of DNA-PKcs in innate immunity, but wanted to use an alternative model to 
RPE-1 cells due to the poor stimulation of innate pathways in these cells and because 
non-primary cells such as RPE-1 cells generally produce low levels of IFNβ (Section 3.8). 
A method was optimised to culture primary murine skin fibroblasts (MSFs) from WT 
C129 and Prkdc-/- C129 mice (Section 2.10.9). To test the responsiveness of these cells to 
innate immune stimuli, WT MSFs were infected with ΔICP0 HSV-1 at MOI 5, or 
transfected with 5 μg/mL of concatenated DNA. ΔICP0 HSV-1 was used because ICP0 
induces the degradation of DNA-PKcs (Lees-Miller et al., 1996; Parkinson et al., 1999), 
and also inhibits innate immune responses to infection (Eidson et al., 2002b; Lin et al., 
2004b; Mossman et al., 2001). Cells were harvested six hours after stimulation because we 
have previously observed significantly increased transcription of IFNβ and other genes 
at this time (Ferguson et al., 2012), the RNA was purified, and cDNA was created for 
gene expression analysis by qPCR. The culture of MSFs ex vivo produced a low yield of 
cells for a given area of skin, and the MSFs progressed to senescence after two passages, 
so culturing large numbers of cells was difficult. Therefore, we did not create biological 
repeats for this experiment. However, we were able to show that after six hours both 
infection with ΔICP0 HSV-1 and stimulation with concatenated DNA were sufficient to 
induce Ifnb, Cxcl10, Isg15, and Ifna transcription in WT MSFs (Figure 28A-D).  
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Figure 28: Prkdc-/- murine skin fibroblasts respond normally to infection and DNA transfection.  
Murine skin fibroblasts (MSFs) were cultured ex vivo from mice, and used within the first two passages. WT 
MSFs from C57BL/6 mice were infected with ΔICP0 HSV-1 at MOI 5, stimulated by transfecting 5 μg/mL of 
concatenated DNA, or left untreated (mock), and the transcription levels of A) Ifna, B) Ifnb, C) Cxcl10, and D) 
Isg15 after six hours were determined relative to Hprt by qPCR. These graphs were created from data 
without biological repeats. In a separate experiment, WT and Prkdc-/- MSFs from C129 mice were infected 
with ΔICP0 HSV-1 at MOI 5, infected with MVA at MOI 5, transfected with 5 μg/mL of concatenated DNA, 
or left untreated (mock). Transcription levels of E) Ifna, F) Ifnb, and G) Cxcl10 were quantified after five 
hours using qPCR, and calculated relative to Hprt. The boxes represent two biological repeats, and the lines 
and crosses represent the mean. Data are representative of two independent experiments.  
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Having demonstrated that WT MSFs were responsive to infection and stimulation 
with DNA, we compared the responses of WT and Prkdc-/- MSFs. We aimed to establish 
whether DNA-PKcs-dependent DNA sensing was compartment-dependent, and so we 
compared the cytoplasmic-replicating VACV with the nuclear-replicating HSV-1 in this 
context. WT and Prkdc-/- MSFs were infected with MVA at MOI 5. MVA is an attenuated 
form of VACV which lacks many innate immune modulators, resulting in greater 
stimulation of innate immune signalling pathways than WT VACV. We had hoped to 
conduct this experiment under the same conditions as in Figure 28, but infected Prkdc-/- 
cells had very advanced cytopathic effect (CPE) six hours post infection with ΔICP0 
HSV-1, and we were concerned that cell death pathways may interfere with innate 
immune signalling pathways. We therefore tested transcription levels five hours post 
stimulation instead. This difference in timing can explain some differences between 
levels of stimulation, for example lower levels of Ifnb transcription five hours post ΔICP0 
HSV-1 infection as compared with six hours post infection (Figure 28B and F). 
Nevertheless good stimulation was observed for most treatments and genes. Although 
mean transcription levels were generally higher in WT MSFs than Prkdc-/- MSFs, there 
were no instances where this was statistically significant. It is interesting to note that in 
both WT and Prkdc-/- MSFs at both five and six hours post infection, the Ifna genes are the 
only ones which have higher levels of transcription following ΔICP0 HSV-1 infection 
than following concatenated DNA transfection (Figure 28A and E).  
5.7 PRKDC-/- RPE-1 cells exhibit advanced CPE during 
HSV-1 infection 
While conducting the above experiments we observed that PRKDC-/- RPE-1 cells and 
Prkdc-/- MSFs showed more advanced CPE during infection than WT cells. Indeed, the 
advanced CPE of Prkdc-/- MSFs after six hours was significant enough that we decided to 
change our experimental design while testing the innate immune responses of MSFs 
(Section 5.6). The processes behind HSV-1-induced CPE are poorly understood; despite 
work showing the potential for qualitative analysis of cellular volume using 
stereological analysis (Motamedifar and Noorafshan, 2008), this method does not 
capture the extent of morphology changes, and analysis in the literature remains largely 
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qualitative and subjective. To represent our observation we infected WT and PRKDC-/- 
RPE-1 cells with HSV-1 at MOI 0.01, and photographed the cell monolayer at various 
times post infection (Figure 29). RPE-1 cells were used because we have previously 
observed this phenotype in these cells, and because Prkdc-/- MSFs were not easily 
cultured ex vivo at a large enough scale for this experiment. CPE was first observed after 
24 hours in cells of both genotypes, but PRKDC-/- cells appeared more rounded, and the 
plaque appeared larger. 48 hours post infection with HSV-1 at MOI 0.01, almost all 
PRKDC-/- RPE-1 cells exhibited advanced CPE, whereas WT cells were still forming 
individual plaques. 72 hours post infection all PRKDC-/- cells had dissociated from the 
plate, while many WT cells still did not show signs of CPE. 
To further probe the advanced CPE in PRKDC-/- cells, we also examined CPE 
following infection at MOI 4 (Figure 30). Most PRKDC-/- cells had CPE after only 12 
hours of infection, as compared with very few WT cells. After 24 hours most PRKDC-/- 
had advanced CPE, whilst WT cells were forming plaques. 48 hours post infection all 
PRKDC-/- cells were fully detached from the plate, and almost all WT cells displayed 
signs of at least early CPE. This phenotype is disconnected from our preliminary 
observations that early in infection WT RPE-1 cells may produce more infectious HSV-1 
virions (Figure 26). 
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Figure 29: PRKDC-/- RPE-1 cells exhibit advanced CPE during HSV-1 infection at low MOI.  
WT and PRKDC-/- RPE-1 cells were infected with HSV-1 at MOI 0.01 and photographed at the indicated times 
post infection using a Zeiss Vert.A1 microscope with an AxioCam Mrc camera. The scale bars represent 
100 μm. Data are representative of three independent experiments. 
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Figure 30: PRKDC-/- RPE-1 cells exhibit advanced CPE during HSV-1 infection at high MOI.  
WT and PRKDC-/- RPE-1 cells were infected with HSV-1 at MOI 4 and photographed at the indicated times 
post infection a Zeiss Vert.A1 microscope with an AxioCam Mrc camera. The scale bars represent 100 μm. 
Data are representative of three independent experiments.  
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5.8 Discussion 
There is a growing literature on the functions of DNA repair proteins during DNA 
virus infection (Section 1.2), and their impact on HSV-1 infection is an area of ongoing 
investigation (Section 1.2.6). DNA-PKcs was amongst the first DNA repair proteins to be 
identified as a factor regulating HSV-1 infection following the discovery that it was 
degraded by ICP0, and that human malignant glioma cells deficient in DNA-PKcs 
expression produce more infectious HSV-1 virions two days post infection (Lees-Miller et 
al., 1996; Parkinson et al., 1999). Further work showed that DNA-PKcs is involved in the 
induction of cytokine transcriptional responses during HSV-1 infection in vivo, and to 
DNA in cultured cells (Ferguson et al., 2012; Morchikh et al., 2017). The innate immune 
roles of DNA-PKcs might be sufficient to explain the detrimental impact of DNA-PKcs 
on HSV-1 infection, but this link has not been formalised, and there are alternative 
explanations. For instance, there have been roles proposed for DNA-PKcs during HSV-1 
genome replication, including the inhibitory effects of DNA-PKcs-induced 
circularisation of the HSV-1 genome (Smith et al., 2014), but these have not been tested 
experimentally. Similarly, although DNA-PKcs has previously been linked to cell death 
pathways (Section 1.1.2.3), this has not been characterised in the context of HSV-1 
infection.  
This chapter aimed to investigate these roles of DNA-PKcs during HSV-1 infection, 
and as part of this we created PRKDC-/- RPE-1 cells using CRISPR/Cas9 and used 
immunoblotting and immunofluorescence to demonstrate that DNA-PKcs is not 
expressed at detectable levels in these cells (Figure 255). We attempted to address some 
of the limitations of CRISPR/Cas9 by creating multiple clones, but unfortunately this was 
not successful. Future work should try some alternative sgRNAs, preferably targeting 
the N-terminus of PRKDC, and sequence the clones to demonstrate that the 
CRISPR/Cas9 worked as intended. 
 Although these limitations are important to address, the phenotypes we have 
observed make sense in the context of what is already known about DNA-PKcs, and we 
remain confident that they are due to the reduction in DNA-PKcs expression. We will 
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now discuss these phenotypes and some of the interesting implications arising from our 
work. 
5.8.1 DNA-PKcs degradation during HSV-1 infection 
The first reports of an interaction between DNA-PKcs and HSV-1 arose following the 
observation that the HSV-1 protein ICP0 induces the degradation of DNA-PKcs 
(Lees-Miller et al., 1996; Parkinson et al., 1999). It has previously been reported that this 
degradation is not observed in Vero cells (African green monkey kidney fibroblasts) 
(Wilkinson and Weller, 2004), although this observation was made only 7 hours post 
infection which may be too early to be conclusive. Insignificant changes in DNA-PKcs 
protein levels have also been observed in rat cortical cells, although this was at MOI 0.01 
and using HSV-1 strain F (De Chiara et al., 2016). Other proteins important in restricting 
HSV-1 are known to be degraded by ICP0, including IFI16 (Johnson et al., 2013; Orzalli 
et al., 2016). WhetherICP0 has a direct effect on cGAS is unknown, but ICP0 targets other 
components of the pathway for degradation, such as STING (Kalamvoki and Roizman, 
2014), and inhibits IRF3 and IRF7 activation (Lin et al., 2004b). 
We tested the effect of HSV-1 infection on DNA-PKcs protein levels in RPE-1, U2OS, 
and HFFF cells. A drop in DNA-PKcs protein levels was observed in RPE-1 and HFFF 
cells, although degradation appeared to be faster in the latter (Figure 24A and B). This 
reduction in DNA-PKcs protein was dependent on ICP0, and so it is likely that ICP0 is 
inducing degradation of DNA-PKcs as previously described (Lees-Miller et al., 1996; 
Parkinson et al., 1999). We observed that DNA-PKcs protein levels are stable during 
HSV-1 infection of U2OS cells (Figure 24C), which has not been reported previously. 
During HSV-infection ICP0 initially localises to promyelocytic leukaemia (PML) nuclear 
bodies and induces their degradation (Cuchet-Lourenço et al., 2012). U2OS cells have 
defects in expression of the PML nuclear body components ATRX and Daxx, and it has 
been proposed that this is why U2OS cells are permissive to ΔICP0 HSV-1 infection 
(Lukashchuk and Everett, 2010). Normally ICP0 induces the degradation of a number of 
factors whilst interacting with the PML nuclear bodies, so this may be why DNA-PKcs 
degradation is not observed in U2OS cells. It would be interesting to look at other 
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degradation targets of ICP0 and determine whether these are degraded during infection 
of U2OS cells. 
Ku80 protein levels drop during HSV-1 infection of rat cortical cells (De Chiara et al., 
2016), but levels were stable in all cell types that we tested. In fact, we found that Ku70 
and Ku80 protein levels were more stable than α-tubulin, levels of which frequently 
varied independently of other proteins. ICP0 dismantles microtubule networks during 
infection, and is also able to bind to α-tubulin, although there is no direct evidence of 
ICP0-induced degradation of α-tubulin (Liu et al., 2010). 
5.8.2 DNA-PKcs, genome replication, and infectious virus 
production 
Although functions for DNA-PKcs in the regulation of HSV-1 genome replication 
have been proposed, to our knowledge these have not yet been investigated. Our 
preliminary southern blotting data suggest that DNA-PKcs is not required for the 
formation of endless genomes, and that five hours post infection the signal of the K 
fragment is similar between WT and PRKDC-/- RPE-1 cells (Figure 27). However, later in 
infection the HSV-1 genome replicates less efficiently in PRKDC-/- cells, suggesting that 
DNA-PKcs may actually promote HSV-1 infection. Alternatively, it is possible that the 
reduced genome replication observed in PRKDC-/- cells is linked to the advanced CPE 
observed in these cells (Figure 29 and Figure 30; Section 5.8.4). 
It is interesting that less HSV-1 genome replication is observed by 12 and 24 hours 
post infection in both PRKDC-/- and PAXX-/- RPE-1 cells (Figure 8; Figure 27), however 
different mechanisms may be at play; PRKDC-/- cells do not have a defect in the 
formation of endless genomes after five hours, whereas PAXX-/- RPE-1 cells do have 
fewer endless genomes than WT cells. This suggests that PAXX and DNA-PKcs may be 
functioning differently in HSV-1 genome replication, but it is important to remember 
that the experiment with PRKDC-/- cells needs to be repeated before strong conclusions 
can be made. It would also be interesting to complement these experiments with qPCR 
to quantify viral genome copy number, as we have done with PAXX (Figure 7).  
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Preliminary growth curve experiment suggest that at early times post infection with 
HSV-1, PRKDC-/- RPE-1 cells produce significantly fewer infectious virions than WT 
RPE-1 cells (Figure 26A and B). This was observed 12 hours post infection at MOI 0.01, 
and 24 hours post infection at MOI 4 WT RPE-1 cells. At both MOIs, later in infection 
PRKDC-/- RPE-1 cells end up producing more infectious virus. This is an unusual 
dynamic, and suggests that either cells lacking DNA-PKcs are delayed in producing 
HSV-1 virions, or that there are different phases during which DNA-PKcs has different 
effects upon infectious virion production. Given the multiple roles of DNA-PKcs, it is 
easy to suggest examples for the second hypothesis, for example early in infection DNA-
PKcs could promote genome replication (as observed by southern blot and qPCR) while 
later in infection DNA-PKcs could create an antiviral state by triggering an innate 
immune response (Section 5.8.3). These hypotheses are limited by the preliminary nature 
of the experiments, and repetition of the experiments are required before any 
conclusions can be made. However, the observation that PRKDC-/- RPE-1 cells produce 
more infectious virus at later stages of HSV-1 infection is in agreement with the 
observation that PRKDC-/- human malignant glioma cells produce more infectious 
virions after two days of infection than their WT counterparts (Parkinson et al., 1999). 
It is notable that in RPE-1 cells the DNA-PKcs protein is mostly degraded by eight 
hours post infection, yet we continue to notice its effects on genome replication and 
infectious virion production long after this time. Naturally, this raises questions 
regarding the CRISPR/Cas9 clone that we have used, and this major limitation of our 
experiments needs to be addressed in future work. However, some of our observations, 
for example the advanced CPE phenotype in DNA-PKcs-deficient cells (Section 5.8.4), 
have been confirmed in MSFs, which raises our confidence in these data. There are also 
other explanations for the long-lasting effects of DNA-PKcs; most notably, that we 
continue to observe DNA-PKcs protein at a low level in RPE-1 cells throughout the first 
18 hours of HSV-1 infection (Figure 24). It is also possible that DNA-PKcs will have 
initiated multiple DDR pathways which will have long-lasting effects on the cell. Finally, 
any innate immune roles of DNA-PKcs are also likely to have long-lasting effects on 
HSV-1 genome replication and infectious virion production.  
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If our results are reproducible, it would be interesting to consider the role of other 
NHEJ factors in HSV-1 genome replication and infectious virion production. LIG4 and 
XRCC4 are so far the only NHEJ factors published to affect these processes, and are 
required for the formation of endless HSV-1 genomes, and for efficient production of 
infectious virions (Muylaert and Elias, 2007). This phenotype is different from PAXX and 
DNA-PKcs, and so it would be interesting to consider whether other factors, such as Ku 
and XLF, share one of the phenotypes, or have novel functions during HSV-1 infection.  
In light of the data which show that DNA-PKcs may in fact promote the production 
of infectious HSV-1 virions early in infection, it is perhaps unsurprising that we did not 
find that PRKDC-/- RPE-1 cells were permissive to ΔICP0 HSV-1 infection (Section 5.3). In 
fact, given the potentially beneficial role of DNA-PKcs early in infection, the loss of 
DNA-PKcs might make these cells even more hostile to ΔICP0 HSV-1 infection. It would 
therefore be interesting to test whether cells normally permissive to ΔICP0 HSV-1, for 
example U2OS cells, produce fewer infectious virions if DNA-PKcs expression or 
activity is abrogated. 
5.8.3 DNA-PKcs and the innate immune response to DNA 
DNA-PKcs is a cytoplasmic sensor of DNA (Ferguson et al., 2012; Morchikh et al., 
2017), and we hoped to further investigate this function of DNA. Our experiments 
testing the innate immune responses of RPE-1 cells in Chapter 3 showed that RPE-1 cells 
are not easily stimulated by DNA or ΔICP0 HSV-1 infection (Figure 12). We therefore 
optimised a system to isolate and culture MSFs from WT and Prkdc-/- mice ex vivo. 
Although transcription of Cxcl10 and interferons was generally slightly higher in WT 
MSFs than Prkdc-/- MSFs, these differences were not significantly different (Figure 28).  
DNA-sensing is likely to be critical for IFN-I production, and viruses have evolved 
multiple mechanisms to inhibit the DNA-sensing pathway. There are numerous putative 
innate immune sensors of cytoplasmic DNA, and it has not been determined why so 
many should exist. However, there are a number of theories as to why this might be 
(Unterholzner, 2013), including that innate immune sensing pathways are cell-type 
specific, and that some receptors may have a degree of redundancy. ICP0 targets DNA-
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PKcs for degradation and it may also target IFI16, but it has not been shown to inhibit 
cGAS (Cuchet-Lourenco et al., 2013; Lees-Miller et al., 1996; Orzalli et al., 2012). As such, 
prevention of ICP0 expression might not be sufficient to prevent inhibition of DNA-
sensing pathways, and thereby observe their effects on IFN and cytokine production. 
Furthermore, HSV-1 infection in the absence of ICP0 expression can destabilise STING, 
which would dampen innate immune responses in all cell types (Kalamvoki and 
Roizman, 2014). Any of these hypotheses could be used to explain why DNA-PKcs does 
not appear to be important in stimulating an innate immune transcriptional response in 
these MSFs.  
5.8.4 DNA-PKcs, CPE, and cell death 
The advanced CPE observed in DNA-PKcs-deficient cells during HSV-1 infection 
(Figure 29 and Figure 30) is interesting, and we have observed the phenotype enough 
times to be confident that it is reproducible. However, it is important that the 
implications of this are not overstated, and, ultimately, more experiments are required to 
understand the cause and mechanism of this phenotype. However, for the purpose of 
this thesis, it remains interesting to consider potential explanations of our observations. 
DNA-PKcs has functions in cell death, and these generally appear to be 
pro-apoptotic (Hill and Lee, 2010; Wang et al., 2000, 2016). DNA-PKcs phosphorylates 
γH2AX and induces apoptosis following DNA damage and TNF-related 
apoptosis-inducing ligand (TRAIL) treatment (Hill and Lee, 2010; Solier and Pommier, 
2009; Solier et al., 2009). DNA-PKcs also induces apoptosis in lymphocytes via p53 
activation (Callén et al., 2009), including during integration of the HIV-1 genome into the 
host genome (Cooper et al., 2013).  
It is therefore interesting that DNA-PKcs-deficient cells show CPE more quickly than 
WT cells, because it might be expected that DNA-PKcs would promote cell death. At this 
point it is important to clarify that we are indeed observing CPE and not cell death, two 
very different things. However, it is tempting to hypothesise that although DNA-PKcs is 
required for driving apoptosis, in its absence other forms of cell death or stress occur. 
These alternative pathways may even create an environment more conducive for HSV-1 
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genome replication late in infection, a potential explanation for the higher titres of virus 
observed late in infection in PRKDC-/- RPE-1 cells than in WT cells (Figure 26). Although 
HSV-1 activates necroptosis in mouse cells, it inhibits the necroptotic pathway in human 
cells, making this pathway unlikely to be the cause of the CPE (Guo et al., 2015; Wang et 
al., 2014; Yu and He, 2016), The role of pyroptosis during HSV-1 infection has not been 
studied in depth, and so this could be a potential candidate. 
It would be of great interest to the field to test these hypotheses. It would be 
interesting to investigate whether PARP-1 cleavage observed during HSV-1 infection of 
RPE-1 cells (Figure 24A) is still observed in PRKDC-/- cells. There are also multiple assays 
available to test which cell death pathways are activated in infected cells (Kepp et al., 
2011). Following the identification of relevant cell death pathways, specific cell death 
inhibitors could be used during HSV-1 infection to test whether the CPE phenotype 
could be rescued, and to investigate the impact of these inhibitors on infectious HSV-1 
production.  
An alternative explanation to cell death is that the increased production of HSV-1 in 
DNA-PKcs-deficient cells is sufficient to cause CPE through the stresses placed on 
cellular metabolism. However, the difference in CPE is disproportionate to the increase 
of infectious virus production in PRKDC-/- cells, and five hours post infection is very early 
to be observing stress-induced CPE in Prkdc-/- MSFs. Therefore, although further 
experiments would be required to confirm this, we think it is unlikely that metabolic 
stress is the cause of HSV-1-induced CPE in the absence of DNA-PKcs.  
5.8.5 Summary 
The data presented in this chapter has given some insight into the functions of 
DNA-PKcs during HSV-1 infection, but there is much yet to be understood about its 
role. Our data suggest that DNA-PKcs is beneficial to the early production of infectious 
virions, but restricts infectious virion production late in infection. Preliminary data 
suggest that HSV-1 genome replication is supported by DNA-PKcs. In the absence of 
DNA-PKcs, both RPE-1 cells and MSFs displayed advanced levels of CPE, which might 
be indicative of interesting roles of DNA-PKcs in regulating cell death pathways. 
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Together, these data support the argument that DNA-PKcs has multiple functions 
during HSV-1 infection, and that further study of these will give insight into a number of 
pathways important in viral infection. 
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Concluding remarks 
In this study we have investigated how HSV-1 infection is affected by PAXX and 
DNA-PKcs, two NHEJ factors about which little is known in this context. We observed 
that cells deficient in either of PAXX or DNA-PKcs support reduced viral genome 
replication but increased production of infectious virus late during infection relative to 
WT cells, indicating that they restrict HSV-1 infection.  
PAXX has not previously been studied in the context of viral infection. We 
demonstrated that viral gene expression and protein production was unaffected by 
PAXX deficiency, and that EM shows normal packaging and wrapping of virions in 
PAXX-/- cells. We also showed that PAXX is not required to control HSV-1 infection in 
mice, or for the production or activation of lymphocytes. Interestingly, however, PAXX 
may have functions in the innate immune response to DNA. Future work should seek to 
address whether PAXX influences the particle:PFU ratio of HSV-1, as this one possible 
explanation of our data. 
DNA-PKcs has previously been studied during viral infection, although this is 
limited within the context of HSV-1 infection. We confirmed previous reports that 
DNA-PKcs is degraded in infection, but observed that this is not the case in U2OS cells. 
We hypothesised that this may be linked to U2OS cells being permissive to ΔICP0 
HSV-1, but the PRKDC-/- RPE-1 cells we generated with CRISPR/Cas9 do not support 
ΔICP0 HSV-1 infection. We also showed that Prkdc-/- MSFs were able to initiate innate 
immune gene expression following HSV-1 infection or nucleic acid stimulation, 
suggesting that DNA-PKcs is not important for detecting cytoplasmic DNA in these 
cells. Finally, Prkdc-/- MSFs and PRKDC-/- RPE-1 cells exhibit CPE faster than their WT 
counterparts, an observation which may have implications for our understanding of the 
drivers of cell death, and which demonstrates that HSV-1 is a useful model for studying 
cellular fate during infection.  
This study has shown that both PAXX and DNA-PKcs restrict HSV-1 infection, and 
provides the basis for further exploration of the mechanisms involved. In conjunction 
with those previously described, multiple NHEJ factors have now been shown to be 
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beneficial or detrimental to HSV-1 infection, and future work should consider how these 
different NHEJ factors interact during HSV-1 infection. Rather than a linear pathway, it 
is likely that complexes form and direct multiple pathways, much like in the DDR 
response to DSBs. Indeed, this is not limited to NHEJ - HSV-1 directs different DDR 
factors from multiple repair pathways to promote infection, and instead of considering 
DDR pathways in isolation, progress is likely to come from studying the combined 
effects of such factors.  
As such, our study not only contributes to the understanding of the effects of NHEJ 
on HSV-1, but rather should be seen in the context the entire DDR response. 
Understanding the interactions between viruses and the DDR will enable new 
approaches to control viral infection, but is also increasingly recognised as important in 
a myriad of other areas including cancer, neurological diseases, and autoimmune 
diseases. 
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